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ABSTRACT
The role of the pentose phosphate pathway as a 
source of NADPH required for cytoplasmic processes such 
as lipogenesis and detoxification reactions has been 
examined. G6PDH and 6PGDH are known to be strongly 
inhibited by the high NADPH/NADP^ ratio which is thought 
to occur in the cytoplasm but no effector at physio­
logical concentrations has yet been found which can over­
come this inhibition.
Initially a possible role for F2 ,6P2 as an activator 
of G6PDH, 6PGDH and FAS was investigated but no signifi­
cant effect of this regulatory metabolite on any of these 
enzymes was discovered. An attempt was also made to 
demonstrate the reported reversal of the inhibition by 
GSSG and the cofactor reported by Eggleston and Krebs
(1974). This too could not be demonstrated.
In the course of the work, a cytosolic NADPH- 
consuming reaction has been characterized. This has 
been shown to involve the reaction of a peptide- 
substrate with a cytoplasmic reductase specific for 
NADPH and a high affinity for the peptide. The 
physiological role of this reaction remains to be 
established, but it has been observed that the reaction 
exhibits a diurnal variation, the pattern of which is 
the reverse of that observed with lipogenesis.
The low molecular weight peptide, which appears 
to be distinct from glutathione, contains cystine 
residues which are apparently reduced in the presence 
of NADPH, resulting in the appearance of free thiol 
groups. The peptide may be phosphorylated but the 
nature of the linkage between the peptide and 
phosphate has not been established.
A possible role for this and other NADPH-dependent 
reactions in the regulation of the pentose phosphate 
pathway is discussed in this thesis.
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I . INTRODUCTION
23
The regulation of the pentose phosphate pathway 
(PPP) has been the focus of a considerable amount of 
research. In particular, research workers have 
attempted to determine the regulatory mechanisms 
enabling glucose-6-phosphate dehydrogenase (G6PDH) and
6-phosphogluconate dehydrogenase (6PGDH), the rate 
limiting enzymes of the oxidative branch of the PPP, to 
function in the presence of the inhibitory NADPH / 
NADP^ ratios found in the cell.
Two regulatory mechanisms for de-inhibition have 
been proposed: one is the possible existence of a de­
inhibitor functioning in conjunction with oxidised 
glutathione (Eggleston and Krebs, 1974, Rodriguez- 
Segade, et al., 197#, 1979, 1980), and the other is the 
"PULL" hypothesis (Tepperman and Tepperman, I963; 
Bonsignore and DeFlora, 1972; Taketa et al., 1970), 
which states that the primary event in the 
de-inhibition of the PPP dehydrogenases is the 
oxidation of NADPH (the inhibitor) by NADPH requiring 
processes, with consequent production of NADP^ (the 
activator). This thesis is primarily concerned with 
the short-term regulation of G6PDH and 6PGDH.
A. THE PENTOSE PHOSPHATE PATHWAY
1• Distribution and function
The PPP is widely distributed in nature and has 
been shown to exist in mammals, plants, micro-organisms 
and yeast (Negelein and Gerischer, 1936, Noltmann and 
Kuby, 1963; Muller, I96O; Pon, 1964; Levy, 1979).
This metabolic route represents an alternative mode of 
glucose oxidation coupled with the production of NADPH 
(Glock and McLean, 1953î Bonsignore and DeFlora,
1972).
24
The NADPH generated by the oxidative branch of the 
PPP is used for reductive biosyntheses, notably 
lipogenesis (Abraham and Chaikoff, 1959; Tepperman and 
Tepperman, I96I; 1963; Kather et al., 1972a; Kelley and 
Kletzien, 19&4) in hepatic and adipose tissue and for the 
reduction of glutathione (Bonsignore and DeFlora, 1972; 
Puente et al., I981). The PPP also provides pentose for 
LL ^nucleotide synthesis and triose phosphates which can
enter the glycolytic pathway and can therefore be used 
for energy production (Gumaa and McLean, 1969; Yoshimoto 
et al., 1983). It has been postulated, however, that 
the limiting function of the PPP is the supply of reducing 
equivalents for reductive biosynthesis (Bonsignore and 
DeFlora, 1972; Raivio et al., I981). Fig. 1.1 summarises 
the functions of the PPP.
G6PDH deficiency has been associated with increased 
susceptibility to haemolytic anaemia and the aging of 
the erythrocyte cell (Marks, 1964; Fornaini, 1967; 
Bonsignore and DeFlora, 1972; Zilva and Pannall, 1979; 
Stryer, I98I). In the latter case the cause of the 
pathological condition is thought to be the reduced 
NADPH availability in G6PDH deficiency, which is required 
to reduce oxidised glutathione. The reduced glutathione 
is thought to be essential for the maintainance of normal 
erythrocyte structure.
In some cases the G6PDH deficiency may be 
advantageous. For instance a lack of G6PDH appears to 
protect against falcip^um malaria, presumably because the 
parasites require reduced glutathione for optimal growth 
(Luzzato, et al. 1969; Motulsky, 196&; WHO Tech.' Ser. 366,
1967).
Increased G6PDH activity has been associated with 
hepatocarcinogenesis (Bannasch et al., 1984). These 
authors reported that the advance of carcinogenesis
25
Fi(T. 1 .1 : The oxidative branch of the pentose
phosphate pathway.
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was characterised by a progressive shift away from 
glycogen metabolism towards glycolysis and the PPP,
These considerations highlight the physiological 
significance of the PPP and justify : investigations in 
the mechanisms involved in the regulation of this 
pathway.
2, Regulation of the oxidative branch of the PPP
A number of metabolic processes utilize NADPH and one 
could postulate that the oxidation of glucose 6-phosphate 
(G6P) and its control is important for the modulation of 
the NADPH-consuming processes and vice versa. The initial 
substrate for the PPP, G6P, can also be utilized by other 
pathways, notably glycolysis and glycogen synthesis.
Thus it would be expected that the regulatory enzymes of 
the PPP could be closely regulated in response to 
external influences.
The demand of the cells for NADPH is also 
continually changing and the pathway must be regulated in 
such a way that it adjusts quickly and efficiently to 
changing needs. This regulation is thought to occur at 
the level of G6PDH and 6PGDH, both in the long and short­
term (Glock and McLean, 1955; Rudack et al., 1971a,
1971b, 1971c; Sapag-Hagar et al., 1973; Eggleston and 
Krebs, 1974; Levy and Christoff, 1903; Kelley and 
Kletzien, 1984; Stumpo and Kletzien, 1984, 1905).
a. Long term regulation
Several workers (Tepperman and Tepperman, 1950;
1964; Fitch et al., 1959; Fitch and Chaikoff, I96O;
Muto and Gibson, 1970; Dao et al., 1902; Kelly and 
Kletzien, 1904) have demonstrated quantitative changes in 
the PPP dehydrogenases in response to hormonal and 
nutritional stimuli. In particular it has been shown
27
that starvation, alloxan-induced diabetes and fat-rich 
diets cause a marked reduction of both dehydrogenases in 
rat liver (Glock and McLean, 1955c; Yugari and Matsuda, 
1967) and that carbohydrate refeeding of the animals leads 
to a characteristic increase in G6PDH and 6PGDH activity 
(Glock and McLean, 1955a, 1955c; Tepperman and Tepperman, 
1958, 1963; Fitch et al., 1959, I960; Niemeyer et al., 
1962; Johnson and Sassoon, 1967; Novello et al., I969). 
G6PDH is induced to a greater extent than 6PGDH under 
these conditions (Cohen et al., 1972). Fructose feeding 
results in greater degrees of induction compared to 
glucose feeding.
This increase in enzyme activity resulting from 
carbohydrate refeeding of previously starved rats has 
also been demonstrated for other lipogenic enzymes 
(Burton et al., I969; Cohen et al., 1972; Craig et al., 
1972). Cohen et al., (1972) also observed that sucrose
induced NADPH generating enzymes to a greater extent 
than isocaloric amounts of starch. These authors 
claimed that in livers of rats fed a normal balanced 
diet G6PDH is the rate-limiting enzyme, whereas 
prolonged sucrose-feeding results in 6PGDH being the 
rate-limiting enzyme. However, it was G6PDH rather 
than 6PGDH, which was shown by these authors, to be most 
susceptible to nutritional stimuli.
The profound effect of sucrose feeding on lipogenic 
enzymes is consistent with the elevated serum lipid levels 
and increased hepatic content and synthesis of lipids 
which have been observed in sucrose feeding experiments 
(Portman et al., 1956; McDonald and Roberts, 1965;
Allen and Leahy, I966; Cohen and Teitelbaum,I966).
Rudack et al. (1971a, 1971b) and Procsal et al.
(1976) have demonstrated that both G6PDH and 6PGDH 
synthesis is increased by feeding carbohydrate rich 
diets. Furthermore, Rudack et al. (1971b) showed that
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both the rate of synthesis and the rate of degradation 
increases upon high carbohydrate refeeding of fasted rats.
Johnson and Sassoon (I967) attempted to elucidate the 
dietary component responsible for triggering this increase 
in the PPP dehydrogenases. They failed in their objective 
but indicated that the site at which the induction of G6PDH 
is regulated is at the transcriptional level. It has been 
further suggested that there are two forms of molecular 
control in rat liver involved in the response of lipogenic 
enzymes to nutritional stimuli. These are changes in the 
concentration of the mRNA species (Nakanishi et al., 1976; 
Flick et al., 1975; Flick et al., 1977; Hutchison and ' 
Holten, 1978; Miksicek and Towle, 1982; Yoshimoto et al., 
1983) and possibly changes in the translational efficiency 
of the mRNA species (Sun and Holten, 1978; Towle et al., 
I98O; Schwartz and Abraham, I983).
Stumpo and Kletzien (1984) have measured the levels 
of functional mRNA encoding G6PDH in hepatocytes from 
fasted and fasted/carbohydrate-refed rats. Using a cell- 
free protein synthesis system in vitro,they found that 
hepatocytes from fasted/carbohydrate-refed rats contain 
twelve times as much of the mRNA as those from starved 
rats. The elevation in mRNA content found by these 
authors and Miksicek and Towle (1982) is sufficient to 
account for the increase in the activity of G6PDH observed 
in the induced hyperlipogenic state. In the light of 
these experiments Stumpo and Klietzen (1984-) have 
concluded that there is no need to postulate possible 
translational control in the manner proposed by Sun and 
Holten (1978).
Hormones have been shown to be involved in the 
induction of the lipogenic enzymes due to fasting followed 
by refeeding carbohydrate-rich diets. Garcia and Holten
(1975) demonstrated that cAMP (or glucagon) decreases the 
rate of enzyme synthesis in vivo in the case of G6PDH and 
has no effect on 6PGDH synthesis or degradation. Insulin
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injection (Rudack et al., 1971b; Nepokroeff et al., 1974) 
has been shown to increase G6PDH activity. Rudack et al.,
(1971b) attributed this effect of insulin to the ability of 
this hormone to stimulate the appetite. However, recent 
work by Stumpo and Kletzien (1984, I985) suggests that . 
the insulin-effected increase in G6PDH is due to increases 
in the level of G6PDH mRNA. Furthermore, these authors 
have provided evidence which suggests that glucocorticoids 
amplify the insulin effect on G6PDH. The effects of 
insulin and glucocorticoids on the level of mRNA encoding 
G6PDH in cultunEd hepatocytes are additive, but the 
glucocorticoid-induced mRNA appears not to be translatable 
in the absence of insulin (Stumpo and Kletzien, I984).
These findings are in disagreement with those reported by 
Nakamura et al. (I982) who observed that in their
hepatocyte culture system glucocorticoids do not affect the 
basal or insulin stimulated G6PDH. The discrepancy in 
results can probably be attributed to the different conditions 
of incubation employed by the two groups. The latter group 
included serum and glucocorticoids in their culture media 
whereas the former did not.
Kelley and Kletzien (I9 8 4 ) have reported that 
glucocorticoids by themselves do not increase G6PDH activity 
but amplify the effects of insulin. In the course of their 
studies, these authors also found that ethanol strongly 
potentiated the increase in G6PDH activity caused by 
glucocorticoids and insulin. This observation could 
account for the occurrence of alcohol-induced fatty liver, 
since the effect of ethanol would result in a greater 
availability of NADPH for lipogenesis in addition to 
providing a carbon source for acetyl-CoA synthesis.
Insulin appears to exert a regulatory effect at the 
pre-translational level (Yoshimoto et al., 1983; Stumpo 
and Kletzien, 1984)" The findings of Stumpo and Kletzien 
(1984 ) suggest that glucocorticoids may regulate G6PDH
activity and synthesis at the pre-translational level, while 
insulin may also exert control over translation, in such a
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way that the glucocorticoid-induced mRNA is efficiently 
translated.
It is important to note that Stumpo and Kletzien 
(1984 ) could not account for all the mRNA encoding for
G6PDH found in starved/carbohydrate refed rats. Gluco­
corticoid and insulin together only raised the translatable 
G6PDH mRNA to less than 50% of the level observed in 
hepatocytes from carbohydrate-refed rats. It is possible, 
therefore, that other hormones and regulatory effectors are 
involved in the regulation of enzyme synthesis.
Miksicek and Towle (1982) have shown that triiodothyronine 
(T^) administration to rats maintained on a diet of laboratory 
chow increases G6PDH activity, relative synthetic rate and 
functional mRNA activity. Spence and Pitot (I982) have 
reported similar results with cultured hepatocytes. These 
authors have also reported that glucose can only induce 
lipogenic enzymes in the presence of insulin, whereas insulin 
is not necessary for the induction of lipogenic enzymes by 
fructose or glycerol. Recently, Grigor and Gain (1983) 
have demonstrated that a parallel increase in serum insulin 
and prolactin levels accompanies the induction of lipogenic 
enzymes caused by starvation followed by refeeding a high 
carbohydrate diet.
6PGDH is also under genetic regulation, and a good 
correlation between the rate of appearance of 6PGDH mRNA 
and the increase in the rate of 6PGDH synthesis has been 
demonstrated to occur in primary cultures of hepatocytes, 
(Hutchison et al., 1984). However, it has been suggested 
that 6PGDH regulation may differ from that of G6PDH since 
its rate of synthesis is not affected by either glucagon 
or dibutyrylcyclic AMP under conditions where these 
compounds reduce the rate of synthesis of G6PDH (Procsal 
et al., 1976). The mRNA levels coding for 6PGDH are 
unaffected by glucagon or dibutyrylcyclic AMP (Hutchison 
and Holten, 1978).
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A 4-fold increase in 6PGDH mRNA in the induced animals 
(48h starved/carbohydrate refed), when compared to control 
animals, has been reported by Hutchison et al. (1984).
This observation is in agreement with those obtained by 
Hutchison and Holten (1978) and Miksicek and Towle (1982). 
Insulin was shown to stimulate large increase in the 
synthesis of 6PGDH and of translatable mRNA for the enzyme 
in cultured hepatocytes (Hutchison et al., I984). However, 
it is not known yet if insulin regulates mRNA levels 
directly or indirectly.
Mariash et al. (1981) and Miksicek and Towle (I982)
have demonstrated a synergism between T^ and high-carbo- 
hydrate diet for the in vivo induction of 6PGDH in rats.
A small stimulatory effect, in the presence of insulin, on 
6PGDH induction by T^ has been demonstrated by Hutchison 
et al. (1984), using cultured hepatocytes.
Acetate was also found to increase 6PGDH in the presence 
of insulin (Hutchison et al., 1984). These authors have 
also confirmed that cAMP does not alter the extent or 
kinetics of the induction of 6PGDH in cultured hepatocytes 
indicating that insulin does not exert its effects via 
changes in the second messenger.
In addition to carbohydrate, the lipid content of diets 
also affects the activity of lipogenic enzymes, which 
include G6PDH and 6PGDH. For instance Muto and Gibson 
(1970) have reported the selective lowering of the activities 
of lipogenic enzymes by administration of exogenous poly­
unsaturated fatty acids to rats adapted to the hyperlipogenic 
state. The same authors have also reported a severe 
deficiency in linoleic and arachidonic acid in rat liver 
which coincides with the adaptive rise in lipogenic enzymes 
when rats are maintained on a high-carbohydrate, low-fat 
diet.
Tepperman and Tepperman (1958, I963) demonstrated a
marked enhancement of lipid synthesis which parallels the
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diet-induced increases of G6PDH activity. Taketa et al. 
(1970) showed that it was not necessary to induce G6PDH in 
order to increase NADPH output under conditions of adaptive 
hyperlipogenesis. In other words, the apparent induction
of G6PDH by high carbohydrate diets appears to be secondary 
to enhanced lipogenesis - an observation favouring the 
"PULL' hypothesis which states that the primary event in 
the observed increased capacity of the PPP dehydrogenases 
is the removal of NADPH by processes such as lipogenesis. 
This statement could apply to any system involving NADPH 
oxidation and regeneration and could have consequences for 
the short term regulation.
An overview of the documentation on the long term 
regulation of the PPP dehydrogenases and other lipogenic 
enzymes shows that the mechanisms involved are varied and 
complex. Furthermore the understanding of the regulation 
of the PPP at the genetic level is still in its early 
stages and investigation is likely to continue in this 
field.
b. Short-term regulation
The mechanism for the short-term regulation of the 
PPP dehydrogenases remains largely unresolved. In 
particular, it is not known how the potent NADPH inhibition 
of the two PPP dehydrogenases is overcome in the cell. In 
vitro experiments with liver extracts in which attempts 
were made to duplicate physiological conditions have 
revealed that G6PDH and 6pGDH are extensively inhibited by 
NADPH (Sapag-Hagar et al., 1973; Eggleston and Krebs,
1974; Thompson et al., 1976: Holten et al., 1976). It
has been argued (Thompson et al., 1976; Holten et al.,
1976) that the residual activity of these dehydrogenases 
is sufficient for the NADPH requirements of the cell. 
However this conclusion has been based on the unlikely 
assumption that there are no other physiological inhibitors 
of these enzymes in vivo, apart from NADPH.
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Eggleston and Krebs (1974) demonstrated that the 
NADPH inhibition of the dehydrogenases depends on the 
NADPH / NADP^ ratio, and that the inhibition of the 
dehydrogenases approaches 100% when this ratio is near 9: 1 « 
The in vivo ratio of the free nicotinamide dinucleotide 
phosphates is thought to be 99:1 (Veech et al., I969;
Lagunas et al., 1970; Greenbaum et al, 1971). F or this
reason Eggleston and Krebs (1974) emphasized the need for 
a de-inhibition mechanism to counteract the NADPH inhibition
In the course of their search for this mechanism of 
de-inhibition, Eggleston and Krebs (1974) reported that 
oxidised glutathione de-inhibits G6PDH, in dialysed liver 
extracts. A cofactor was also involved in this process, 
and glutathione could not de-inhibit G6PDH in its absence. 
Rodriguez-Segade et al., (1978, 1979 and I98O) reported the 
isolation, purification and characteristics of this co­
factor. It was, apparently, a peptide with a molecular 
weight of about 10,000 in rat liver (Rodriguez-Segade et 
al., 1979). Other workers have failed to confirm these 
observations (Gonzalez and Lagunas, 1977; Levy and 
Christoff, 1983). The latter group has presented evidence 
which suggests that the observations made by Eggleston and 
Krebs (1974) were artifacts of the methods used in the 
investigation. Another key difficulty is in the under­
standing of how GSSG could exert its effects on G6PDH in 
vivo where its concentration has been shown to be very 
low in the normal fed state (7*1 nM according to Veech et 
al. (1969)). Eggleston and Krebs (1974) reported that 
reduced glutathione (GSH),which is the abundant form of 
glutathione in the cell, could not replace GSSG in this 
mechanism. In these experiments 5O/1M-GSSG was required 
to overcome the NADPH inhibition by about 50%; 200^M 
totally de-inhibited the enzyme.
In the course of the present study no evidence for 
the participation of glutathione in the regulation of the 
PPP dehydrogenases was found. However, in view of the 
many reports of the involvement of thiol/disulphide ratios
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in the regulation of general metabolism, and of G6PDH 
activity in particular (Hilf et al., 1975b 1975a, 1978; 
Isaacs and Binkley, 1977; Francis and Ballard, 1980a,b; 
Puente et al., I981), the possible involvement of
glutathione cannot be lightly dismissed.
Significantly, Eggleston and Krebs (1974) confirmed that 
the•inhibition of G6PDH by. NADPH is competitively reversed by
NADP^, and observed that the potent inhibition of rat liver
G6PDH occurs despite the fact that the K^ for NADPH is 
greater than the K^ for NADP*. Sapag-Hagar et al. (1973) 
reported K^ . values for NADP* of 6PGDH and G6PDH to be 9|iM 
and 6^^, respectively. The K^ values for NADPH were found 
to be 13^M for 6PGDH and 30p-^  for G6PDH by the same authors. 
These values were obtained with rat liver from animals 
which had been starved for two days and refed a high 
glucose diet for three days. These authors have also 
reported K^ and K_ values of 7P^ and 5^^ for NADP* and 
NADPH, respectively, for rat liver 6PGDH obtained from 48h 
starved rats. The values for G6PDH are not given under 
these conditions. These figures would suggest that NADPH 
is a more effective inhibitor of 6PGDH in vivo. However, 
there is little evidence to suggest that this is so.
In the normal fed state the K ' values of 6PGDH for 6PGm
and NADP were found to be 71 and 13f»M by Procsal and Holten 
(1972). The K^ for NADPH under these conditions was 20P^. 
The values for G6PDH, provided by Thompson et al. (1976)
are 2, 29 and 13pM for NADP*, G6P and NADPH,respectively. 
These figures (except for those obtained for 6PGDH from 
starved rats) would suggest that both enzymes have a higher 
affinity for NADP* than for NADPH but presumably the high 
in vivo free NADPH / NADP* ratio more than offsets the
effects of the affinity of the enzyme for the two
nicotinamide dinucleotide phosphates.
A comparison of the K^ value for G6P and the cellular 
concentrations of the substance under the three nutrition­
al states (table 1.1b) implies that G6P concentration
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Table 1.1a: The effect of the nutritional status 
on the NADPH : NADP* ratio.
Nutritional
state
NADPH / NADP* 
ratio
Fed (control) 110
Fasted 175
Fasted/fat re-fed 203
Fasted/carbohydrate
re-fed
4 5
Diabetic 1B6
The table shows the data obtained by Greenbaum 
et al., (1971) in their experiments with 
rat liver.
Table 1.1b: The cellular concentrations of G6P and
6PG under different nutritional conditions
Nutritional
state
6PG
(KM)
G6P
(k m )
Fed (control) 14-2 217.0
Fasted 13.7 85.7
Fasted/carbohydrate 55.7 120.0
re-fed
The data recorded was obtained from 
Greenbaum et al., (1971).
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would not limit the activity of G6PDH, which catalyses
the first committed step of the oxidative branch of the
PPP. However, Thompson et al. (19?6) have shown that
the kinetic mechanism of the G6PDH catalysed reaction is 
such that the binding of the substrates to the enzyme occurs 
in an ordered, sequential manner, with NADP* binding first. 
This means that the reaction can be limited by the avail­
ability of NADP*. The absolute concentration of free 
NADP* is thought to be very low (in the order of ,
since the total NADPH (free and bound) is about 0.38nM
(Williamson et al.. 1971) and since the NADPH / NADP* 
ratio is about 100. This calculation assumes that most 
of the NADPH is present in the free form. A consideration 
of the values for NADP* for both G6PDH and 6PGDH in the 
fed state (2 and 13pM, respectively) and the expected 
cellular concentration of NADP* in rat liver (4fiM or less) 
would suggest that it is NADP* rather than G6P availability 
that regulates these two dehydrogenases. It is conceivable 
that in the cell the requirement for NADP* can be met by 
reactions involved in the re-oxidation of NADPH. The 
NADP* so provided would act both as substrate and de­
inhibitor of the NADPH-inhibited PPP dehydrogenases.
These reactions would also remove the inhibitor (NADPH), 
which would further increase the capacity of the PPP 
dehydrogenases.
Another factor which is thought to have general 
significance in the regulation of the PPP dehydrogenases 
is the ATP concentration. ATP has been shoivn to inhibit 
the PPP dehydrogenases (Kauffman et al., 1979; Avigad, 
1966). The K^ for G6PDH and 6PGDH have been reported to 
be 1.85 and 0.1ImM^respectively (Kauffman et a1. , 1979)
Van Schaftingen et al. (l980a) reported that the ATP
concentration of isolated hepatocytes is 3-42 - 0 .02m^. 
These values enable one to postulate a physiological role 
for ATP. However, addition of equimolar amounts of Mg^* 
with ATP lowers the inhibition of G6PDH by 30% (Kauffman 
et al., 1979) and since ATP exists to a considerable extent 
chelated with Mg^* i n vivo (Alberty, I968; Rose, I968;
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Veloso et al., 1973)'ATP inhibition of G6P0H may not be 
significant in vivo. 6PGDH appears to be inhibited 
regardless of the presence or absence of Mg^*. The low 
value for this enzyme suggests that it may be inhibited 
by ATP in vivo.
The ATP inhibition is competitive with the cofactor 
NADP* (Avigad, I966; Kauffman et al., 1979). Since ATP 
shares structural similarities with NADP*, it is likely 
that ATP binds to the cofactor site.
Rat liver G6PDH has also been shown to be inhibited
by long chain acyl-CoAs (Eger-Neufeldt et al., I965;
Taketa and Pogell, I966). The K f o r  stearyl-CoA has
been reported to be 0.4kM* The K_^ values for palmityl-
CoA and lauryl-CoA were found to be 0.6 and 8.7KM
respectively. These figures suggest that the extent of
inhibition by long chain acyl-CoAs diminishes with the
shortening of the chain-length of the fatty acid moiety.
Eger-Neufeldt and co-workers showed that the affinity of
G6PDH for G6P is reduced by stearyl-CoA such that the K
increases from 23KÜ to 172KM. The maximal velocity is
not affected by stearyl-CoA, indicating that the stearyl-
CoA-induced inhibition of G6PDH is competitive with
respect to G6P. At a fixed concentration of G6P,stearyl-
CoA causes a shift in the K^ for NADP* from 17KM in the
absence of the inhibitor to 54kM in its presence. In
this case the V is also reduced by 54%. The long max ^
chain acyl-CoAs could act as negative feedback inhibitors 
in vivo. For instance, the decrease in G6PDH activity 
during starvation, fat feeding or acutely decompensated, 
diabetes may be in part due to the inhibition described 
here, since tissue long chain acyl-CoAs have been shown 
to increase markedly under these conditions (Bortz and 
Lynen, 1963; Garland and Tubbs, I963; Wieland, 1964)*
Mita and Yasumasu (1979) have reported that the
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inhibition by palmityl-CoA of purified yeast G6PDH can be 
reversed by polyamines. The polyamines, putreseine, 
spermidine and spermine, are thought to be essential for 
the growth and proliferation of the mammalian cell (Heby 
et al., 1984). A reduction in the polyamine content of 
the cell has been associated with a reduced growth rate. 
The polyamine depletion apparently reduces the rate of 
DNA synthesis by affecting the nucleotide pools. The 
reversal of the palmityl-CoA induced inhibition of G6PDH 
by polyamines suggests that the latter would cause an 
elevation of G6PDH activity in the presence of high 
intracellular concentrations of long chain fatty acyl- 
CoA thioesters. This relationship between polyamines 
and G6PDH would appear to highlight the connection 
between the PPP,protein metabolism and nucleotide 
metabolism (see fig. 1 .2 ), since polyamines have been 
found to exert a stimulating effect on the activities of 
DNA and RNA polymerases (J&nne et al., 1975). Since the 
PPP provides pentose for nucleotide synthesis and possibly 
NADPH for the reduction of thioredoxin, which in turn is 
used as a reductant in the ribonucleotide reductase re­
action, the elevation of G6PDH activity by the polyamines 
would lead to an increase in intracellular levels of DNA 
and RNA and would be consistent with the proposed role of 
polyamines in cell growth.
The physiological significance of the inhibition of 
the PPP enzymes by long chain acyl-CoAs has been 
questioned because of the apparently indiscriminate 
inhibition of various unrelated enzymes by these compounds 
as a result of their detergent properties. However, an 
allosteric model for the inhibition of glucokinase by 
these compounds has been proposed by Tippett and Neet 
(1982a,b)• Their results suggest that the physiological 
role of fatty acyl-CoAs has to be further investigated 
before any conclusions can be reached.
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Fig. 1.2: The relationship between the PPP, RNA
and DNA synthesis and polyamines.
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Long chain fatty acids have also been shown to 
inhibit rat liver G6PDH (Yugari and Matsuda, I967).
These authors showed that the fatty acids disaggregate 
the active enzyme into inactive sub-units and that NADP^ 
(and to a lesser extent, G6P) protects the enzyme against 
this inactivation. ATP was shown to facilitate the 
inhibition by fatty acids. However, this effect was 
reversed by ADP and AMP. The same observation was made 
for other nucleotide triphosphates and their corresponding 
di - and monophosphates.
Myristic (C^^) and lauric (C^^) acids were the most 
effective inhibitors, among saturated fatty acids of 
G6PDH. Overall, the unsaturated fatty acids (linoleic 
and oleic acids) were shown to have a much higher 
inhibitory activity than laurate or stearate. On the 
basis of their results, Yugari and Matsuda (1967) 
concluded that fatty acid synthesis was controlled in two 
ways by free fatty acids: one by inhibiting acetyl-CoA
carboxylase and the other by restricting the supply of 
NADPH through the inhibition of G6PDH.
The short term regulation of the PPP dehydrogenases 
is still an area of intense research; it has, however, 
become apparent from a consideration of the available 
evidence that the two enzymes are primarily regulated 
by the NADPH / NADP* ratio. Furthermore, it is 
possible that the reoxidation of NADPH, a known 
inhibitor of the two enzymes, with the consequent 
production of NADP* (an activator of the dehydrogenases) 
may, at least in part, enable the normal functioning of 
the PPP (May, I98I; Elsayed et al., 1982; Kather et al., 
1972a,b; ' Levy and Christoff, I983; Yeh et al#, I984). 
This mechanism of control does not rule out regulation of 
the enzymes by de-inhibition in the manner proposed by 
Eggleston and Krebs (1974).
1.
M
B. THE PRODUCTION AND UTILIZATION 
OF NADPH IN RAT LIVER
General considerations
Since the discovery of the nicotinamide dinucleotides 
(Warburg et al., 1935) the basic structural features of 
NADP^ have been characterised and correlated vith its 
major biochemical functions. The structure of NADP^ is 
shown below; -
00 CH,
HO OH
cleaved in
adénylation
CH
0 CH
HO ÔPO?”
The structure of NADP^
Redox reactive site 
0i
NH.
The dihydroband formed in reduced nicotinamide dinucleotide 
phosphate (NADPH) causes an absorption at 340nm, a fact 
that has been made use of in biological studies. 
Biologically, NADPH is considered to be the major electron
h 2
donor in reductive biosyntheses, such as fatty acid 
synthesis.
In liver the total nicotinamide adenine dinucleotide 
phosphate (NADP + NADPH) content has been reported to be 
^ 2 8  nmoles g wet weight, compared to 804 nmoles g  ^ liver 
for nicotinamide adenine dinucleotide (NAD^ + NADH) 
(Jacobson and Kaplan, 1957i Klingenberg, I9 6 I; Bucher 
et a l ., 1964; Heldt et al., I9 6 5 ; Williamson, I9 6 9 ;
Tischler et al., 1977).
A considerable amount of work still remains to be 
done on the regulation of the total cellular level as well 
as the subcellular distribution of the nicotinamide 
nucleotides. However, it has been shown that the bio­
synthesis of nicotinamide nucleotides occurs in different 
compartments. The synthesis of NAD from nicotinamide 
mononucleotide (NMN) and adenosine tri-phosphate (ATP) by 
NAD^ pyrophosphorylase occurs almost exclusively in the 
nucleus (Hogeboom and Schneider, 1952). Since the 
mitochondrial NAD^ synthesizing activity is low, the 
nuclear synthesis is thought to be the main supplier of 
NAD^ to the extramitochondrial spaces of the cell (Siebert 
and Humphrey, I9 6 5 ). The mitochondrial pool is generally 
thought to be supplied by the mitochondrial synthesizing 
system (Lehninger, 1955; Purvis and Lowenstein, I9 6 ]; 
Grumicke et al., 1975).
The synthesis of NMN from nicotinamide (imsande and 
Handler, I9 6 I) as well as the conversion of NAD^ to NADP^ 
by NAD^ kinase (Vignais, 1962) are cytosolic processes.
The regulation of the latter process is not fully 
understood.
The NADP system is 6 5 % mitochondria] wliereas the 
NAD^ system is 20% mitochondrial in rat liver (Si es,
1 9 8 2 ). The NADP^ system is more reduced than the NAD^ 
system and the difference in reduction depends on the
availability of energy (Klingenberg and Slenczka, 1959).
In terms of total values,measured in terms of nmol 
liver wet weight,the ratio of NADPH / NADP^ is 65:47 
in the extramitochondrial spaces <Sies, 1982).7 This ~ 
ratio is substantially different from that obtained for 
free NADPH / NADP^, obtained by using redox indicator 
metabolite systems (Sies et al., 1977; Tischler et al.,
1977). These authors calculated the redox potential 
(E^) of the cytosolic NADP^ system in isolated hepatocytes 
by using the Nernst equation:
r,* « o RT , feeduced substratj
” m ~ nF [oxidised substrat^
where is the mid-point potential at pH 7,0 at a defined 
ionic strength (usually I * 0,25) and temperature. E^ is 
measured in mV, and n is the number of electrons. Basing 
their calculation on the subcellular fractionation of the 
components of the NADP^ - isocitrate dehydrogenase 
indicator system, the redox potential was shown to be 
about -400mV. This is equivalent to a free NADPH / 
NADP^ ratio of about 100 (Sies, 1982) at pH 7-0. This 
value is in agreement with that obtained from data of 
total cellular contents of the components of the isocitrate 
dehydrogenase (NADP^), malic enzyme and pentose phosphate 
dehydrogenase systems (Veech et al., I969; Greenbaum 
et al., 1971). The enzymes used in the calculation of 
the redox state of the free nicotinamide-adenine 
dinucleotide phosphate in the cytoplasm of rat liver are 
assumed to satisfy the following conditions: (i) they
are only (or almost entirely) active in one cell 
compartment (ii) they are active enough to establish a 
near equilibrium state (iii) their products and reactants 
are present in sufficiently high concentrations to allow 
for their accurate determination. In addition the 
equilibrium constant (Keq) of the system must be known 
for the purified enzyme at the pH , temperature and 
ionic strength of the tissue. Veech et al. (1969)
used the equilibrium equation shown below in their 
calculation : -
h h
Ipxidised substrat^ tNADPIij = Keq
[reduced substrate] [NADPt]
Determination of the oxidised and reduced substrates 
would permit the calculation of the NADPH / NADP^ 
ratio if the Keq for the reaction is known.
Since the ratio of total contents of NADPH /
NADP^ is 65:47 and that of the free nicotinamide 
adenine dinucleotide phosphates is 99:1 , preferential 
binding of NADP^ in the manner demonstrated for NADH 
(Bucher, 1970; Bucher et al., 1972, Sies et al., 1972; 
Brauser et al., 1972; Bucher and Sies, I98O) has been 
postulated to explain the discrepancy between the two 
methods of determining the ratio.
Kauffman et al. (1979) have questioned the validity
of assuming near-equilibrium conditions for the reactions
catalysed by the NADP^-dependent dehydrogenases since
they claim that these enzymes, in particular malic
enzyme (K^ = 9pM) , isocitrate dehydrogenase ( = l8l[lM)
and 6PGDH (K^ = 114^M), are likely to be inhibited by ATP
in vivo. However, the authors concede that the degree
of inhibition of these enzymes by ATP may be largely
diminished in vivo since ATP exists largely as MgATP,
2 +and since Mg diminishes the degree of inhibition, by 
ATP, of G6PDH, malic enzyme and NADPt.dependent isocitrate 
dehydrogenase.
The mitochondrial ratio of NADPH / NADP^ at 
pH 7.0 has been estimated to be about 100 (Sies et al., 
1974; Bucher and Sies, 1976; Williamson, 1976; Sies 
et al., 1977) but the lack of a suitable redox indicator 
metabolite system in the mitochondria has given rise to 
uncertainties about the absolute accuracy of these 
values. However, this discourse is mainly concerned 
with the cytosolic NADP^ pool and its consequences for 
the availability of NADPH for reductive biosyntheses 
in the cytoplasm.
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2 , The Cytosolic NADPH-generating systems in rat liver
The enzymes known to be responsible for the 
production of NADPH in the rat liver cytosol are the PPP 
dehydrogenases (fig.l.l), malic enzyme (fig.1 .6 ) and 
NADP^-linked isocitrate dehydrogenase (fig.1.4).
NADP^-linked isocitrate dehydrogenase, 6PGDH and 
malic enzyme are ^-hydroxyacid decarboxylases which 
catalyse reversible reactions of the general type :-
R - CH.OH R. C=0
I + NADP"^ I + CO + NADPH
r '- C.COO" R' .CH JJ+
On the other hand, G6PDH oxidises G6P to 6-phospho-D- 
no
glucolactone.
a . NADP^-linked isocitrate dehydrogenase
Isocitrate dehydrogenase (NADP^) was first purified 
by Adler et al. ( (1939), who established the stoichio­
metry of the reaction and the requirement for divalent- 
ions and NADP^. The enzyme, which was found to be 
widely distributed in nature, was shown to catalyse a 
reversible reaction by Ochoa (1948):-
coo" NADPH H"^  CH .c o o "
I + /  I
CH„ NADP / CHg + COg
CH. coo" C=0
1-OOC.CH. OH COO
Isocitrate - Ketoglutarate
The distribution of the enzyme is tissue-specific
ranging from S 0 % extramitochondrial in liver to 90%
mitochondrial in heart (Pette, 1966; Fatania and 
Dalziel, 19?8). This distribution is consistent with 
the function of NADP^-linked isocitrate dehydrogenase.
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In the liver, the enzyme contributes to the cytosolic 
NADPH pool, the latter being required for hepatic 
reductive reactions* - The heart-, on the other hand,— is-* - —  
a tissue with a low demand for cytosolic NADPH.
The K value of NADP^-dependent isocitrate m
dehydrogenase for the metal-tribasic isocitrate complex, 
at pH 7*0, is 1.65jJ>M (Colman, 1975) and that for NADP^ 
is 2 *5}iM (Dalziel, I98O). Ahn and Kim (I984) have
reported K values of and 4.28liM for DL isocitrate
+ ^ “  ■“ 2 +and NADP , respectively. The concentration of Mg is
important in the determination of the of the enzyme
for isocitrate. For example, the for total threo-
D^-isocitrate decreases from 90|iM in the presence of
0.2mM-Mg^'^ to lO^iM with (Dalziel, I980). On
2 +the other hand, the K for the Mg - isocitrate complex
^  2 + 2  +is 3p.M - independent of the concentration of Mg . Mn
has also been s h o v m to increase the affinity of the
enzyme for isocitrate. The concentration of the
divalent ions does not affect the K for NADP^.m
NADP^-isocitrate dehydrogenase exhibits a random 
mechanism for the binding of its substrates, with 
catalysis more rapid than product release (Uhr et al.,
1974). It has been reported that the enzyme binds isocitrate 
firmly in the absence of cofactor (Villafranca and Colman, 
1972; Erlich and Colman, 1975; Reynolds et al., 1978).
In experiments with perfused rat liver, Brunengraber 
et al. (1973) calculated that extramitochondrial NADP^-
isocitrate dehydrogenase is capable of providing up to 54% 
of the total NADPH required for fatty acid synthesis.
Under their experimental conditions, using a perfusate 
containing 25mM-glucose and no amino acids, the rate of 
fatty acid synthesis was 170^imoles of acetyl groups 
incorporated into fatty acids per g dry wt. per hour.
NADP^-isocitrate dehydrogenase is also thought to
48
play a significant role in the provision of NADPH for 
drug oxidation. On the basis of their results obtained 
with isolated hepatocytes, Weigl and Sies (197?) concluded 
that during drug oxidations dependent on cytochrome P-450, 
the activity of NADP^~isocitrate dehydrogenase is essential 
because of the inhibition of the PPP by NADPH. This 
conclusion was based on the observation that during drug 
metabolism, citrate and isocitrate levels and the citrate 
/ (^L-ketoglutarate ratio decreased in a manner correlated 
to the overall decrease in the NADPH / NADP^ ratio 
observed under the same conditions. These authors 
postulated that the supply of NADPH by cytosolic NADP^- 
isocitrate dehydrogenase accompanies the NADPH supply by 
the PPP dehydrogenases. The decrease in the NADPH / 
NADP^ ratio caused by the oxidation of NADPH by the cyt. 
P-450 system results in the activation of the PPP 
dehydrogenases, which can then contribute to the NADPH 
pool.
Apart from the tricarboxylates, Weigl and Sies (1977) 
have presented evidence which suggests that amino­
transferases may also be significant in the supply of 
NADPH to the cytosol during starvation. These authors 
have shown that the rate of drug oxidation is reduced by 
about 33% in the presence of aminotransferase inhibitors. 
This suggests that there is a requirement for transaminat­
ion steps in the transfer of NADPH-reducing equivalents 
from the mitochondria to the cytosol under these conditions. 
This observation may be accounted for by the possible 
requirement for the aspartate aminotransferases in the 
NADPH transfer system, A scheme for the operation of 
this mechanism of NADPH transfer is sho^^ in fig. 1.5.
It is of interest that of the four cytoplasmic NADPH 
generating enzymes, NAPP^isocitrate dehydrogenase activity 
was not shown to vary significantly with the dietary status 
(Fitch and Chaikoff, I96O).
4 9
Fie. 1.5: The role of aminotransferases in the
transfer of redncine equivalents from 
mitochondria to the cytosol. The 
figure shows the system incorporating 
the cytosolic and mitochondrial 
aspartate aminotransferases in the 
supply of NADPH to the cytosol (Weigl 
and Sies, 1977). The requirement for 
the aminotransferase could result from 
a rate limitation of the malate/ 
ketoglutarate exchange system 
(fig. 1.4). If such a condition 
arises the transamination of 
oC- ketoglutarate would provide 
glutamate, which can then enter the 
mitochondria on the efficient 
aspartate/glutamate exchange system 
(La Noue et al., 1974). Trans­
amination of mitochondrial glutamate 
with oxaloacetate would provide - 
ketoglutarate, which would in turn 
fuel the cytoplasmic NADP^-dependent 
isocitrate dehydrogenase catalysed 
reaction.
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The enzyme is also not significantly reduced by 
starvation for 48h, (Veech et al., 1069). The results 
reported by Take ta et al. (1970) indicate that NADP""- 
linked isocitrate dehydrogenase is not increased by 
refeeding 4 8h starved rats with, casein, glucose or 
casein plus glucose. In fact, the activity was sho^ vn 
to decrease by 12, 50 and 22% when rats were refed
casein, glucose and glucose plus casein, respectively.
Under the same conditions, G6PDH, 6PGDH and malic 
enzyme activities increased considerably. For instance, 
for the rats refed the glucose-casein diet 6PGDH, G6PDH 
and malic enzyme activity increased to 145, 451 and 5l6% 
of the control values. These results suggest a 
different role for NADP^-linked isocitrate dehydrogenase.
The in vitro activity of NADP^—isocitrate dehydrogenase
(cytoplasmic) in rat liver has been reported to be
between 22.4 to 52.5 p-moles min  ^ g  ^ (Veech et al.,
1969; Taketa et al., 19?0). Under conditions where
the activity of NADP^-isocitrate dehydrogenase was
“1 -1reported to be 52.5 ^moles min g (Taketa et al.,
1970) the rates of G6PDH, 6PGDH and malic enzyme were 
reported to be 2.90, 6.94 and 5-71 p-moles min  ^ g ^liver, 
respectively. These values (see also Veech et al.,
1969) imply that NADP^-isocitrate dehydrogenase is the 
most active of the four cytoplasmic NADPH-generating 
enzymes.
In the mitochondria of isolated hepatocytes, the 
quantitative contribution of the flux through mito­
chondrial NADP^ isocitrate dehydrogenase can contribute 
more than 80% of the NADPH required for urea synthesis, 
in model systems restricted to utilization of 
and lactate (Petcu and Plaut, I980). Hence both the 
mitochondrial and the cytoplasmic NADP -isocitrate 
dehydrogenase activities are important sources of 
reducing equivalents in rat liver.
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b . Malic enzyme
NADP -specific malic enzyme was discovered by Ochoa 
et a1., (1952) who established the reaction stoichiometry
and metal ion requirement for this enzyme. Like NADP- 
dependent isocitrate dehydrogenase, malic enzyme is mainly 
extramitochondrial (95%) in the liver and 70% intra- 
mi tochond ri a 1 in heart muscle. Unlike isocitrate 
dehydrogenase, which is a small dimer (90,000 M^), malic 
enzyme is tetrameric with a molecular iveight of about 
200,000 (Dalziel, I98O).
Malic enzyme catalyses the reaction shown in fig.1.6.
The K values for malate and NADP^ have been reported to
^ q..b
be 25pM and l-5pH, respectively (Hsu and Lardy, 196%) for
I
the purified enzyme from pigeon liver. Schimerlik and
Cleland (1977) reported K values of 4.luM and 0.29mM for  ^ m —  —
NADP and malate, respectively.
A simple ordered mechanism (co-enzyme binding first) 
has been demonstrated for malic enzyme in pigeon liver 
(Hsu et al., I967), and NADPH release appears to be the 
rate-limiting step in the oxidative decarboxylation 
(Schimerlik and Cleland, 1977).
Malic enzyme is believed to play a significant role 
in the provision of NADPH for lipogenesis both in rat 
liver and adipose tissue (Young et al., 1964 ; Wise and
Ball, 1964; Rognstad and Katz, 1979i Yoshimoto et al.,
1983). Young et al. (1964) have presented evidence
which implies that both liver and adipose tissue can 
transhydrogenate NADH to NADPH by coupling cytoplasmic 
malate dehydrogenase to malic enzyme.
Wise and Ball (1964) showed that white adipose 
tissue has a higher activity of malic enzyme than liver 
in rats. The distribution of the enzyme is tissue 
specific and probably relates to the function of the
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enzyme in that particular tissue. Since the enzyme is 
90 and 95/c extramitochondrial in rat adipose and hepatic 
tissue, respectively, and is 26 and 31% cytoplasmic in 
rat heart and brain^respectively, one could postulate a 
role for malic enzyme in the provision of NADPH for 
lipogenesis and other NADPH—requiring processes.
However, large variations in the levels of NADP^-malic 
enzyme in livers of different species (ranging from no 
activity .in beef liver to 69 U/g in humming bird liver) 
have been reported by Brdiczka and Pette (1971). .These 
variations could be related to differences in lipogenic 
rates between various species or would suggest that malic 
enzyme is not an essential source of NADPH in some species
The role of malic enzyme in the provision of NADPH 
for lipogenesis in hepatocytes has been investigated by 
Rognstad and Katz (1979). These authors used the malic 
enzyme inhibitor, 2,4 dihydroxybutyrate (K. =
Schimerlik and Cleland, 1977), to determine the effect of 
blocking this source of NADPH on lipogenesis- They 
found that while lOm^—2,4 dihydroxybutyrate greatly 
reduced the randomization of C into lactate from sub­
strates such as Ijs -  ^ fructose or ^ glucose,
it did not inhibit lipogenesis significantly. This 
implied, to the authors, that the pyruvate cycle is 
operative in rat liver and that a compensatory increase 
in the activity of the PPP or some other NADPH-generating 
system was necessary. Rognstad and Katz (1979) showed 
that 2 ,^  dihydroxybutyrate increased the flux through 
the PPP by as much as 90% of the control values. This 
increase in the flux through the PPP, leads to the 
production of NADPH, by the pathway, which exceeds the 
amount required for lipogenesis under the conditions 
used in their experiments. These results suggest that 
the PPP dehydrogenases normally operate below their 
capacity in hepatocytes from starved/re-fed rats, and 
that when malic enzyme is inhibited, the PPP is capable 
of producing an increased amount of NADPH. A role for 
malic enzyme in the provision of NADPH for lipogenesis
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is indicated by these observations.
The production of NADPH by the PPP .over that - .
required for lipogenesis can be used for other NADPH- 
utilizing reactions such as microsomal NADPH reactions, 
glutathione reduction and amino acid syntheses.
Young et al. (1964) showed that malic enzyme is
under dietary regulation. The activity of the enzyme in.
liver and adipose tissue was found to be decreased by
starvation, and increased by carbohydrate refeeding of
previously starved rats. Recently, V4»ljSoH and McMuesqV
(1981) have shown that hormones are involved in the
induction of malic enzyme in cultured rat hepatocytes.
T^ was found to induce malic enzyme by 36%. This
induction by T^ increased to l G k % in the presence of
insulin and cortisol. The concentration of T^ required
for maximum induction was found to be 1.54 x 10
Thyroxine was found to be effective in the same range of
concentration, although it had a negative effect at
concentrations higher than 10 ^M. The potentiating
effect of insulin and cortisol was found to be maximal
“5 -4at high concentrations - 10 and 10 M, respectively. 
Cortisol and insulin, individually, only caused a 19-24% 
induction of the enzyme. These results suggest that 
cortisol and insulin act synergistically in their 
potentiating effect on the T^ induction.
In the work with chick liver hepatocytes, Goodridge 
and Adelman (19?6) have reported that malic enzyme was 
increased 2-, 23-, and 77- fold by insulin, T.^ , and
insulin plus T^, respectively. Glucagon suppresses the 
induction of malic enzyme. None of these hormones were 
shm^m to affect the rate of degradation of the enzyme. 
Goodridge and Adelman further demonstrated that T^ 
induction of malic enzyme was blocked l>y the specific. RNA 
polymerase II inhibitor, amanitin. This observation
suggests that the induction of malic enzyme by T^ requires
56
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the continued synthesis of mRNA. These authors also 
reported that the suppressive effect of glucagon resulted 
from decreased synthesis of enzyme protein, and further 
postulated that the site of action of glucagon was at the 
level of translation or at the cytoplasmic mRNA processing 
stage,
Yoshimoto et al. (I9B3) have demonstrated reciprocal 
effects of epidermal growth factor (EGF) on G6PDH and malic 
enzyme in primary cultures of adult rat hepatocytes. EGF 
was found to inhibit both lipogenesis and the induction of 
malic enzyme. Furthermore, the induction of malic enzyme 
by insulin or by insulin plus T^ was found to be inhibited 
by EGF or Bt^ cAMP (dibutyryl cAMP). On the other hand 
EGF or Bt^ cAMP did not affect G6PDH induction. In 
addition the induction of malic enzyme by insulin or T^ 
was lower at low cell densities. Since fatty acid 
synthesis has been shown to b e .higher at high cell densities, 
the increased induction of malic enzyme by insulin and T^ 
at high cell densities is in agreement with its role as a 
lipogenic enzyme. G6PDH, on the other hand can be induced 
substantially at low cell densities, where the rate of DNA 
synthesis has been shovm to be high, and this induction is 
not prevented by EGF. These observations are consistent 
with the dual role of G6PDH as a supplier of NADPH for 
lipogenesis (and possibly the thjoredoxin reductase- 
catalysed reaction in DNA synthesis) and pentose for nucleic 
acid synthesis.
c . Glue ose .«6-phosphate dehydrogenase (G6PDH)
G6PDH is a cytoplasmic enzyme catalysing the oxidation 
of G6P (Cori and Lipman, 1952). The immediate product, 
6-phosphogluconolactone, is rapidly hydrolysed by a 
lactonase to 6-phosphogluconate. These two reactions 
liave a large free energy change which has been estimated 
to be about -3?kJ mol”  ^ at 25^C, pH 7.0 ( Bassham and Krause, 
1969). These characteristics mean that the G6PDH catalysed 
reaction would be expected to be irreversible, favouring the 
oxidation of G6P in vivo. However, as discussed previously.
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G6PDH is potently inhibited by NADPH.
Hoi ten et al..—  (1976)- reported that the enzyme is
inhibited by over 98% in rat liver. If this figure is
applied to the activity of G6PDH in rat liver, in vitro,
reported by Veech et al. (1969), the activity of G6PDH
in vivo would be expected to be in the region of 0.02 
-1 -1pmoles min g liver wet weight. This is comparable
to the xsapacity of 6PGDH in the fed cell. Crawford and
Blum (1983) using isolated hepatocytes incubated with
1^ 1 - glucose, have estimated the total flux through
the oxidative arm of the PPP to be 7.4 nmol/20min mg~^ of
protein, corresponding to approximately 74 nmol min ^
liver. On the other hand Bacquer et al. (1976) using
liver slices incubated with £l - glucose estimated
a flux through the PPP of about 46 nmol min  ^ g ^. The
flux through the PPP was shown to increase to I50 nmols 
~  1 - 1min g in the presence of phenazine methosulphate.
The effect of this compound, which has also been 
demonstrated by McLean (196O), implies that the PPP is 
not maximally stimulated, even under conditions of dietary 
carbohydrate induced hyperlipogenesis.
Rognstad and Katz (1979) have shown that the PPP can 
provide 50-75% of the NADPH required for lipogenesis in 
rat liver. It is of interest that in the avian liver the 
activity of the PPP dehydrogenases does not change 
significantly with dietary manipulations (Goodridge, I968), 
indicating that this pathway plays a minor role in the 
provision of NADPH for lipogenesis. Malic enzyme is 
believed to be the major source of NADPH in avian liver. 
Rognstad and Katz (1979),as a result of their work with 
isolated hepatocytes from fasted-refed rats incubated 
with |l - galactose, have concluded that in rat
liver, as in adipose tissue, the main sources of cyto­
plasmic NADPH are malic enzyme and the PPP dehydrogenases.
Bauer et al., (I983) have suggested that since the 
initial G6PDH catalvsed reaction has a standard free 
energy at pH 7.0 of only -400 J mol , and since the
physiological NADPH / NADP^ ratio is unfavourable.
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the G6PDH reaction will not favour the oxidation of G6P 
unless the cellular levels of 6-phosphogluconolactone 
are less than 10 nmol g . This necessitates the 
presence of 6-phosphogluconolactonase (6PGL), an 
enzyme which has been shown to be highly active in fatty 
acid-synthesizing organs such as liver and epididymal 
fat (Bauer et al., I983). In rat liver the activity 
of 6PGL is 7 times that of G6PDH, when measured in vitro. 
Hence 6PGL forms an important link between the two 
dehydrogenases of the oxidative branch of the PPP and 
appears to be a pre-requisite for the normal function of 
the PPP dehydrogenases in generating NADPH, 6PGL does 
not appear to be rate-limiting.
Eggleston and Krebs (1974) have postulated that 
even though the G6PDH catalysed reaction is far removed 
from equilibrium, the steady state established by this 
system, as a result of the reversible inhibition of the 
reaction by NADPH in vivo, would behave like a near­
equilibrium system inasmuch as withdrawal of NADPH 
decreases the inhibition and causes the withdrawn NADPH 
to be replaced. Hence the basic control of this first 
step of the oxidative arm of the PPP may still be 
considered to be a matter of near-equilibrium relations. In 
addition, Gumaa et al., (1971) have also concluded that 
control is not achieved by G6P limitation but rather by 
NADP"^ limitation.
Multiple forms of rat liver G6PDH have been reported 
(Holten, 1972). These forms appear to be based on the 
same basic active unit which is a dimer of about 130,000. 
The higher molecular weight forms are formed by the 
aggregation of dimers. 90% of the purified enzyme exists 
in at least three different dimeric forms and the remain­
ing 10% is made up by the higher molecular weight 
aggregates.
These multiple forms of GoPDH can be separated by 
electrophoresis on polyacrylamide gelsi the bands that 
have been obtained have been found to correspond to
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dimers, tetramers and hexamers of an inactive monomeric 
sub-unit of molecular weight 60,000-64,000. The dimer 
can be further resolved into -three-bands,-designated - —
I, II and III, by inclusion of NADP^ in the cathode 
buffer (Schmukler, 1970; Holten, 1972; Taketa and 
Watanabe, 1971). Band I corresponds to the fastest 
moving band, and band III the slowest. In most tissue 
homogenates the dimer form predominates and in rat liver 
only forms II and III are present and the latter pre­
dominates (Holten, 1972; Taketa and Watanabe, 1971; 
Vatanabe et al.. 1972; Chang et al., 1979). The 
patterns of the liver dimers can be manipulated to show 
all three forms. For instance, depletion of GSH in rat 
liver supernatants by treatment with diamide results in 
the conversion of slower moving components to. faster ones 
(Watanabe et al., 1972). Regeneration of GSH has the 
reverse effect. Liver extracts from carbon tetra­
chloride-injured cells also Exhibited an increased 
proportion of faster moving forms of the dimers of 
G6PDH, with a concomitant decrease in the GSH 
concentration. Overall, the increased intensity of the 
faster moving components observed in rat liver was found 
to be closely associated with an increased ratio of 
G6PDH activity to GSH levels.
Although the regulatory significance of the inter­
conversions between these dimeric forms of G6PDH is not 
clear it is conceivable that a differential susceptibility 
to disaggregation of the various forms of the dimer to the 
inactive monomer could be a regulatory process. In this 
context Grdgor (1984-) have argued that the three dimeric 
forms could be significant in the turnover of G6PDH from 
the mammary g3and. He has postulated that there are 
two disulphide bonds per dimer, which can be reduced by 
sulphydryl reagents. Following reduction, a portion of 
the peptide is exposed, altering the total charge of the 
protein. The author has argued that form I has two 
intact disulphide bonds, form II has one disulphide bond
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reduced and I'orni III has both di sulphide bonds reduced. 
These three forms have the same specific activity and 
similar kinetics. However, the oxidised i'orm is more 
rapidly inactivated by chymotrypsin or a mammary gland 
microsomal preparation. In the liver the predominant 
form oi' G6PIMI is the fully reduced dimer, and it is 
possible that the high levels of GSH found in this organ 
maintain the relatively stable, fully reduced dimeric 
form in its reduced state. This could also stabilize 
the enzyme by protecting it against general proteolysis.
The role of thiol and disulphide groups -have been 
further implicated in the regulation of G6PDH by Francis 
and Ballard (198O a,b) who have shown that the 
inactivation of G6PDH by a rat liver microsomal membrane 
protein (Francis and Ballard, 1 ^ 8 o b) is partially 
reversed by dithiothreitol (DTT). Furthermore, pre­
incubation of the microsomal protein with DTT, followed 
by the removal of DTT, resulted in the loss of the 
protein’s capacity to inactivate G6PDH. A possible 
explanation for this being that the microsomal activity 
is dependent on the presence of intact disulphide bonds 
and that DTT reduces these bonds. NADP'*' was shown to 
protect G6PDH against inactivation, whereas the 
disulphide, L-cystine was shown to stimulate the inhibit­
ion of G6PDH by the protein. These results led Francis 
and Ballard (198O b) to conclude that the inactivation of 
G6PDH proceeds by a disulphide-thiol exchange mechanism 
(fig. 1.6a), the rationale being that DTT reduces the 
disulphide links in the inactivating protein, thereby 
rendering it ineffective against G6pdH. Isaacs and 
Binkley (1977) have presented data which shows that 
G6PDH has a diurnal variation with activity highest 
during the period of maximal and lowest during the 
period of minimal mixed disulphide formation. All 
these observations suggest a role for thiols and 
disulphides in the regulation of GOPDH.
6l
/ S H
Enzyme
^ S H
RSSR Membrane
MS.
RSH + R' SH Enzyme Membrane
HS
denatured enzyme
2GSH
GSSG
Fig.1.6a: The proposed mechanism for the involvement
of thiols and disulphides in the degradation 
of G6PDH (Francis and Ballard, 1980b).
(1 ) The active enzyme (G6PDH) is
oxidised to an inactive form by 
the disulphides; (2) the reduced 
thiols in the microsomal protein 
are reoxidised by disulphides 
such as oxidised glutathione 
(GSSG); (3) the inactive 
enzyme can now be denatured 
(Ballard et al., 1974; Francis 
and Ballard I980 a,b).
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d . 6-Phospho,elucong.te dehydrogenase (6PGDH)
6PGDH is a dimeric, cytoplasmic enzyme (M^_
94,000-101,000) which catalyses the oxidation of 6PG
to ribulose-3-phosphate (fig. l.l) with the release of
NADPH and carbon dioxide. It has been purified from
rat liver (Procsal and Holten, 1972) and values of
71^M and 13p^ for 6PG and NADP^, respectively, have been
reported. Rudack et al  ^ 1971a) showed that the maximal
capacity of normal rat liver to oxidise 6PG is 5*8 JJLmoles 
-1 -1min g liver. When the rats were induced to produce
higher levels of 6PGDH (starvation followed by high
carbohydrate re-feeding) the capacity was increased to
14.8 pmoles min  ^ g  ^ liver. However, at the
concentration of substrates and products expected in
vivo, this capacity decreases to 0.02 and 0.06 pmole 
“1 -1min g liver for the control and induced rats,
respectively (Procsal and Holten, 1972). These 
calculations are based on an NADPH / NADP^ ratio of 
100, and a cellular concentration of 30pM 6PG and 
indicate that the enzyme is almost completely inhibited 
in vivo.
Unlike G6PDH, the K for 6PG of 6PGDH ( 71[i^ ) andm
the cellular concentration of 6PG (l4.2-30pNp are 
related in such a way that 6PG could be rate-limiting 
for the 6PGDH catalized reaction in vivo. It is there­
fore conceivable that an increase in cellular concen­
trations of 6PG such as that occurring under lipogenic 
conditions (table 1 .1b) could activate the enzyme.
The understanding of the precise role of 6PGDH in the 
provision of NADPH in the cytoplasm has been hindered by 
the lack of knowledge concerning the short-term regulation 
of the enzyme in vivo. However, as an integral part of 
the PPP, dt is likely to be a significant source of NADPH.
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3. The major cytosolic NADPH-consnming processes 
in rat liver.
a . Li p n g e n e  si s .
(i). General consideration?: A number of biosynthetic
pathways use NADPH in the rat li-v'-er cytosol. Notable 
among these is lipogenesis which has been extensively 
studied. Other abiotic reactions using NADPH, such as 
drug oxidation via the mixed function oxidase system, 
have been shown to be major processes utilizing NADPH 
(Smith and Wills, I981). Rognstad and Katz (1979) 
using isolated hepatocytes from rats previously fasted 
for two days and refed a high-carbohydrate diet for one 
day, reported that fatty acid synthesis uses 803pmol g 
dry weight h  ^ of NADPH. Under the same conditions the 
PPP was reported to produce 430 pmoles of NADPH g  ^ dry 
weight h . Assuming that the dry weight is approxi­
mately 2 3^ of the wet weight (Brunengraber et al., 1973)1
these figures correspond to I85 and 103 pmoles NADPH g  ^
-1
h for fatty acid synthesis and the PPP respectively.
These figures suggest that lipogenesis is a major NADPH- 
consuming process.
Lipogenesis in the liver involves the conversion of 
acetyl-CoA to palmitate. The physiological substrate 
for fatty acid biosynthesis in rat liver is a matter of 
current investigation. Recently Geelen and Hindricks 
(1984) have suggested that lactate may be the substrate 
in rat liver. They have shown that glycogen, like 
glucose, is not a major substrate for fatty acid 
synthesis. In isolated hepatocytes incubated with 
hepatic glycogen pre-labelled with from glucose,
only 20% of the total carbon used in fatty acid synthesis 
is derived from glycogen. Experiments with D- [u-^*c3 
glucose showed that only high concentrations of glucose 
(30mM) contributed appreciably (25%) to the carbon pool 
for fatty acid synthesis.
6'»
Nevertheless, the acetyl-CoA required for 
lipogenesis is mainly derived from the mitochondria and 
is exported to the cytoplasm as citrate (figs.l.N, 1 .5 i 
1.6 ). Acetyl-CoA is generated from citrate by the 
action of ATP-citrate lyase (fig. 1.8). Endemann e t 
al., (1982) have proposed that the formation of aceto-
acetate in the mitochondria and its utilization in the 
cytosol may be a secondary pathway of acetyl group 
translocation operating concurrently with the pre­
dominant citrate cleavage pathway. Using isolated 
perfused rat livers and measuring the incorporation of 
ketone bodies into fatty acids and 3 - ^  - hydroxy 
sterols, and comparing the values obtained with the 
values for total lipid synthesis measured by incorpora­
tion of tritium from tritiated water, Endemann et al. 
(1982) have reported that in fed rats ATP-citrate lyase 
contributes 3l% to the carbon incorporated into fatty 
acid while acetoacetyl-CoA synthase provides only 4%.
In the presence of oleate and hydroxycitrate, which 
inhibit the citrate cleavage pathway, the contribution 
of acetoacetyl-CoA synthetase increases to 8.6%. When 
livers from starved rats were used the flux through 
acetoacetyl-CoA synthetase increased to 26%. The 
specific activity of tracer amounts of ^ —hydroxy 
^3-^ C ^  butyrate were measured in these experiments. 
These results suggest that other carbon sources are 
involved since the citrate cleavage pathway and the flux 
through the acetoacetyl-CoA synthetase together only 
account for 85% of the carbon incorporated into fatty 
acids. Cytoplasmic acetyl-CoA can also be furnished by 
acetyl-CoA synthetase which utilizes acetate and CoA 
(Veech and Guynn, 1974).
In rat liver the NADPH required for lipogenesis is 
derived mainly from the PPP dehydrogenases and malic 
enzyme (Rognstad and Katz, 1979). The role of NADP - 
isocitrate dehydrogenase has been discussed. It has 
been suggested that at low rates of lipogenesis the PPP
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dehydrogenases are able to supply all the NADPH required 
for fatty acid synthesis in both rat liver and adipose
tissue (Katz et al., 3966; Saggerson and Greenbaum,
1970; Thompson et al., 1976; Holten et al., 1976).
In cells actively synthesizing fatty acids, malic enzyme 
can contribute as much as 50% of the NADPH required for 
lipogenesis (Flatt and Ball, 1964; Wise and Ball, 1964; 
Kornacker and Ball, I965; Ball, I966; Rognstad and 
Katz, 1966; Rognstad and Katz, 1979).
The committed step of lipogenesis is the carboxy­
lation of acetyl-CoA to form malonyl-CoA. The reaction 
is catalysed by the biotin containing acetyl-CoA carboxy­
lase. The intermediates in fatty acid synthesis are 
then attached to an acyl-carrier protein (ACP) by the 
action of transacylase and fatty acid synthesis proceeds 
as in fig. 1.7. The overall stoichiometry of the 
reaction is : -
8 CHj,
5 CoA
,0
+ ACP + 7 HCO 7 ATP + 1 4  NADPH
H'
CH^ ^^^2\ 4^^ACP + • ^ CoA + 14 NADP+ + 7 H^O + ? ADP
+ 7 Pi 7 CO
Rates of fatty acid synthesis are dependent on the 
nutritional status of the animal (Vinegrad and Renold, 
1958; Wieland et al., 1963; Wjeland and Eger-NeufeIdt, 
1963; Butterworth et al., I966; Brunengraber et al., 
1973; Endemann et al., I982). Fatty acid synthesis 
has been shown to be markedly reduced by fasting, fat 
feeding or in the diabetic state. Similar conditions 
have been shown to result in a cf 1 rqmubiOH of the level 
of the PPP dehvdrogenases.
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Enzyme activity Reaction
1. Biotin carboxylase BCCP + HCO” + ATPu!
BCCP/^COO + ADP + P^
2. Carboxyl transferase 1
BCCP
COO
3. Acetyl transacylase
4 . Malonyl transacylase
:0
CH  C + ACP-SH
 ^ ^SCoA
^  + CoA-SHC H — C
COO
S-ACP
CH- + ACP-SH
 ^ ^SCoA
COO
L:
1
CH— C, + CoA-SH
'S-ACP
5. yS -Ketoacyl-ACP
synthase (condensing 
enzyme)
^ 0
a. CH— C ^  +
^ ^S-ACP
Enz-SH
C H — C
b. CH^— C
0 1
+ ACP-SH
S-Enz
0
S-Enz
COO 
+ CH„— C
2 \ s -S-ACP
I
CH^— C— CH— C
0
S-ACP
+ COg + Enz-SH
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6 . ^  -Ketoacyl-ACP reductase CH CCH - C ^
 ^ ^S-ACP
+NADPH n
9H ^ 0
D-CH ÙHCH -C
 ^ S-ACP
+ NADP^
7. ^  -Hydroxyacyl-ACP 
dehydratase
8. Enoyl-ACP reductase
Recycle 5-8 five times
9* Thioesterase
CH^CHOH CHg-C
0
S-ACP
,0
trans-CH^CH=CHC
S-ACP
+ HgO
CHjCH=CHC + NADPH
0
S-ACP
CH CH C H - C ^  + NADP+
 ^  ^ ^ ^  S-ACP
CH3 ctg.AcP “2°
n
CH (CH ) , C ^  + ACP-SH
-* 2 A4 OH
Fig.1.7: The reactions of lipogenesis (Wakil et al..
1903).
Reactions 1 and 2 are catalysed by acetyl 
- CoA carboxylase, and 3-9 by FAS.
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Boca and Flatt (D969) have postulated that the 
impairment of lipogenesis found in the fasted animal is 
primarily due to a decrease in the tissues ability to 
generate acetyl-CoA from glucose rather than the 
inhibition of or change in the level of the enzymes 
directly involved in lipogenesis. In contrast,
Butterworth et a l . (I966) have reported quantitative
changes in the amount of fatty acid synthase in response 
to starvation.
Brunengraber et a l . (1973) using tritiated water
to measure lipogenesis in perfused rat liver have
reported a lipogenic rate of about 0.65|-inioles of acetyl
-1 -1
groups incorporated g min in fed rats, whilst
Endemann et al. (I982) have reported values of O.32 and
-1 -1
0.007 Immoles of acetyl groups incorporated g min for
the fed and 48h starved rats, respectively. A higher
rate for the 48h starved rats (0.02p.moles acetyl groups 
-1 -1
incorporated g min ) has been reported by Brunengraber e^ 
al. (1973).
Lipogenesis is under both hormonal and nutritional 
regulation and lipogenic enzymes have been shown to be 
co-ordinately induced or inhibited by various factors.
Spence and Pitot (I982) have demonstrated that in 
primary cultures of rat hepatocytes G6PDH, malic enzyme, 
ATP-citrate lyase, acetyl-CoA carboxylase, fatty acid 
synthase and stearoyl-CoA desaturase are co-ordinately 
induced by insulin or T^. These hormones produce a 2-3 
fold increase in the individual enzyme activities, where­
as glucagon slightly decreases the enzyme activities. 
Fructose and glycerol, both in the absence and presence 
of insulin, were shown to increase the individual enzyme 
activities to the same extent as insulin or T ^ . These 
increases in activity were showni to be the result of 
enhanced de novo synthesis of the enzymes. Hence a 
relationship between carbohydrate metabolism and
lipogenesis, independently in part of hormonal effects, 
was demonstrated. Further involvement of hormones in
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the regulation of lipogenesis has been indicated by the 
observation that vasopressin, adrenaline and angiotensin 
II inhibit lipogenesis (Hems, and Hems, 1975),
Non-esterified fatty acids are thought to be acute 
regulators of lipogenesis since these compounds have 
been shown to inhibit lipogenic enzymes (Jeffcoat and 
James, 1977; Jeffcoat et al., 1979). In addition 
elevated levels of free fatty acids in vivo, as is the 
case in starved, fat-fed or diabetic rats, is associated 
with depressed lipogenesis (for a review see Volpe and 
Vagelos, 1976). Topping and Mayes (I982) have presented 
evidence which suggests that insulin can stimulate 
lipogenesis in perfused rat liver, in the presence of 
elevated concentrations of serum non-esterified fatty 
acids. The implication of this finding is that insulin 
could counteract the inhibitory effects of fatty acids in 
starved-refed, fed or insulin-treated diabetic rats.
ii. ATP-citrate lyase
ATP-citrate lyase, the enzyme catalysing the cleavage 
of citrate into acetyl-CoA and oxaloacetate (fig 1.8), is 
a key lipogenic enzyme since it provided most of the 
acetyl-CoA required for fatty acid synthesis (Endemann 
et al., 1982). The reaction catalysed by the enzyme is 
shown below:-
Citrate + CoA + ATP Acetyl-CoA + ADP
+ P. + oxaloacetate 
1
The K values of ATP-citrate lyase have been reported to
m
be 0.07mM, 0.2 8mM and 1. 6|iM for citrate, ATP and CoA, 
respectively (Plowman and Cleland, 1967). The citrate 
required for this reaction is derived from the mitochondria 
where it is formed by the activity of citrate synthase.
The substrates of this latter enzyme are mitochondrial 
oxaloacetate and acetyl-CoA, which are derived from 
pyruvate and generated by the action of pyruvate
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carboxylase and pyruvate dehydrogenase.
The free acetyl-CoA / CoA ratio in rat liver 
cytoplasm has been found to be high in starved and fed 
rats, and in conditions of rapid fat synthesis. This 
suggests that the supply of acetyl-CoA is never limiting 
for fat synthesis under most in vivo conditions (Veech and 
Guynn, 197'0. The activity of ATP-citrate lyase in both 
starved and fed rats is more than four times that of 
acetyl-CoA carboxylase and fatty acid synthase (Veech and 
Guynn, 1974). Recently, Spence and Pitot (1982) have 
reported that ATP-citrate lyase activity is not depressed 
by starvation.
ATP-citrate lyase is known to be regulated in response 
to hormones and metabolites (Spence et al., 1979); Spence 
and Pitot, I982). Spence et al. (1979), using cordycepin
and cycloheximide (protein synthesis inhibitors) have shown 
that the induction of ATP-citrate lyase in isolated hepatocy­
tes by insulin, insulin plus glucose, glycerol and fructose 
is dependent on protein synthesis. These authors immuno- 
precipitated ATP-citrate lyase, and by following the 
incorporation of leucine into this specific protein,
showed that the changes in the activity of the enzyme 
correlate with changes observed in the rate of synthesis 
of the enzyme. Similar observations have been made by 
Pearce (I980) for rats fed a fructose-based diet.
Fat-feeding results in a dimrnution of the enzyme and 
Schwartz and Abraham (I98I) have reported the conversion 
of ATP-citrate lyase into a catalytically inactive form 
by polyunsaturated fatty acids.
Glucagon treatment of hepatocytes and thyroidectomy 
diminish the measurable activity of ATP-citrate lyase 
(Spence et a]., 1979). Although phosphorylation of the
enzyme by a glucagon-stimulated cAMP-dependent protein 
kinase and by an insulin-stimulated cAMP-independent
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mechanism has been demonstrated (Janski et a l ., 1979i 
Ranganathan et. a 1 . , 19^0; 1982; Alexander et a l ., 19^2 ),
the regulatory significance of this ph osphoryla t i on i s not 
clear, since no changes in the regulatory or catalytic 
properties of the enzyme have been found. Hence the 
proposal that the enzyme may be subjected to hormonal 
influences which alter its susceptibility to degradation 
(Ostei'lund et a 1. , .1980; Vogel and Bridger, I981).
iii. Acetyl-CoA carboxylase.
Acetyl-CoA carboxylase catalyses the ATP- and 
bicarbonate-dependent carboxylation of acetyl-CoA to form 
malonyl-CoA. The carboxylation of acetyl-CoA requires 
the presence of biotin carboxyl carrier protein (BCCP), 
biotin carboxylase (DC) and carboxyl transferase (C T ).
The carboxylation proceeds in two stages:-
BC, Me^"
1. BCCP + HCO^ 4 ATP BCCP ^ C O O "  +
ADP + P.
1
COO 0
—  PT' I ^
2 . B C C P ^ C O O -  4 ; = = = 2  BCCP +
The of acetyl-CoA carboxylase for acetyl-CoA is 8op.M,
that for the bicarbonate is 6mM and that for ATP is 0 .2mM 
(Alberts and Vagelos, 1972; Soler-Argilaga et a l ., 1978; 
Song and Kim, 1981),
Rat liver acetyl-CoA carboxylase consists of two 
apparently identical sub-units of M 230,000 (Tanabe 
et a l ., 197.5; Nakanishi et al., 1976; Song and Kim,
1981). The acetyl-CoA carboxylase protomer is the 
multi functional 230,000 ( ) sub-unit which contains the
functions of BCCP, BC and CT.
Several studies have shown that the activity of 
acetyl-CoA carboxylase measured in crude extracts
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correlates well with the rate of fatty acid synthesis, and 
that changes in the rate of fatty acid synthesis imposed 
by insulin and glucagon are due to alterations in the 
activity of acetyl-CoA carboxylase (Allred and Roering, 
1973; Watkins et al., 1977; Geelen et al., 1978; Beynen 
et al., 1979; Witters et al., 1979). Hence, acetyl-CoA 
carboxylase provides a point of control an<i has been 
regarded as a rate-limiting enzyme of lipogenesis (Lane 
et a l ., 197'i; Volpe and Vagelos, 1976; Giffhorn and Katz, 
1984).
The hormonal regulation of hepatic acetyl-CoA 
carboxylase is thought to occur through changes in the 
cellular concentration of citrate (Watkins et a l ., 1977; 
Wakil et al., 19#3), and/or by a phosphorylation- 
déphosphorylation mechanism (Carlson and Kim, 1973;
Hardie and Cohen, 197&, 1979; Guy and Hardie, I981), or 
both (Geelen and Beynen, I98I).
Citrate has been shown to be able to activate acetyl- 
CoA carboxylase by converting the inactive protomer to the 
active polymer (for reviews see Lane et al., 1974; Moss 
and Lane, 1971; Lane and Moss, 1971). In the cell the 
enzyme is believed to exist as a polymeric structure 
(Meredith and Lane, 1978; Buechler et al., I984). The 
physiological significance of this citrate-(or tricarb­
oxylic acid-) induced polymerisation of the enzyme has 
been questioned since citrate does not activate the enzyme 
in the presence of physiological concentrations of ATP, 
and the K for citrate is 3~4mM, ten timnp the concentra­
tion of citrate thought to exist in the cell. However, 
Wakil et al., (I983) have explained the regulatory role of 
citrate in the regulation of fatty acid synthesis in terms 
of the inhibitory effect of glucagon on phosphofruelo- 
kinase-1 and its effect of rJecreasing cytosolic citrate 
concentration. They have argued that tho consequent 
decrease in citrate concentration results in a decrease in 
acetyl-CoA carboxylase activity, which results in a reduced
7''
rate of fatty acid synthesis.
The polymerisation of acetyl-CoA carboxylase is 
enhanced by a high enzyme concentration, inorganic phos­
phate and pH in the range 6.5 - 7*0 . Depolymerisation
is induced by alkaline pH, HCO", fatty acyl-CoA and ATP- 
2 +Mg (Lane et al., 1974). CoA has also been shown to 
cause the allosteric activation of acetyl-CoA carboxylase 
by inducing polymerisation (Yeh and Kira, I980). CoA acts 
at a different site, on the enzyme, from citrate, but 
appears to compete with palmityl-CoA for the same site 
(Yeh and Kim, I980).
Fatty acyl-CoAs, on the other hand, regulate fatty 
acid synthesis by inhibiting acetyl-CoA carboxylase as a 
result of its depolymerisation (Wakil et al., I983).
Both the binding of the acyl-CoA and depolymerisation of 
the carboxylase is competitive with citrate and is 
reversed by albumin (Goodridge, 1972, 1973). One acyl- 
CoA binds per carboxylase subunit with a dissociation 
constant of 5nM (Ogiwara et al. , 1978 and Sreekrishma e_t 
al., 1980). The inhibition is reversed by phosphatidyl­
choline in the presence of citrate. Palmitoyl-, stearoyl- 
and arachidyl-CoA are the most effective inhibitors of the 
carboxylas# (Nikawa et al., 1979). Since palmitoyl- 
dephospho-CoA is a poor inhibitor of acetyl-CoA carboxylase 
with a 40-fold higher K^ than palmitoyl-CoA a specific 
binding site for the acyl-CoA dependent on the chain length 
of the fatty acid and the 3 -phosphate CoA is implied by 
these observations. Wakil et al. (I983) have stated
that the regulation of the carboxylase by the long-chain 
acyl-CoAs is reciprocal to that by citrate and may reflect 
the physiological role of these metabolites in regulating 
fatty acid synthesis.
Physiological concentrations of guanine nucleotides 
(Witters et al., I981) stimulate acetyl-CoA carboxylase 
activity in dialysed rat liver supernatant preparations
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but have no effect on the purified enzyme. On the other 
hand, CoA can activate even the purified enzyme and this 
activation is accompanied by both a change in the value of 
for acetyl-CoA from 0.2mM to about |^iM, and by poly­
merisation of the enzyme independent of citrate (Yeh and 
Kim, 1980; Yeh, I981).
Malonyl-CoA has been reported to be a potent inhibitor 
of the enzyme exhibiting a of IO^lM (Gregolin et al.,
1966; Chang et al., 196?). This inhibition could, con­
ceivably prevent unnecessary consumption of acetyl-CoA 
for lipogenesis.
Acetyl-CoA carboxylase is inactivated by phosphory­
lation (Hardie and Cohen, 1978). It has been suggested by 
Hardie and Cohen (1978) that glycogen and fatty acid syn­
thesis may be regulated synchronously, since both glycogen 
synthetase and acetyl-CoA carboxylase are phosphorylated 
in the same manner. The phosphorylation may involve both 
cAMP-dependent and independent protein kinases (Guy and 
Hardie, I981).
Giffhorn and Katz (1984) have investigated the long­
term regulation of acetyl-CoA carboxylase in primary 
hepatocyte cultures. These authors have demonstrated 
glucose- and insulin- dependent increases in the acetyl- 
CoA carboxylase activity, which they have attributed to 
increases in the amount of enzyme protein. This increase 
in the amount of enzyme was specifically effected by an 
increase in the rate of enzyme synthesis rather than by 
decreased enzyme degradation oC- amanitin , an inhibitor 
of RNA polymerase II (Faulstich, I981), and cordycepin 
prevented the induction of acetyl-CoA carboxylase by 
glucose or glucose plus insulin. Buechler et al., (1984) 
have also demonstrated the short-term hormonal regulation 
of lipogenesis in isolated hepatocytes. In the presence
of glucagon (lOnM) the rate of lipogenesis from^H o]
-1 -1decreased 10-fold from 0.154 |imol of acetyl units g min.
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Insulin (85nM) on the other hand, increased the rate to
0.246 (iimol g  ^ rain.  ^ These authors also attempted to 
relate the rate of fatty acid synthesis to the activity of 
acetyl-CoA carboxylase. They found that when the enzyme 
was prepared under conditions of maximal activity (i.e. 
preincubation with citrate) the rate elicited was 
comparable to the rate of fatty acid synthesis, but insulin 
and glucagon appeared to have no effect on enzyme activity. 
However, under certain conditions such as the homogeniza­
tion of the cells in the absence of Triton X-100 and with­
out preincubation, acetyl-CoA carboxylase appeared to be 
hormone-sensitive, the activity being suppressed by 
glucagon and increased by insulin. Under these conditions 
acetyl-CoA carboxylase activity was shown to be only 13%, 
l6% and 57% of the rate of lipogenesis when compared to the 
untreated, insulin - and glucagon - treated hepatocytes, 
respectively. Hence a role for acetyl—CoA carboxylase 
in the short-term regulation of lipogenesis is implied.
iv. Fatty acid synthase (FAS)
Fatty acid synthase catalyses the de novo synthesis 
of long-chain fatty acids from acetyl-CoA and malonyl-CoA 
(Simonis et al., 1967; Prescott and Vagelos, 1972; Volpe 
and Vagelos, 1973). The fatty acid synthase (FAS) 
isolated from animal tissues is a multifunctional enzyme 
consisting of two identical subunits (M^ 250,000). Unlike 
the yeast enzyme, animal FAS has no requirement for FMN 
as a cofactor and yields free palmitate and stearate as 
the end products (Wakil et al., I983). The enzyme 
contains a total of seven enzymic activities. Dissoci­
ation of the enzyme into monomers results in the retent­
ion of six of the enzymic activities: acetyl trans-
acylase, malonyl transacylase, ^&-hydroxyacyl dehydratase, 
enoyl reductase and thioesterase. The seventh activity, 
yS -ketoacyl synthase (condensing enzyme), has an active 
center which requires the presence of two juxtapositioned 
thiols each derived from one subunit. This latter
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activity can, therefore, only be detected in the native 
dimer (Wakil and Stoops, 198]). FAS therefore catalyses 
reactions 3-9 in fig.1 .7-
The short-term regulation of FAS in animal tissues
is not well understood. Nevertheless,several hypotheses
have been advanced and reviews on the general regulation
of FAS have appeared (Volpe and Vagelos, 1976; Stoops
et al., 1977; Wakil et al., I983). Phosphorylated
sugars, especially fructose 1, 6-bisphosphate, have been
shown to stimulate FAS. Plate et al.. (I968) showed that
the effect of fructose 1,6-bisphosphate is to reduce the
K of FAS for NADPH. However, this stimulation occurs m
at a non-physiological concentration (lOmM) of the 
diphosphate.
Acetyl-CoA and malonyl-CoA competitively inhibit FAS 
(Katiyar and Porter, 1974; Srinivasan and Kumar, I98I). 
The liver enzyme is also inhibited by palmitoyl-CoA and 
free fatty acids (Hsu et al., I969; Knoche et al., 1973) 
but evidence that this inhibition is of physiological 
significance is circumstantial. Indeed, Dorsey and 
Porter (1968) have shown that the inhibition by the 
thioester is dependent on the molar ratio of 
palmitoyl-CoA to protein, implying a detergent action 
rather than a site-specific action. The inhibition was 
found to be irreversible and similar to that produced by 
SDS (sodium dodecyl sulphate). In contrast, acetyl—CoA 
carboxylase exhibits a competitive, reversible, inhibition 
by long-chain acyl-CoAs(Ogiwara et al., 1978). The 
observations made with FAS do not support a role for long- 
chain acyl-CoA derivatives in the short-term regulation of 
this enzyme.
Stoops and Wakil (I982) have demonstrated a rapid, 
irreversible inactivation of chicken liver FAS by 1,3 
dibromo-2-propanoa«i which is used as a probe of the /6 - 
ketoacyl synthase site. Acetyl-CoA, but not malonyl-CoA, 
protects the enzyme against this inactivation. The
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reason given for the different effects of these two sub­
strates is that while acetyl-CoA can reside on both the 
cysteine-SH and the pantetheine-SH, malonyl-CoA can only 
reside on the latter, leaving the active cysteine-SH 
exposed for reaction with dibromopropanone with subsequent 
inactivation of the enzyme. It was shown in these experi­
ments that dibromopropanone inhibits the enzyme by forming 
3-bromo-2 keto derivatives of the cysteine residue. The 
effect of dibromopropanone was accompanied by the cross- 
linking of the two subunits.
In experiments with cold inactivated FAS, Stoops and 
Wakil (1982) showed that dibromopropanone inactivated FAS 
activity but failed to bring about the cross-linking of 
the two subunits presumably because of the dissociation of 
the dimer which occurs during the reversible cold in­
activation of FAS (Fig.1 .9 ). NADPH, but not NADH, was 
shown to enhance the restoration of the cold inactivated 
enzyme at room temperature. CoA, acetyl-, and malonyl- 
CoA had no effect on the rate of reactivation. As a 
result of these findings the authors suggested that the 
correct positioning of the phosphate group on NADPH may 
be critical in the reactivation process, and proposed a 
role for phosphates in the regulation of full FAS activity 
through a conformational change such as that shown in
Fig.1 .9 .
In this respect the potent inhibition by NADP* of 
goose uropygial gland FAS has been reported by Poulose and 
Kolattukudy (I981). They have shown that FAS activity is 
inhibited by increasing the NADP* / NADPH ratio.
The NADP^ induced inhibition of the overall activity of 
FAS, the ketoreductase and the enoyl reductase is competi­
tive with respect to NADPH with values of 6p.M, 40M-M and 
26O11M, respectively. Furthermore the condensing activity 
of FAS was found to be severely inhibited, and this 
inhibition was abolished by modification of the NADPH
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binding site of the enoyl reductase domain with pyridoxal 
phosphate. Under these conditions NADPH was unable to both 
induce the dimerization of the FAS subunits and prevent 
proteolysis of the modified enzyme. NADPH has been shown
to fulfil both these functions in the presence of the un­
modified enzyme. On the basis of these results, Poulose 
and Kalattukudy proposed that the enoyl reductase domain 
of FAS plays a key role in the interdomain interactions
which regulate the activity of the enzyme via the NADP^ /
NADPH ratio.
~Cys-SH HS-Pant
Lpant-SH HS-Cys-
HS-Cys-t rPant-SH
Conformation 
change, O C
HS-Pant-J K^ys-SH
,Cys-SH
— Dissociation
Pant-SH
ACTIVE DIMER TWO INACTIVE 
FORMS OF FAS
INACTIVE
MONOMER
Fig 1.9: The proposed mechanism for the cold inactivation
of FAS (Stoops and Wakil, 198l)
The active dimer requires the juxtapositioning 
of the pantetheine-SH (Pant-SH) and the 
cysteine-SH (Cys-SH). Upon incubation at 0°C 
a conformational change occurs resulting in two 
inactive forms which further dissociate into 
inactive monomers.
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A role for CoA in the regulation of FAS has been 
postulated (Linn and Srere, I98O; Linn et al., I980).
These workers have shown that CoA depleting systems inhibit 
the activity of highly purified rat liver (FAS). Addition 
of CoA to these systems reverses the inhibition (Linn and 
Srere, I98O; Linn et al., I98O; Sedgwick and Smith, I981). 
The rate of elongation of acyl moieties on the enzyme was 
reduced a 100-fold in the absence of CoA, which when 
present promoted the elongation process. Linn and Srere 
(1980) have suggested that CoA is required for the 
termination of the FAS reaction.
In common with other lipogenic enzymes, the synthesis 
of FAS is a well-regulated process, affected by diet and 
hormones. Morris et al., (I982) have measured directly 
the FAS mRNA levels in goose liver using cDNA probes 
isolated from cloned plasmids containing cDNA sequences 
prepared from FAS mRNA. These workers have correlated 
the rate of hepatic fatty acid synthesis in neonatal 
goslings to the increase in the amount of the mRNA for 
FAS.
It has been known for a long time now that fasting 
and the diabetic condition results in a reduction in the 
activity of FAS, while re-feeding with a high carbo­
hydrate, low-fat diet and insulin administration increases 
the enzyme activity (Craig et al., 1972; Lakshmanan et al., 
1972; Craig and Porter, 1973). Fructose has been report­
ed to be a better inducer of the hepatic FAS than glucose 
(Bruckdorfer et al., 1972; Volpe and Vagelos, 1974).
Hormonal regulation of the dietary induction of liver 
FAS has been demonstrated (for review see Volpe and Vagelos, 
1976). Glucagon and cAMP have been found to inhibit FAS 
induction in fasted-refed rats (Lakshmanan et al., 1972; 
Volpe and Marasa, 1975). These authors have suggested 
that the relative levels of insulin and glucagon in the 
blood regulate the activity of this enzyme. Some authors
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have attributed the hormone-induced changes to alterations 
in the rate of enzyme synthesis operating at the trans­
lational level of protein synthesis (Lakshmanan et al.,
1972, 1975; Pry and Porter, I981). In diabetic, but not 
normal, rats, adrenalectomy can restore the depressed (FAS) 
levels (Volpe and Marasa, 1975). Spence and Pitot (1982) 
have demonstrated the effect of insulin and other hormones 
in rat hepatocytes (see ].a.(i)). Joshi and Kasturi (I982) 
have reported that antimicrotubular agents (colchicine, 
colcemid, and vinblQ‘5b»n6. ) inhibit the insulin induction of 
FAS and stearoyl-CoA desaturase in cultured liver explants. 
For instance IM-M colchicine inhibits the insulin induction 
of the two lipogenic enzymes by 90%. The colchicine effect 
was shown to be specific for the insulin-induced synthesis 
of the synthase and the A  ^  desaturase. Since colchicine 
has no effect on the induction of malic enzyme by T^, 
colchicine appears to interfere with the induction of 
synthase by insulin. Lumicolchicine, an inactive isomer 
of colchicine, does not inhibit insulin induction of 
lipogenic enzymes.
The overall regulation of lipogenesis has been re­
viewed recently (Saggerson, I98O; Wakil et al., 1983).
It is clear from these reviews that while the long-term 
regulation of fatty acid synthesis is becoming clearer, 
the short-term regulation of the enzyme is still not well- 
understood.
b. Glutathione reductase
Glutathione reductase catalyses the reduction of 
oxidised glutathione as shown below:-
GSSG + NADPH ----------- ► 2GSH + NADP+
The enzyme has been purified from rat liver (Mize and 
Langdon, 1962a; Carlberg and Mannervik, 1975). The 
native enzyme is a dimer with a molecular weight of
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125,000. The enzyme contains two FAD molecules which 
are reducible by NADPH, GSH or dithioerythritol (Carlberg 
and Mannervik, 1975). GSSG reoxidises the reduced FAD. 
However, Mize and Langdon failed to demonstrate the 
presence of FAD in the enzyme molecule. The flavoenzyme 
purified by Carlberg and Mannervik can also utilize NADH 
at about 10% of the rate with NADPH, under optimal 
conditions. 1 he pH dependence of the two activities w<us 
however, different, optimal activity with NADH being 
obtained between pH 5.0 and 5.5 and that with NADPH being 
about pH 7.0. Next to GSSG, the mixed disulphide of CoA 
and GSH (CoA-SSG) was shown to be the best substrate, 
being able to elicit a glutathione reductase activity of 
10% of that obtained with GSSG. Cystine and Cy-SSG were 
shown to be very poor substrates iO,J+% Vmax) . The pH 
dependence of the CoA-SSG and Cy-SSG reductions exhibited 
lower pH optima (about pH 6 ) than the reduction of GSSG 
(pH 7). On the other hand Mize and Langdon reported that 
cystine was utilized at about 5% of the rate with gluta­
thione .
The K of glutathione reductase for NADPH was found m
to be 7.9(J>M and that for GSSG was 56.7|-l^  (Carlberg and 
Mannervik, 1975). These values are comparable with the 
figures reported by Mize and Langdon (1962a). NADP* was 
shown to be a non-competitive inhibitor with respect to 
NADPH. The inhibition was 50% with lOOliM-NADP"^ when the 
concentrations of NADPH and GSSG were lOp-M and l.OmM, 
respectively. NADPH ( 340p>M) was shown to fully inhibit 
glutathione reductase (Mize and Langdon, 1962a).
Mize and Langdon (1962b) proposed that one thiol 
residue on the enzyme protein participates in the 
catalytic event leading to the reduction of oxidised 
glutathione, as shown below:
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Enzyme - SH + GSSG4
Enzyme - SSG + GSH
+ NADPH
Enzyme - SH + GSH + NADP^
i.e. Enzyme + GSSG + NADPH- ^ Enzyme + NADP* + 2GSH
The GSH produced by the action of glutathione reductase is 
involved in a wide range of enzymatic reactions. A major 
function of GSH is to serve as a reductant in oxidation- 
reduction processes, a function resulting in the re­
generation of GSSG (Boyland and Chasseaud, 1969; Meister,
1982). The reduction of GSSG is consequently of 
fundamental importance in organs exhibiting high activities 
of most of the GSH-dependent biochemical reactions, such 
as mammalian liver. In phagocytosis, for example, the 
HgOg levels are raised in order to destroy bacteria 
ingested during phagocytosis; this H^O^ has to be removed 
to prevent tissue damage. Under these conditions reduced 
glutathione, the predominant form of glutathione (Owens 
et al., 1965), can be oxidised to GSSG with consequent 
removal of H O  as shown below (Reed, I969):-
HgOg + 2GSH --------^ GSSG + 2H^0
glutathione
peroxidase
The GSSG can be reduced to GSH by the action of gluta­
thione reductase, this being accompanied by the removal 
of NADPH and the production of NADP* which would favour 
the stimulation of the PPP.
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May (1981) has attempted to determine the role of 
glutathione in the short-term regulation of the PPP 
activity in rat adipocytes. He showed that incubation 
of adipocytes with H^O^ (60|J.M) in the presence of l.lmM 
glucose over a 20min period resulted in a small reduction 
in GSH concentration and a more rapid recovery when 
compared to incubations performed in the absence of 
glucose. In addition, H^O^-treated cells showed an 
increase in glucose C-l oxidation when compared to cells 
incubated with glucose alone. The implication of these 
results is that the PPP activity was increased by H^O^ 
treatment and that the cycle was providing NADPH for rapid 
regeneration of GSH via glutathione reductase. Lowering 
of GSH to 35-60% of control values by addition of agents 
such as t-butyl hydroperoxide, diamide or the sulfhydryl 
blocker N-ethyl-maleimide resulted in the stimulation of 
the PPP.
May (1981) did, however, demonstrate that the PPP 
could also be stimulated by reducing the NADPH / NADP* 
ratio without affecting the cellular GSH content (for 
example by addition of methylene blue). The conclusion 
drawn from this work was that the PPP contributes to the 
regeneration of GSH, and that glutathione metabolism, 
directly or indirectly, may play a significant role in 
the regulation of the PPP. Furthermore, the PPP is 
likely to be regulated by a mechanism independent of 
glutathione metabolism.
Elsayed et al., (I982) have related the activity of 
the PPP in lungs of mice to glutathione metabolism and 
dietary selenium levels. They have observed that when 
animals are exposed to air, selenium deficiency causes a 
reduction in glutathione peroxidase activity when 
compared to animals on selenium-supplemented diets.
However, exposure to ozone results in an increase in 
glutathione reductase, G6PDH and 6PGDH activity, which 
is in proportion to the dietary selenium levels. Under 
these conditions glutathione peroxidase activity remained
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constant. The stimulation of the PPP was found to be 
dependent on the presence of selenium in the diet.
An important aspect of this inter-relationship between 
the PPP and glutathione metabolism is that, coupled together 
the two systems form an important cellular defence mechanism 
by which the cell can withstand the damaging effects of
oxidant stress from exogenous (inhaled 0 , NO or high
J
levels of 0^) or endogenous (such as hydrogen peroxide or 
other peroxides formed in the membrane) sources. Since the 
PPP has been reported to contribute to the biosynthetic 
processes in cells under oxidant stress (Tierney et al., 
1973), inhibition of the PPP would interfere with the 
capacity of the injured cells to regenerate new cell 
components.
It is important to note that the regulation of the PPP 
dehydrogenases by GSH/GSSG ratios depends on the oxidation 
of GSH to GSSG, which is in turn reduced to GSH by gluta­
thione reductase. Since in the normal animal most of the 
glutathione is in the reduced form (Owens et al., 1965;
Veech et al., I969) it is difficult to ascertain the role 
of glutathione reductase in the regulation of the PPP in 
the absence of oxidant stress. This consideration 
emphasises the need for a regulatory mechanism independent 
of the glutathione reductase catalysed reaction.
Another cytoplasmic enzyme that could utilize NADPH 
indirectly is thioltransferase (Axelson et al., 1978).
This enzyme catalyzes the thioldisulphide interchange of 
glutathione and disulphides as shown below;-
RSSr'+ 2GSH ----------»R'SH + RSH + GSSG
NADPH
glutathione reductase 
The regulatory significance of the consumption of NADPH by
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these thiol-disulphide exchange reactions is still an.area 
that is little understood. The elucidation of the precise 
effect that these reactions have on the cytoplasmic NADP^ 
pool and the NADP / NADPH ratio still remains to be 
determined.
c. Other NADPH-dependent disulphide reducing reactions
Tietze (1970b) has reported the presence of a non­
specific NADPH-dependent disulphide reductase in the 
soluble fraction of rat liver homogenates. This enzyme 
promotes the reduction of the disulphide bonds of protein 
and non-protein substrates in the presence of NADPH, but 
not NADH. The activity could not be detected in the 
mitochondrial or microsomal fractions and was therefore
assumed to be exclusively cytoplasmic. The enzyme is
~*4completely inhibited by incubation with 10 M-arsenite, a 
treatment which, according to Tietze, had no effect on 
glutathione reductase, under similar experimental 
conditions. Mize and Langdon (1962a) have, however, 
reported that sodium arsenite (3x10 ^M) inhibited their 
preparation of glutathione reductase provided the enzyme 
was not preincubated with EDTA (3*3x10 ^M) or GSSG 
(5.6x10"^M). Unlike glutathione reductase, the non­
specific reductase was destroyed by heating to 70° for 
30min (Tietze, 1970b).
The stoichiometry of this reaction was reported to be;- 
R-S-S-R* + NADPH ----- ^ R^SH + RSH + NADP+
The enzyme shares some common characteristics with 
the enzyme system participating in the reduction of 
ribonucleotides in deoxyribonucleotide synthesis (Fig.1.10). 
These characteristics are: the specificity towards NADPH,
the sensitivity to arsenite and the capacity to be resolved 
into heat-stable and heat-labile components (Reichard,
1968; Tietze, 1970b).
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The enzyme system involved in the reduction of 
ribonucleotides includes thioredoxin reductase which is 
NADPH-dependent and ribonucleotide reductase which is 
thioredoxin specific but shows a broad specificity toward 
the disulphide substrates (Gonzales-Porque et__al. , 1970; 
Hall et al., 1971). This is similar to the enzyme system 
of Tietze (l970b). The reaction scheme for the thio­
redoxin system is shown below:-
SH
NADP
NADPH
H+
Thioredoxin
(reduced)
Thioredoxin
reductase
SH \ + NADP
Ribonucleoside 5 -di­
phosphate
Ribonucleotide reductase
Thioredoxin^ 1 + deoxyribonucleoside 5 ^-di-
(oxidised) S phosphate
Fig.1.10: The Thioredoxin system: oxidised thioredoxin
is reduced by NADPH dependent thioredoxin 
reductase. Reduced thioredoxin then reduces 
ribonucleotide reductase which can then 
catalyse the reduction of ribonucleotides.
Luthman and Holmgren (1982a)have purified reduced
thioredoxin and thioredoxin reductase from rat liver.
These authors have failed to purify the oxidised form of
thioredoxin. The molecular weight of thioredoxin was
found to be 12 000 and the compound was shown to contain
about 110 amino acids including 4 half cystines and an
N-terminal valine. Thioredoxin reductase has a native
molecular weight of ll6 000. The enzyme is highly
specific for NADPH (K = 6^M), contains FAD as them —
prosthetic group, is sensitive to inhibition by arsenite
and exhibits a K of 2.5^M for rat liver thioredoxin.m '
Holmgren (1977) reported that thioredoxin will not 
form a stable complex with thioredoxin reductase when the 
two purified proteins are mixed in solution and the two 
proteins separate completely when a crude extract of liver 
is subjected to gel filtration. Holmgren (1977) has 
proposed that the non-specific NADPH-dependent disulphide 
reductase described by Tietze (l970b) is identical with 
the mammalian thioredoxin system. This is feasible since 
the dialyzed rat liver high speed supernatants would 
contain both the thioredoxin reductase and the ribonucleo­
tide reductase.
d. The mixed function oxidase system
The mixed function oxidation (MFO) of abiotic 
compounds, by the liver, involving cytochrome P-450, is 
thought to be a quantitatively important use of hepatic 
cytoplasmic NADPH (Altman and Chayen, 1970; Chayen et al., 
1973; Smith and Wills, 1981^. In glycogen-rich livers 
from fed rats the supply of NADPH reducing equivalents for 
the monooxygenase system is thought to be met by the PPP, 
whereas in glycogen-depleted livers, the cytochrome P-450 
linked monooxygenase system depends on the mitochondrial- 
derived production of reducing equivalents (Thurman and 
Scholz, 1969; Moldeus et al., 1974; Junge and Brand, 
1975). The cytosolic and mitochondrial NADP^-linked 
isocitrate dehydrogenases and the tricarboxylate/ 
dicarboxylate translocators provide a transfer system 
for NADPH reducing equivalents (Papa, 1969; Hoek and 
Ernster, 1974) from the mitochondria.
Weigl and Sies, (1977) have presented evidence which 
suggests that the supply of NADPH for the monooxygenase 
system by the PPP is accompanied by the supply of NADPH 
by extra-mitochondrial NADP^-linked isocitrate dehydro­
genase even in the fed state.
Changes in nicotinamide and adenine dinucleotides
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that accompany mixed function oxidation have been shown 
to have significant effects on intermediary metabolism.
For example, steady-state concentrations of intermediates 
associated with glycolysis, the PPP and citric acid cycle 
have been found to change during mixed function oxidation 
(Sies and Kendal, 1970; Kauffman et al., 1977). Further­
more, the NADPH / NADP^ ratio in rat liver is select­
ively decreased (by about 42%) during MFO, whereas the 
NADH / NAD^ ratio remains unchanged (Sies et al.,
1981). The oxidation of NADPH occurs in both the mito­
chondrial and cytosolic compartments of the hepatocyte 
(Weigl and Sies, 1977). Kauffman et al. (1979) have 
demonstrated that fructose infusion of starved rats 
increases the rate of p-nitro-anisole 0-demethylation by 
50%. Fructose has been shown to lower intracellular 
ATP levels (Woods et al., 1970; M^enpaa et al., I968) 
and Kauffman et al. (1979) have attributed the increase 
in MFO to the de-inhibition of NADPH-cytochrome c reductase 
resulting from the decreased ATP concentration.
Since cytochrome c reductase is the rate-limiting 
component of mixed function oxidation (Vermilion and Coon, 
1978), the increased consumption of NADPH and the reduced 
levels of ATP (see A.l.b) could, in turn, relieve the PPP 
and other NADPH-generating enzymes.
Thurman and Scholz (1973) have postulated that the 
cyt. P-450-linked monooxygenase system may compete with 
lipogenesis for NADPH, since inhibition of lipogenesis 
occurs during the oxidation of aminopyrine. The authors 
found that in livers of phenobarbital-pretreated rats, 
the addition of aminopyrine to the perfusate inhibited 
the incorporation of ^ H^(^ into total lipids by about 40%.
It is possible that this apparent inhibition is an 
artifact resulting from isotopic dilution of the j^ H*3 in 
NADPH, which would be expected to occur as a consequence 
of the increased turnover in the NADPH pool due to the 
enhanced mixed-funetion oxidation. The authors
90
eliminated this possibility by demonstrating a similar 
inhibition of incorporation of glucose into lipids.
The aminopyrine effect was found to be induced by 
phénobarbital, this being a known inducer of MFO. Amino­
pyrine by itself only caused an l8% inhibition of Lipo­
genesis. This suggested to the authors that it was the 
metabolism of aminopyrine, rather than the compound itself, 
that elicited the inhibition of lipogenesis. Aminophenyl- 
pyrazolone, a product of aminopyrine metabolism was shown 
to have no inhibitory effect on lipogenesis. Since amino- 
phenylpyrazolone can be acetylated with acetyl-CoA, the' 
lack of effect of this compound on lipogenesis, and the 
observation that the rate of acétylation of aminoanti- 
pyrine (another product of aminopyrine metabolism) was 
insignificant, implies that there was no diversion of 
acetyl-CoA from fatty acid synthesis to acétylation. 
Aminopyrine was shown not to affect the ATP/ADP ratio.
This eliminates the involvement of an altered energetic 
state of the liver.
Under their experimental conditions Thurman and
Scholz (1973) estimated that the NADPH requirement for
-1 -1the MFO was about 40^mol NADPH g liver h and that for
-1 -1lipogenesis was 50|lmol NADPH g liver h . The total 
requirement of NADPH under these conditions may surpass 
the capacity of the liver for NADPH generation and result 
in the inhibition of one or more of the NADPH utilizing 
pathways.
Smith and Wills (I98W have reported that the cyto­
chrome P-450 content of rat liver is increased by fat- 
feeding, whereas feeding a fat-free diet was shown to 
result in a decrease in both the cyt. P-450 content and 
the rate of aminopyrine N-demethylation, relative to the 
stock diet-fed rats. Fat-feeding depressed fatty acid 
synthesis, and feeding a fat-free diet had the reverse 
effect. The feeding period was 10-24 days, S odium pheno- 
barbitone, which was shown to increase both the cyt. P—450
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content and the rate of aminopyrine N-demethylation, only 
had a slight inhibitory effect on the activity of fatty 
acid synthase (4.94 to 4 .71^mol NADPH oxidised min”  ^ g”  ^
of cytosolic protein).
G6PDH activity was shown to be twice as high in the 
centrilobular hepatocytes as in the periportal hepato­
cytes from stock—diet fed rats. Furthermore sodium 
phenobarbitone selectively increased G6PDH in the centri­
lobular hepatocytes. On the other hand, transferring 
rats from a stock diet to a fat-free diet caused a 
significant increase in the activity of G6PDH in both 
regions of the liver, the increase being more marked in 
the periportal hepatocytes. A diet containing herring 
oil, but not c o m  oil, significantly reduced the G6PDH 
activity in both regions. These observations, coupled 
with the finding that the ratio of the rate of drug 
oxidation to the rate of fatty acid synthesis was twice 
as high in the centrilobular hepatocytes as in the 
periportal cells suggest that more NADPH is available 
to the MFO in the former cells, and that these cells 
which have a higher cyt. P-450 content. (Smith and 
Wills, 1981a) are more important in the oxidative 
metabolism of foreign compounds than periportal cells.
The effect of phenobarbitone, a known inducer of MFO, 
implies that more NADPH is channelled towards MFO in the 
centrilobular hepatocytes after phenobarbitone pre­
treatment. This implies a competition for NADPH between 
the two pathways of NADPH consumption under consideration. 
Two groups support the view that the rate of supply of NADPH 
may be the rate limiting factor in controlling MFO and 
lipogenesis in whole liver cells (Thurman and Scho]^^
1973; Thurman et al. , 1977; Smith and Wills, 198l|), 
although it has been argued that NADPH cannot be limiting 
since the activities of the NADPH-generating enzymes are 
an order of magnitude higher than the activity of FAS.
The latter argument is, however, based on in vitro 
observations which may not necessarily reflect in vivo
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conditions (see 1.2).
Data on the absolute quantitative distribution of 
NADPH between the various pathways of NADPH utilization 
is not available. Research workers in this field have, 
in the main, assumed that lipogenesis is the major 
NADPH-utilizing biosynthetic process and have based their 
calculations on this. However, it is possible that 
there are other pathways of comparable rates, which use 
NADPH (for instance the reduction of disulphides) and 
significantly affect the cytosolic NADPH pool.
C. FRUCTOSE 2,6-BISPHOSPHATE
1. General considerations
Fructose 2,6-bisphosphate (F2,6Pg) was first reported
to be a positive effector of ATP-D-fruetose-6-phosphate-l-
phospho-transferase (PFK-l) a key regulatory enzyme of
glycolysis by Van Schaftingen et al. (I980a). This role
of fructose 2,6-bisphosphate has been confirmed by other
groups of workers (Claus et al., I98I; Kitajima and
Uyeda, I983; Pilkis et al., I981). PFK-l is now
believed to be regulated primarily by AMP, fructose 2,6-
bisphosphate and fructose 6-phosphate (Van Schaftingen
et al., 1980a,b,c). These authors have indicated that
fructose 2,6-bisphosphate and AMP act synergistically in
their stimulation of PFK-l. Under these conditions of
stimulation the K of PFK-l for fructose 6-phosphatem
(F6P) is reduced from 6mM to 0.6 mM, the latter being 
closer to the physiological value. Fructose 2,6- 
bisphosphate, AMP and inorganic phosphate counteract the 
inhibition of PFK-l by citrate and ATP. Conversely, 
fructose-1,6-bisphosphatase, a key regulatory enzyme of 
gluconeogenesis, is inhibited by fructose 2,6-bisphosphate 
and AMP (Pilkis et al., I981). A review on the physical 
and regulatory properties of fructose 2,6-bisphosphate has 
appeared (Hers and Van Schaftingen, I982).
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A number of workers (Van Schaftingen et al. , c ;
Hue et al., 1983a ; El—maghrabi et al. , I981) have shown 
that an enzyme which is distinct from PFK-l catalyses the 
formation of fructose 2,6-bisphosphate from fructose 6- 
phosphate and ATP. This enzyme has been called PFK-2 and 
the stoichiometry of the reaction it catalyses is shown 
below:-
F6P + ATP Mg ------------ ^ADP Mg +
F2,6P2
Furuya and Uyeda (I98I) have shown that PFK-l is almost 
500 times as active as PFK-2. This is in agreement with 
the concept that PFK-l catalyses a major step in the 
glycolytic pathway and that only a small amount of fructose
2,6-bisphosphate is required to stimulate PFK-l. The Km
values reported for ATP and F6P are 0 .2-0.4 and 5nM, 
respectively.
An enzyme catalysing the breakdown of F2,6 P^ has been 
isolated and is a specific fructose-2,6-bisphosphatase 
(Van Schaftingen et al., 1982a,b}. PFK-2 and FBPase- 2
(or F2,6BPase) activities appear to be present on the same 
protein.
The level of fructose 2,6-bisphosphate in rat liver 
is regulated by both hormonal and metabolic factors. Hue 
et al. (1981a) have reported that vasopressin, phenylephrine 
and A23187 cause an accumulation of fructose 2,6-bisphos­
phate in hepatocytes from fed rats. The effect was
2 +abolished by overnight starvation, Ca -depletion and 
phosphorylase kinase deficiency. On the other hand 
glucose can cause the accumulation of fructose 2,6-bis- 
phosphate regardless of the state of activation of phos­
phorylase or of the glycogen content of the cells. These 
findings indicate that it is the increased concentration 
of F6P, due to increased glycogeneolysis resulting from 
treatment with these hormones, which is responsible for 
the observed increase in F2^6Pg. This hypothesis is 
reinforced by the correlation observed between hexose 6-
9''
phosphate concentration and the level of fructose 2,6-bis- 
phosphate (Hue et al., 198la), Treatment of rats with 
glucagon or incubation of hepatocytes with this hormone 
was also shown to cause an inactivation of PFK-2. This 
inactivation was attributed to a stable modification of 
the enzyme, which was accompanied by changes in the 
kinetic properties of the enzyme such that the activity is 
reduced at both low and high concentrations of substrate. 
The implication of these results is that the effect of
^  glucagon to decrease the level of fructose 2,6-bisphosphate 
I vesutt
/ is the'] of cyclic AMP-dependent phosphorylation
and inactivation of the enzyme responsible for its 
synthesis. Van Schaftingen et al. (I98lb)have shown that 
treatment of PFK-2 with the catalytic sub-unit of cAMP- 
dependent protein kinase reduces the affinity of PFK-2 for 
fructose 6-phosphate, its V^^^, and its sensitivity to the 
stimulatory effect of P^. The susceptibility of the 
enzyme to inhibition by phospho-enol-pyruvate and citrate 
were increased. Since glucagon also increases the 
concentration of phospho-enol-pyruvate in rat liver (Exton 
and Park, 1968), these two mechanisms would act in concert 
to reduce fructose 2,6-bisphosphate levels. The rapid 
disappearance of fructose 2,6-bisphosphate observed in 
glucagon-treated cells is the result of an increased 
fructose 2,6-bisphosphatase activity.
Alloxan diabetes and starvation (?2h) were shown to 
decrease the level of fructose 2,6-bisphosphate to 10% of 
the value found in livers of normal, fed rats (lOnmol 
g  ^ liver) (Neely et al., I981). The activity of PFK-2 
was also shown to be reduced by diabetes. Insulin 
administration for 24h to diabetic rats restored the 
fructose 2,6-bisphosphate levels. Refeeding a high 
carbohydrate diet for 24h to the ?2h-starved rats resulted 
in a fructose 2,6-bisphosphate level that was 2.5 fold 
higher than that found in livers of fed rats. The 
decrease in fructose 2,6-bisphosphate levels correlates 
well with the decreased rates of glycolysis and enhanced 
rates of gluconeogenesis that are observed in diabetes
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and starvation, hence supporting the role of this effector 
in the regulation of carbohydrate metabolism. The decreas­
ed levels of fructose 2,6-bisphosphate can be attributed to 
the increase in glucagon which occurs during starvation and 
diabetes. The elevated glucagon content (and decreased 
insulin levels) would inactivate PFK-2 and reduce fructose
2,6-bisphosphate concentration as discussed above. Further­
more, Neely et al. (I981) have demonstrated a decreased 
level of glucokinase in starvation and diabetes - a 
condition which would result in the reduction of F6P 
content. Insulin has been shown to antagonise the effects 
of glucagon (Pilkis et al., I983).
Bartrons et al. (I983) have shown that PFK-2 and 
fructose-2 ,6-bisphosphatase (FBPase 2) are poor substrates 
for cyclic AMP-dependent protein kinase, in isolated 
hepatocytes, when compared to pyruvate kinase and phos­
phorylase. They also showed that PFK-2 and FBPase 2 were 
inactivated and activated, respectively, in parallel and 
that the time required to reach half-maximal modification 
was 5-10-fold longer than for the inactivation of pyruvate 
kinase. The half maximal effect of glucagon was usually 
obtained at 0 .2-0 .4nM, which is comparable to that reported 
for phosphorylase and pyruvate kinase, and implies that the 
fructose 2,6-bisphosphate system is equally sensitive to 
the cAMP dependent phosphorylating system. This suggests 
that fructose 2,6-bisphosphate concentration plays a 
significant role in the control of gluconeogenesis by 
glucagon. No evidence has been presented for a cyclic- 
AMP independent mechanism for phosphorylating the apparent­
ly single bifunctional protein, which is thought to contain 
PFK-2 and FBPase-2 activity.
These experimental observations imply that the 
physiological regulators of fructose 2,'G-bisphosphate 
concentration in rat liver are glucagon and fructose 6- 
phosphate availability. Van Schaftingen et al. (1984) 
have reported that ethanol administration to fed rats
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(intragastrie) causes a 20-fold decrease in the concentrat­
ion of fructose 2,6-bisphosphate, an activation of FBPase, 
an inactivation of PFK-2 but no change in cAMP. Isolated 
hepatocytes incubated in the presence of ethanol were 
found to exhibit a rapid increase in sn-glycerol 3-phos­
phate content and a continuous decrease in fructose 2,6- 
bisphosphate, with no change in the hexose 6-phosphate 
content. These authors found that at a given concentration 
of hexose 6-phosphate, there was an inverse relationship 
between the concentration of fructose 2,6-bisphosphate and 
that of sn-glycerol 3-pbosphate. sn-Glycerol 3-phosphate 
inhibits PFK-2 and counteracts the inhibition of FBPase by 
F6P. sn-Glycerol 3-pbosphate was also shown to accelerate 
the inactivation of PFK-2 by cAMP-dependent protein kinase.
Since the effect of ethanol is shared by other sub­
strates of alcohol dehydrogenase (butan l-ol and crotyl 
alcohol^ and by acetaldehyde, and is inhibited by methyl- 
pyrazole, the authors argued that the decrease in the 
concentration of fructose 2,6-bisphosphate in the liver is 
mediated by the reduction of NAD*. Further, l|lM fructose
2,6-bisphosphate inhibited the inactivation of PFK-2 by 
cAMP-dependent protein kinase. Glycerol 3-phosphate 
(imM) had the reverse effect. On the basis of these 
results. Van Schaftingen et al. (1984) have concluded that 
the changes in the activity of PFK-2 and FBPase-2 are the 
result rather than the cause of the decrease in the 
concentration of fructose 2,6-bisphosphate. The cellular
concentration of fructose 2,6-bisphosphate is also decreased 
by adenosine (Bartrons et al., 1984).
The highest concentration of fructose 2,6-bisphosphate 
has been found in liver (Kuwajima and Uyeda, 1982). Livers 
of genetically obese rats, starved for 24h were shown to 
contain more fructose 2,6-bisphosphate, glucose 6-phosphate, 
fructose 6-phosphate and glycogen and more pyruvate kinase 
and PFK-2 activities than livers of control lean rats.
(Hue et al., I983). This was attributed to the change in
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cAMP concentration, which was found to be decreased in 
livers of obese starved rats.
All these observations suggest that fructose 2,6-bis­
phosphate is a key regulator of carbohydrate metabolism.
2• Fructose 2,6-bisphosphate, the PPP and lipogenesis.
Since the PPP and glycolysis share a common substrate, 
G6P, and since the cofactor of Eggleston and Krebs (1974) 
has not been identified the initial aim of the project was 
to determine the effect of fructose 2,6-bisphosphate on the 
activity of the PPP dehydrogenases, with particular refer­
ence to the NADPH inhibition. Furthermore, the isomers 
of fructose 2,6-bisphosphate, fructose 1,6-bisphosphate 
(Fl6Pg) and glucose 1,6-bisphosphate (Gl,6Pg) have been 
shown to inhibit 6PGDH (Dyson and D ’Orazio, 1971; Beitner 
and Nordenberg, 1979) and Fl,6Pg has been reported to be 
an activator of the fatty acid synthase complex (Plate e_t 
al., 1968).
and . (1982) have found that the
stimulatory effect of 6PG on PFK-l was additive to that of 
fructose 2,6-bisphosphate in the presence of physiological 
concentrations of ATP, AMP and ADP. Since 6PG is not an 
intermediate metabolite of glycolysis and since its 
stimulatory effect on hepatic pyruvate kinase is more 
pronounced during lipogenesis (Smith and Freedland, 1979; 
1981), 6PG can be assumed to be a means of communication 
between two pathways central to lipogenesis.
Blackmore and Shuman (I982) have demonstrated a 
parallel increase in the conversion of altro heptulose 7- 
phosphate (sedoheptulose—7—phosphate) to altro heptulose
1,7-bisphosphate with increasing concentrations of F2,6P2* 
The F2,6P2 levels were increased by perfusion with 
glucose. An obvious criticism of this work is that 
F2,6P2 does not have to act directly on the kinase 
catalysing this reaction in order to increase the product­
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ion of altro heptulose 1,7-bisphosphate. Karadsheh et al. 
(1973) have shown that PFK-l can catalyse this reaction, 
and the observed increase in the rate of the reaction may 
just be a reflection of the enhanced activity of PFK-l 
due to the elevated levels of fructose 2,6-bisphosphate. 
Conversely, the effect of glucagon (which was shown to 
decrease the reaction rate) can be attributed to the 
inhibition of PFK-l and the activation of FBPase-1, since 
Bonsignore et al. (I963) have shown that FBPase-1 can 
catalyse the reverse reaction. The observations reported 
by Blackmore and Shuman (1982) can be, therefore, attributed 
to the known effects of fructose 2,6-bisphosphate on these 
two enzymes. These results do, however, suggest that 
F2,6P2 may affect the flux through the PPP, albeit 
indirectly.
The aim of this project was to attempt to demonstrate 
a direct effect of F2,6P^ on the PPP and/or on lipogenesis 
in particular the fatty acid synthase complex. This 
approach was based on the observation that the PPP, lipo­
genesis and glycolysis are interrelated and share common 
regulators most of which have been mentioned. In addition 
the pathways show an interdependence since glycolysis via 
pyruvate provides acetyl-CoA for lipogenesis, and the PPP 
supplies the NADPH required for the reductive steps of the
biosynthesis. Given these considerations it was reasonable
to postulate that a potent regulator of glycolysis, such 
as F2,6P2 been shown to be, would have a direct effect
on either the PPP or one of the regulatory enzymes of
lipogenesis.
However, in the course of this work no such observation 
was made. In fact, apart from PFK-l and FBPase-1, the 
only other enzyme so far shown to be affected by F2,6P2 is 
bacterial and plant PP^-PFK (pyrophosphate: fructose-6-
phosphate phosphotransferase).
Having failed in the initial objective a broader
99
approach to the regulation of the PPP and,in particular, 
the mechanisms involved in the activation of the PPP 
dehydrogenases, was adopted. The effect of glutathione 
and other metabolites was investigated and an attempt 
was made to isolate the cofactor reported by Eggleston 
and Krebs (1974). The observations made are reported in 
the "Results and Discussion" section.
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II. MATERIALS AND METHODS
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A. MATERIALS
1. Chemicals
Analar grade chemicals and solutions prepared in glass 
distilled de-ionised water were used throughout the course 
of this work. Unless otherwise stated, all enzymes and 
substrates were obtained from Sigma (London), as were all 
column materials except Bio-Gel P-2, which was purchased 
from Bio-Rad (Watford, Herts.). BDH Chemicals Ltd.
(Poole, Dorset) supplied the solvents and acid solutions.
All radioactive materials were supplied by the Radio­
chemical Centre (Amersham, Bucks.).
Bovine serum albumin, fraction V (fatty acid-free), 
from Sigma, was used for hepatocyte preparations. Sagatal 
(sodium pentobarbitone) was the anaesthetic used and was 
obtained from Southern Vet. Services Ltd. (Lewis, East 
Sussex).
2. Specified equipment
Plastic-backed silica gel t.l.c. - ready-foils (F 1500, 
20x20 cm, acid resistant) were products of Schleicher and 
Schull (GmbH D-3 35'* Dassel, W. Germany). Ultrafiltration 
membranes were bought from Amicon Ltd. (Stonehouse, Glos.). 
Sterile liver cannuli were obtained from Armour Pharmaceuti­
cal Co. Ltd. (Eastbourne, Sussex) and nylon mesh (Nybolt,
No.10, 132 micron) was from J. Staniar and Co. (Manchester, 
U.K.).
The perfusion cabinet consisted of a metal cabinet 
with a glass door. Inside the cabinet, a fan heater 
connected to a thermostat maintained the temperature at 
37°C. In addition the cabinet contained a glass lung 
made to specification (Miller and Smith, 1973)* The 
perfusion medium was circulated with a Watson—Marlow H.R. 
flow inducer (Watson-Marlow Ltd. Bucks.) and Swinnex-13
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filter units (Buc. France) were used to filter the 
circulating perfusate.
3* Animals
The rats (Wistar strain) were bred in the laboratory, 
animal house and were maintained on a standard commercial 
diet, Diet PMD obtained from Labsure (High Wycombe, Bucks; 
Table 2.1). The rats were subjected to a 12h light/12h 
dark regime in an animal house maintained at 22 - 2°C.
The light period commenced at 6 a.m. and ended at 6 p.m.
Table 2.1: Composition of Diet PMD
Constituent % of feed
crude oil 2.7
crude protein 19.7
crude fibre 5.3
calcium 0.6
phosphorous 0.7
NaCl 1.0
carbohydrate 53.'i8
♦Values obtained from the suppliers (Labsure,
High Wycombe, Bucks.). The total metabolisable 
energy was reported to be 2568 kcal/kg.
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B. METHODS
1. Enzyme Assays
a. Glueose-6-phosphate dehydrogenase (EC 1.1.1.\9)
G6PDH activity was determined by a method of assay 
similar to that used by Eggleston and Krebs (197^) and a 
molar absorption coefficient of 6.22x10^ Mol~^ cm“  ^ was 
assumed in the calculations. The activity of the enzyme 
was measured by following the reduction of NADP* at 340nm.
The assay mixture (total vol. 1ml) was composed of O.IM - 
bis-tris propane (BTP) pH 7.4, 100[lM-NADP^, ImM-MgCl^
(where present), 100|J.M-G6P, and 50|il of a dialysed crude 
high speed supernatant of homogenized rat liver or a 
partially purified preparation (cf. II. B.4a.) of the 
enzyme. The reaction was allowed to proceed at 25°C.
In some experiments NADPH was added to a concentration of 
up to 200[lM.
Crystalline baker's yeast G6PDH (Sigma, type VII) 
activity was determined in the same manner.
b. 6-Phosphogluconate dehydrogenase (EC. 1.1.1.44)
6PGDH was assayed in the manner described by Procsal 
and Holten (1972), with minor modifications. The assay 
mixture was as detailed for G6PDH except that G6P was re­
placed by 100|^M-6PG. The liver enzyme was obtained from 
dialysed high speed supernatants. In some experiments 
the enzyme was partially purified (cf. II. B.4b.). The 
crystalline yeast enzyme (Sigma) was assayed in the same 
manner.
c . Fatty acid synthase
Fatty acid synthase was assayed both (i) spectrophoto— 
metrically (Linn, I981) and (ii) radiochemically (Butterworth 
et al., 1966). In the s p e c trophotometrie method the
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oxidation of NADPH was followed at 340nm at 25°C in a 
reaction mixture (total vol. 1ml) consisting of: 0.09M-
KP^, pH 6.8, 5mM-EDTA, 30uM~ace tyl-CoA, 200|iM-NADPH and 
100^1 of the partially purified (cf. II. B.4c.) or crude 
preparations of the enzyme. Malonyl-CoA (lO(iM) was used 
to start the reaction. In the radiochemical method the 
assay mixture (total vol. 1ml) comprised of 440,000 d.p.m.
Q  - ^'C^ acetyl-CoA, 30|iM-acetyl-CoA, 200pM-DTT;- 200|lM-NADPH, 
EDTA, O.IM-KP^, pH 6.8 and 5-80p.M-malonyl-CoA. The re­
action was allowed to proceed for lOmin before it was 
stopped by the addition of HCLO,^  to a final concentration 
of 1.8 °o (w/v). The synthesized fatty acids were extract­
ed (cf. II. B.3b.) and the incorporation of ^  ^^cj
acetyl-CoA determined by assaying for the radioactivity in 
toluene scintillant (5g PPO/L toluene; 10ml) using a 
Beckman LS 7500 liquid scintillation spectrometer.
d. Phosphofrue tokinase-1 (EC 2.7*1.11)
PFK-1 activity was determined in desalted high speed
(l00,000g) supernatant preparations derived from liver
homogenates by the method of Van Schaftingen et al.
(1980a,b.). The oxidation of NADH in the presence of
ATP and F6P was followed at 340nm. The auxiliary enzymes
phosphoglucose isomerase, triose phosphate isomerase,
glycerophosphate dehydrogenase and aldolase were used as
auxiliary enzymes in this assay system. The assay
mixture (total vol. 1ml) contained 50mM-Hepes, pH 7*1,
lOOmM-KC] , 5mM-MgCl^, lOOpM-NADH, lmM-NH,^Cl , 50pl of the
desalted auxiliary enzymes, 5mM-KP^, pH 7*1, lOOpM-AMP,
50pl PFK-1 and 20-50pl 100mM/350mM-F6P/G6P. The re-
2 +action was initiated with 1.5mM-ATP-Mg (pH 7*0). In 
experiments with F2,6P^, lOpl of the compound was added 
to give the specified concentration.
e. The NADPH-dependent disulphide reductase
The reductase responsible for the oxidation of NADPH 
as described in III.c. was assayed by following the de­
crease in the absorbance at 34 Qnm. The incubation
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mixture (total vol. 1ml) contained; lOOmM-BTP/HCl, 
pH 7.5 , lOOpM-,NADPH, an appropriate volume of the di­
sulphide-containing preparation and enzyme. The sources 
of the enzyme and the substrate are indicated in indi­
vidual legends. The assay was routinely performed at
25 0. Deviations from this standard assay system are 
detailed in the appropriate sections.
f. Glutathione reductase (EC 1.6.4.2)
The method of assay used was essentially that of 
Mize and Langdon (I962) except that BTP/HCl was used as 
the buffer. The oxidation of NADPH ( lOOpH) in the 
presence of lOOpM-GSSG and lOOmM-BTP/HCl at pH 7*0 and 
25°C, in a total volume of 1ml, was followed at 340nm.
2 . Metabolite Assays
a. F2,6P_
When F2 ,6P2 was prepared in the laboratory, its 
presence in preparations was determined by its capacity 
to stimulate PFK-1 (Van Schaftingen et al. 1980c; Hers 
and Van Schaftingen, I982). The assay was performed as 
in II. B. Id. above. A standard curve, based on the 
PFK-1 assay, was prepared by plotting ^/Vmax against 
F2 ,6P2 concentration at sub-optimal concentrations of 
the effector. The latter was synthesized as in II. B.5*
b . Phosphates
( i) The method of Fiske and SubbaRow (1925)
The labile phosphate-content of the samples under 
study was determined by this method as detailed by Leloir 
and Cardini (1957)- The intensity of the blue colour 
resulting from the formation of the phosphomolybdate 
complex was measured at 660nm. The absorbance at 660nm
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was used to determine the phosphate content from a 
standard curve prepared with inorganic phosphate (Leloir 
and Cardini, 1957).
(ii) Hydrolysis of the phosphate bonds with 
alkaline phosphatase
Test samples were hydrolysed by incubation with 
alkaline phosphatase (6 units ml ^) from porcine intestinal 
mucosa, at pH 8.3. The incubation mixture contained 0 .IM- 
BTP/HCl, pH 8*3, the appropriate volume of the test sample, 
alkaline phosphatase and, where included, 0.25mM-ZnCl^ and 
2.5mM-MgCl^. The incubation period was 17h at 4 C and the 
reaction was terminated by heating to 80°C for 15min. 
Parallel control incubations, which did not contain 
alkaline phosphatase, were included and heat-treated in 
the same manner.
c. Carbohydrates
The phenol-sulphuric acid method (Dubois et al.,
1956) was used for the determination of the carbohydrate
content of test samples. The experiments were performed
in the manner described by Ashwell (I966) and the reaction
mixture was composed of 2ml of the test sample and 0 .05ml
of the phenol reagent. To this mixture 5ml of conc.
H SO, was added to initiate the reaction. The colour
2 4
was allowed to develop for 30min after which the absorb­
ance was measured at 485nm.
d. Proteins and amino acids
( i) The Folin-Lowry method
Protein was assayed by the method of Lowry et al.
(1951). In the present study 5Cml of 2% (w/v) Na^ C O ^
in O.lM-NaOH (A) was mixed with 1ml 0.5% CuSO,^  in 1% sodium 
potassium tartarate (B) to give solution C. The Folin 
and Ciocalteu*s .phenol reagent was a commercial preparation
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containing tungstato, rnolybdate, phosphoric and hydro­
chloric acids.
The samples (O.lml) were treated with 0.25ml of 10% 
trichloroacetic acid. The precipitate was removed by 
centrifugation and resuspended in 1ml O.lM-NaOH. Solution 
C (5ml) was added to these samples and allowed to stand 
for lOmin. After this preincubation period 0.5ml of a 
& dilution of the Folin and Ciocalteu's phenol reagent 
was added. The colour was allowed to develop for 30min, 
after which absorbance readings were taken -at 750nm.
The concentration of the protein was determined from a 
standard curve prepared using a standard BSA (500pg ml"^) 
solution.
(ii) Peptide hydrolysis with peptidase and 
carboxypeptidase-A
Peptidase treatment
A peptidase (l unit ml ^) from porcine intestinal 
mucosa with general proteolytic and aminopeptidase activity 
was incubated with samples at pH 7-1 and 37°C. The re­
action was stopped by heating to 90°C for 43min and the 
supernatant, collected after centrifugation, was assayed 
for substrate content by determining the activity of the 
NADPH-dependent disulphide reductase as in II. B.l.e.
Carboxypeptidase-A (EC 3-^"i2.2.) treatment
Carboxypeptidase-A (142.8 units ml ) from bovine 
pancreas was incubated with samples at pH 7-5 and 37 C . 
The reaction was stopped at time intervals in the same 
manner as in the peptidase experiments. The substrate 
content was determined as above.
( iii)Amino acid analysis with an amino acid autoanalyser 
A Joel JLC-6AH analyser was used to determine the
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amino acid content of the peptide substrate (ill. C.).
The samples were hydrolysed with HCl (pH 1.2) at lOO^C for 
24h and then stored at 4°C. Control samples were also 
heated (in the absence of HCl) to lOO^C for 24h and stored 
in the same manner.
Both the control and test samples were run automati­
cally, each being allowed to develop for 5h. The tempera­
ture conditions were 90°C for the reaction bath and 55°C 
for the two columns. A B.D.H. amino acid standard sample 
(Sepramar calibration standard A) was diluted to give a 
sample concentration of O.lnM, and this was used as the 
reference standard.
When calculating the molar concentrations of the 
amino acids, glycine was used as the reference amino acid. 
The control samples were found not to have free amino 
acids after analysis.
(iv) t.l.c. analysis of the dansylated products of
chemical and carboxypeptidase hydrolysis products
The N-terminal amino acid of the peptide described 
in III.C. was determined by reacting the peptide with 
dansyl-chloride (Gray, 196?)- In this procedure, 1ml of 
the Sephadex G-25 product (Fig.3.18) was transferred to a 
small test tube and allowed to dry in vacuo. The peptide 
preparation was then redissolved in 20pl of NaHCO^ (0.2M, 
pH 8 .5 ). To this was added an equal volume of the dansyl- 
chloride solution (2.5 mg ml acetone) to give a final 
concentration of dansyl-chloride of 5mM. The tubes were 
sealed and the reaction allowed to proceed for 2h at 37 C.
At the end of this period the solution, which was colour­
less, was dried in vacuo and redissolved in 5Dpl 6.7N-HCI. 
The tube was quickly sealed in a flame. The sealed tube 
with its contents was then heated in an oven for 24h at I05 C 
After the acid hydrolysis was complete, the HCl was removed 
in vacuo over NaOH pellets and the products were redissolved 
in 50% v/v aqueous pyridine.
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Standard dansy1 amino acids wore prepared by 
dissolving individual amino acids in 0 .3M-NaHC0  ^ to give 
a final concentration of lOmM. To O.lml of each of these 
solutions an equal volume of dansyl-chloride was added 
and the solutions were incubated for 2h at 37°C. After 
the incubation period the solutions were further diluted 
with 2m1 water and stored in sealed tubes.
The standards and the test samples were chromato­
graphed by t.l.c. on plastic backed silica gel t.l.c.- 
ready-foils (F 1500, 20x20cm). The samples were spotted 
on the t.l.c. plates so that they were 1.5cm apart and 
1cm away from the edge of the plate. The plastic backed 
foils were placed in beakers (for support) and placed in 
a solvent-vapour-saturated chromatographic tank. The 
solvent used for the run was ethylacetate: pyridine; 
acetic acid (80;20;2).
At the end of the run, the spots of fluorescent 
material were visualized under u.v. light ( 25 '^ nm) , while 
the plates were still damp. values were determined,
and when an R^ value coincided with a standard, the 
standard and test samples were mixed and chromatographed, 
The identification was considered positive if the amino 
acids co-chromatographed.
In experiments with carboxypeptidase, the amino 
acids released at different time intervals were reacted 
with dansyl-chloride in the manner described for the 
standards. These were chromatographed against the 
standards as described above. A zero time control was 
included in the experiments.
e . Preparation of the cofac tor described by
Eggleston and Krebs (197^)
The cofactor (Eggleston and Krebs, 197'') was pre­
pared from a high speed supernatant of a 33% w/v rat 
liver homogenate. In this case the test system for the
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cofactor activity was composed of lOO^M-GSSG, 33.3^M- 
Z1ÎCI2 , 100^M-G6P, lOOp.M-NADP'^ and 200iiM-NADPH, in a final 
volume of 1ml. GSSG was added to do-inhibit GGPDH, and 
ZnCl^ to inhibit GSSG-reductase.
Alternatively, the high speed supernatants were
treated with an equal volume of 10% perchloric acid and
the precipitated protein removed by centrifugation. The
supernatants were then treated with 0.25 vol. K^CO and
 ^ 3
the precipitate removed by centrifugation. Portions of 
this preparation were then added to the incubation 
mixture of G6PDH as described above.
f. Determination of the disulphide content of peptides
The assay system used for the determination of di­
sulphides was essentially that described by Zahler and 
Cleland (1968). The disulphides were reduced with DTT. 
The resulting monothiols were then reacted with 5*5' 
dithiobis (2-nitrobenzoic acid) (DTNB), and the absorb­
ance of the resulting yellow complex was measured at
4l2nm. A molar absorption coefficient of 1.36x10 
-1 -1Mol cm was used to calculate the concentration of 
monothiols.
The experiment was performed by mixing 0.2ml of the 
peptide preparation with O.lml of 0 .05M-Tris/HCl, pH 9-0 
and O.lml of 3mM-DTT. The reduction was allowed to 
proceed for 25min, after which 0.2ml of IM-Tris/HCl, 
pH 8.1, 1.5ml of 5n^-NaAsO^ and water, to give a final
volume of 2.9ml, was added. This mixture was incubated
for lOmin. At the end of the incubation period, DTNB 
(3mM in 0.05M-sodium acetate, pH 5-0, O.lml) was added 
to the mixture to start the reaction. The increase in 
absorbance at 4l2nm was followed until no further change 
was observed.
3. Preparation and use of hepatocytes
a. Preparation of hepatocytes
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Hepatocytes were prepared by the method of Berry 
and Friend (1969), modified as described by others 
(Cornell, et al., 1973, Krebs, et al., 1974 ; Daneshmand, 
1983). Rats were anaesthetized with Sagatal (60 mg ml~^), 
O.lml/lOOg body weight, approximately. The anaesthetic 
was injected intraperit oneally. The peritoneal cavity 
was opened by lateral incisions so that the portal vein 
and the inferior vena cava were exposed. After removing 
the surrounding tissue, as far as possible, two pieces of 
thread were loosely tied around the portal vein, and one 
around the inferior vena cava just anterior to the right 
renal vein. A sterile luer cannula was inserted care­
fully into the portal vein such that the blood flowed 
freely out of the exposed end of the cannula. The two 
ligatures were tied firmly and the liver perfused with 
Krebs-Ringer bicarbonate (KRB) buffer without Ca“  ^ (Krebs 
and Henseleit, 1932 (Table 2 .2 ) which had been previously 
incubated at 37°C and gassed with 95% 0^ and 5% CO^" The 
inferior vena cava was then severed below the right 
kidney to prevent swelling of the liver and to allow the 
free flow of the perfusate through the liver. The rib 
cage was opened to allow access to the thoracic cavity.
The inferior vena cava was cannulated via the right 
atrium of the heart, the cannula being held in place by 
a tight ligature. The ligature around the inferior 
vena cava in the peritoneal cavity was then tied. The 
perfusion was continued at a flow rate of about 20ml 
min ^. The liver was transferred to a perfusion 
cabinet (37°C) and the perfusion continued until the 
liver appeared pale and the perfusate was free of blood.
The liver was then perfused with collagenase (clostridio- 
peptidase A, EC 3.4.24.3) from £lostridiun^htstolyticum 
(30mg/l00ml KRB with Ca^^) until the liver was smooth 
and the leakage of medium from the liver was substantial. 
Depending on the batch of collagenase, this took between 
15 and 25min. The liver was freed from the rest of the
rat and transferred to a plastic beaker (250ml capacity)
2 +
containing 50ml of KRB (without Ca ) which was gassed
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Table 2 .2: Composition of Krebs-Ringer bicarbonate
Solutions
required
Krebs-Henselei t 
original Ringer HCO^ 
(parts by vol.)
Final concn 
mM
0.90% NaCl 
(0.154> M)
100 118
1.15% KCI 
(0.154 M)
4 3.5
1.22% CaCl 
(0.11 H)
3 2.5
2 .11% KHgPO,^
(0.154 M)
1 1.2
3.82% MgSO, .7HgO 
(0.154 M)
1 1.2
1.3% NaHCO 
(0.154 M) ^
21 24.8
The solutions indicated, except CaCl^, were mixed 
together and gassed with CO^ for Ih and stored at 4 C *
CaClg was added at the start of each experiment. All 
buffer solutions were gassed with 0  ^
before the start of each experiment.
COg (95 : 5 v/v)
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with 95/0 0^ and 5% The tissue was minced and passed
through a funnel with a nylon mesh so that the cells 
filtered into centrifuge tubes (MSE 50ml capacity). The 
cells were sedimented by centrifugation at 50g for 50s in 
an MSE minor bench centrifuge. The supernatant was 
discarded and the cells resuspended in 20ml of KRB (with 
Ca^ ) containing 1.5% (w/v) fatty acid-free bovine serum 
albumin. The number of cells per ml was determined by 
examining a hepatocyte suspension in 0.25% trypan blue 
(in 0.9% NaCl) under a microscope using a haematocrit 
chamber. The hepatocytes were diluted 1:1 (v/v) with 
the trypan blue preparation. The cellular concentrations 
were adjusted as required. The cells were preincubated 
for 20min in KRB (with Ca^^) containing 1.5% BSA and 
gassed continuously with 95% 0^ and 5% CO^ to restore the 
ATP / ADP ratio to normal (Claus et al . 1975).
Siliconized glassware was used throughout the 
preparation, and the method used for siliconization 
involved rinsing the glassware with a solution of dimethyl 
chlorosilane (BDH Chemicals Ltd., Poole, England) in 
1,1,1-trichloroethane (2% w/v) and air^drying overnight. 
The glassware was rinsed with distilled water to remove 
HCl formed in the treatment. The glassware was left to 
air-dry.
Struct^al viability of the hepatocytes was determined 
by counting the cells which excluded trypan blue and 
expressing this as a percentage of the total number of 
cells. The cell preparations used in the experiments 
recorded in Table 3.1 had viability values of 90 and 95%, 
indicating a substantial integrity of the plasma membrane.
It has been demonstrated by other workers in this 
laboratory that under these conditions of extraction, the 
hepatocytes prepared by this method are metabolically 
viable as indicated by their ATP levels and their capacity 
to form glucose from L - c"J lactate (Daneshmand,
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198]).
b. Lipogencsis from fl-^^^cl acetate
Hepatocytes were prepared as in ]a above and pre­
incubated for 20min before the addition of substrates and 
effectors. Each incubation mixture contained 10^ cells 
ml , 1.5n^-acetate, acetate (4.4x10^ d.p.m./
assay), 25mM - and 10 M - glucose and glucagon, 
respectively, in a final volume of 1ml. The incubations 
were carried out in siliconized conical flasks in a 
shaking water bath (200 cycles min” )^ at 37°C, for 30min. 
The rate of fatty acid synthesis was linear for up to 
30min, and the cells were gassed continuously with 95%
0^ and 5% CO2 throughout the incubation period. The 
reaction was stopped by adding 1ml of 6% w/v perchloric 
acid.
The lipids formed during this time period were 
estimated by an adaptation of the method of Folch et al. 
(1957), as described by Daneshmand (1983).
The perchlorate extracts were treated with methanol: 
chloroform (2:1 v/v) (6ml) and the samples ultrasonicated 
for 13s (MSE ultrasonic disintegrator, maximum amplitude). 
After l6h the samples were transferred to plastic, centri­
fuge tubes and 7 .6ml of methanol:chloroform:water (2 :1:0 .8) 
was added to each tube. This was followed by further 
sonication for 15s. Chloroform (4ml) and water (4ml) 
were added and the two phases were separated by centri­
fugation in a bench centrifuge (MSE minor) at 2,000g for 
lOmin. The chloroform layer was retained and treated 
with 25ml water. The chloroform layer was again retain­
ed and filtered into scintillation vials through phase 
separating paper (Whatman IPS) to remove precipitated 
protein and water. The chloroform extract was evaporated 
to dryness, under a stream of nitrogen. The radio­
activity was then assayed in 10ml of a toluene scintillant
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(5g PPO/L toluene) using a Beckman LS 7500 (micro­
processor controlled).
c . Determination of the NAüPH-oxidising activity 
in hepatocytes
Hepatocytes, prepared as in 3a, were harvested by 
centrifugation and then resuspended in 0.25M-sucrose, ImM- 
EDTA 20m£l-BTP/HCi, pH 8.3» The cells wore disrupted by 
sonication at maximum amplitude for 15s and then centri­
fuged at 10,000g for lOmin. The supernatant was heated 
to 60 for Imin, centrifuged and assayed for the NADPH 
oxidising activity as in II.B.l.e.
4 . Purification procedures
a. Glue ose-6-phosphate dehydrogenase
( i) Purification by affinity chromatography
Blue Sepharose CL-6B, which consists of the dye 
Cibacron Blue F3G-A and Sepharose CL-6B, was the chromato­
graphic material used. The Blue Sepharose CL-6B was 
equilibrated with 20mM-BTP/HCl, pH 7-0, 5mM-EDTA and 10% 
glycerol, and packed into a column (20ml capacity).
Livers from rats treated as in II,.B.3«a« were 
homogenized in 3 vol. of 20mM-BTP/HCl, pH 7-5, containing 
5mM-EDTA, 10% glycerol (v/v) and 0.25M-sucrose. The 
homogenate was then centrifuged at 100,OOOg for Ih and 
the resultant supernatant treated with 3>I-acetic acid 
such that the final pH was 5-0. The supernatant was 
stirred for 30min at 4°C. The precipitate formed was 
then removed by centrifugation at 100,OOOg for 3Dmin and 
the pH of the supernatant was then adjusted to pH 7-0 witli 
KOFI. The preparation was clarified by centrifugation at 
10,OOOg for lOmin. The supernatant was applied to the 
Blue Sepharose CL-6B column, which was then washed with 
the equilibrating buffer (containing 0.2M— KCl). The
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enzyme was then eluted with 1.4lmM-NAüP^ and 0 . 3M KCl in 
20mM-BTP/HCl/lmM-EDTA, pH 7.0, 10% glycerol and 0 .25M- 
sucrose. Fractions (4.5ml) were collected and assayed 
for protein content and G6PDH activity. The purification 
procedure was carried out at 4°. The specific activity 
of the enzyme obtained in this way was 0 .63^mol min“  ^ mg~^ 
protein, representing a 105-fold purification and a re­
covery of 24% compared to the high speed supernatant 
fraction.
(ii) Purification of rat liver G6PDH by the method of 
Matsuda and Yugari (I967)
This method of purification of G6PDH was used in the 
initial part of this work. The procedure followed was 
essentially that of Matsuda and Yugari (I967), with minor 
modifications. Livers were obtained and homr>genized and 
centrifuged as above. The high speed (100,OOOg) super­
natant was then treated with ethanol, chilled to 0°C, so 
that the final concentration of ethanol was 25% (v/v).
This mixture was stirred for 30min at 4°C. The precipi­
tate was removed by centrifugation at 10,OOOg for lOmin. 
The supernatant was then treated with O.O3 vol. of freshly 
prepared zinc acetate (O.IM) and stirred for 30min. The 
precipitate was collected by centrifuging at 10,OOOg for 
20min. The precipitate was then resuspended in one-fifth 
of the original volume of 20mM-BTP/HCl, pH 7*5, containing 
5mM-EDTA. This preparation was further treated with 
acetic acid ( 3_M) so that the final pH of the solution was 
5 .0 . The precipitate was then removed by centrifugation 
and the supernatant applied to a DEAE-cellulose column 
(2.5xl2cm) previously equilibrated with 20mM-BTP/HCl and 
5mM-EDTA, pH 7.5. The enzyme was eluted with a linear 
gradient of NaCl (O-IM) in 20mM-BTP/HCl, pH 7.5 and 5mM-
EDTA, in a total volume of 300ml. The specific activity
. -1 -1of this enzyme was about O.24pmols min mg protein 
representing a 40-Fold purification and a 10% recovery.
It was found that G6PDH purified in this manner was very 
unstable and this instability accounts for the ] ow
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recovery and degree of purification. It was for this 
reason that the method in (i) was adopted.
b . 6-Phosphogluconate dehydrogenase
The partial purification of 6PGDH was achieved by 
following the procedure reported by Procsal and Holten 
(1972), with minor differences. The livers from fed 
female rats were weighed and homogenized in four volumes
of O.I5M-KCI and 0.l6mM-KHC0 at pH 7-0- The homogenate
3
was centrifuged at 100,OOOg for Ih and the supernatant 
dialyzed for l6h, during which time the buffer was changed 
four times. The supernatant was treated with an equal 
volume of saturated (NH^igSO^ (4.1M or 767 g/l of salt).
The supernatant was stirred for 30min at 4°C. The 
precipitate was removed by centrifugation and discarded.
The supernatant was treated with 2/3 vol. of saturated 
(NH^)2S0^, at pH 7-0. The mixture was allowed to stand 
for a further 3Gmin, with continual stirring at 4 C.
The 50-70% (NH^)2S0  ^ precipitate was retained and dissolved 
in In^-EDTA (pH 7-0) and dialysed against the homogenising 
buffer at pH 7.0. At this stage the specific activity 
was 0 . 4p.mol min mg protein, representing an l8-fold 
purification and a 40% recovery. Although activity was 
gradually lost over a period of time (2-3 weeks), this 
enzyme preparation was more stable than that of G6PDH.
In some experiments, the enzyme was further purified by 
chromatography on DEAE-cellulose. In this case, the 
dialyzed 50-70% (NH^)2S0  ^ fraction was applied to a DEAE- 
cellulose column (4.2xl2cm), which was previously 
equilibrated with 5n^-potassium phosphate - ImM-EDTA, 
pH 7.0 . The column was eluted with a linear gradient 
from 5 to 40mM-KP^, pH 7.0 and ImM-EDTA in a total volume 
of 300ml. The fractions (3.5ml) containing 6PGDH 
activity were pooled and dialyzed before use. The 
specific activity of the enzyme was only 0.54^mol min 
mg  ^ protein, representing a purification factor of 24.5 
and a recovery of 28.3%. In the purification procedure, 
the enzyme activity was determined at pH 9*0, and not
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pH 7.0, as the former represents the pH optimum of the 
enzyme. Other conditions of assay were; 200(J.M-6PG,
100|iM NADP^ and lOOmM-BTP/HC 1 , pH 0.0.
c . Partial purification of rat liver FAS
The method used for the partial purification of FAS
was that of Linn (I981), the only deviation from the
described procedure being that DEAE-cellulose (DE52)
(Whatman) was replaced by DEAE-cellulose from Sigma and
that rabbit serum was omitted from the buffers. The
procedure was followed up to the DEAE-cellulose step and
the product at this stage had a specific activity of 
-1 -1
5 -5nmol min mg protein in fresh extracts. This 
activity rapidly declined within days (Table 3.3 in 
'Results and Discussion').
In some experiments, the crude high speed super­
natant (100,OOOg) was the enzyme source. This prepara­
tion was obtained by homogenizing livers, from 48h 
starved/3 days refed female rats, in 5 vol. of KP^ buffer, 
pH 7*2, containing In^-MgCl^, lOOfiM-EDTA, 10% glycerol 
and ImM-DTT and centrifuging at 100,OOOg. The resultant
supernatant was then dialyzed against the homogenization
buffer for l6h (3 buffer changes) before assay. The 
enzyme activity was determined as in II.B.l.e (spectro- 
photometrically).
d. The NADPH-dependent reductase and the peptide
substrate from rat liver
The reductase (cf. III.C.) was purified from high 
speed supernatants derived from rat liver homogenates 
(1:2, w/v). The homogenising buffer was 20mM-BTP/4iCl , 
pH 8.3 containing In^-EDTA and 0.2,5M-sucrose and the 
centrifugation (100,OOOg) lasted for Ih at 4 C. These 
preparations contained both the enzyme and the substrate. 
In order to separate the enzyme from the substrate, with­
out losing the latter, the supernatant was either (i) 
heated to 60°C for Imin in a water bath, cooled, centri­
fuged and the precipitate discarded or (ii) ultrafiltered
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through Amicon ultrafiltration membranes (M cut-off
T
10,000), which were stored in ethanol (50% v/v) and 
extensively washed with distilled water before use. The 
product of either of these methods was then assayed for 
NADPH oxidising activity (II.D.I.e.). At this stage in 
the purification procedure the enzyme was still associat­
ed with the peptide substrate.
In some experiments the initial preparative steps 
outlined above were performed at pH 10.0. When this was 
the case, 20mM-glycine/NaOH was the homogenisation buffer 
and it contained 0.25M-sucrose. Solid BTP to a final
concentration of 20mM and an appropriate volume of HCl 
(6^ ) were added to adjust the pH to 7-5 before assaying 
for the NADPH-oxidising activity.
These preparations were then used for the purification 
of (i) the enzyme-substrate complex (cf. III.C.2a), (ii) 
the enzyme (cf. III.C.2b) and (iii) the peptide substrate 
(cf. III.C.2c).
( i) Purification of the enzyme-substrate complex
Two procedures were followed for the attempted 
purification of the enzyme-substrate complex.
In scheme I, the heat treated extracts were treated 
with an equal volume of chilled ethanol (-20°C) and 
stirred for 30min at 4^C. The precipitated protein was 
removed by centrifugation at 100,OOOg for 30min. Both 
the supernatant and the precipitate, resuspended in the 
original volume of buffer (20mM-BTP/HCl, In^-EDTA, pH 8 .3), 
were tested for NADPH-oxidising activity (II.B.l.e). The 
activity was found to be associated with the supernatant.
The ethanolic supernatant was then ultrafiltered
through Amicon membranes (PM 10, M cut-off 10,000) at
2
4 °C under a nitrogen pressure of 3 » ^  Kg/cm . A standard
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Amicon stirred cell (diameter 4 3mm) was used. The 
ultrafiltrate was assayed for NADPH-oxidising activity 
and protein content.
In earlier experiments the ultrafiltration step was 
followed by barium acetate precipitation (Cardini and 
Leloir, 1957). This, however, was omitted in later 
experiments because of the large losses in activity 
incurred by the procedure.
Regardless of whether barium acetate was used or not, 
the enzyme-substrate complex was further purified by 
precipitating it out with 3 vol. of chilled ethanol and 
stirring the solution at 4 °C for 30min. The precipitate 
was collected by centrifugation at 100,OOOg for 30min and 
resuspended in 0.2 vol. of the original volume of buffer 
( 20mM-BTP/HCl, ImM-EDTA, pH 8.3). This sample was then 
applied to a small (5ml capacity) DEAE-Sephadex A-50 
column previously equilibrated with 20mM-BTP/HCl and ImM- 
EDTA, pH 8.3. The complex was eluted with a discontinu­
ous gradient of KCl (O-IM) in 20mM-BTP/HCl and ImM-EDTA,
pH 8.3.
In scheme II, PEG-6OOO fractionation followed the 
heat treatment. PEG-6OOO was added as a solid to the 
heat extracts to a final concentration of lOg/lOOml.
The preparation was stirred for 30min at 4°C and the 
precipitate removed by centrifugation at 100,OOOg for 
30min. The supernatant was diluted with an equal 
volume of buffer (20tiM-BTP/.HCl, Itr^-EDTA, pH 8.3) and 
applied to a Sephadex A-50 column (Fig. 3-11)1 
equilibrated as above. The complex was eluted with a 
continuous gradient of KCl (0-lM) in buffer, as above, 
in a total volume of 300ml.
The eluates containing the complex were pooled, 
diluted 2-fold with the buffer and reapplied to a smaller 
Sephadex A-50 column and eluted with a discontinuous
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gradient of KCl as above.
(ii) Partial purification of the enzyme moietv
The enzyme-substrate complex was resolved by treat­
ing the heat-treated extracts with 30g/l00ml of PEG-600n, 
stirring for 30min at 4°C, and centrifuging at 100,OOOg 
for 30min. The precipitate contained the enzyme and the 
supernatant the substrate.
The enzyme-containing substrate was resuspended in 
20rnM-BTP/HCl, ^ ImM-EDTA, pH 8.3 and made 10% (w/v) with 
PEG-6000. The resultant precipitate was removed.by 
centrifugation and discarded. The supernatant was then 
treated with PEG-60OO so that the final concentration of 
the polymer was 30% (w/v). The precipitate was collected 
by centrifugation and resuspended in the original volume 
of buffer.
The enzyme preparation was then applied to a DEAE- 
cellulose column previously equilibrated with 20mM-3TP/ 
HCl, ImM-EDTA, pH 7-5. The enzyme was eluted with a 
continuous gradient of NaCl (O-IM) in the equilibrating 
buffer (Fig. 3.14).
(iii) The purification of the peptide substrate
The 30% PEG-6000 supernatant (see (ii) above) was 
the substrate source. The supernatant was diluted with 
an equal volume of buffer (20mM-BTP/HCl , ImM-EDTA, pH 8.3) 
and applied to a Dowex Cl 1 (x8—200) column (Fig. 3»l6). 
PEG-6000 was washed off the column with 300ml of buffer. 
The substrate was then eluted with a continuous gradient 
of NaCl (0-lM), in buffer, in a total volume of 350ml.
The s u b strate-containing fractions were pooled, 
diluted with an eaual volume of buffer and applied to a 
Dowex 50 H”^ 50 (x8-400) column. The method was 
essentially that of Cowgill (1957)• After the
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application of the substrate the column was washed with
0.01M-NF% OH (60ml, and pH 8.5). The substrate was then 
eluted with a linear concentration and pH gradient (O.OIM, 
pH 8.5 - O.IM, pH 13.0 ) of NH^OH in a total volume of 
300ml (Fig, 3.17)• The sub strate—containing fractions 
were again pooled, adjusted to pH 8.3 with solid BTP 
(20mM) and 6l^-HCl and divided into three portions.
These portions were applied individually to a' 
Sephadex G-25 column (previously equilibrated with 20mM- 
BTP/HCl, ImM-EDTA, pH 8.3 and lOOmM NaCl), a Bio-Gel P-2 
column (equilibrated with 20mM-BTP/HCl, ImM-EDTA, pH 8.3) 
and a small Dowex Cl 1 (x8-200) column. The first two
columns were eluted with the equilibration buffers 
(Fig. 3«18 and 3.19), and the Dowex Cl 1 (x8-200) column 
with a discontinuous gradient of NaCl (O-IM) in buffer 
(Fig. 3.20).
e. Fractionation of the liver homogenates
Rat liver homogenates obtained as in (lI.B.4d) were 
fractionated by differential centrifugation. The method 
was essentially that of de Duve et al. (1955), with minor 
modifications. The nuclear fraction was precipitated at 
650g, the lysosomal and mitochondrial fraction at 22,500g 
and the microsomal at 100,OOOg. Each particulate fraction 
was resuspended in the original volume of the homogenising 
buffer. The supernatant obtained after centrifugation at 
100,OOOg for Ih was taken to be the soluble fraction. All 
the centrifugation steps were carried out at 4 C for 15min, 
except that performed at 100,OOOg.
All the fractions were sonicated at max. amplitude 
for 30s, heated to 60°C for Imin as described previously, 
and the supernatants were assayed for NADPH-oxidising 
activity as in II.B.l.e.
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5. Synthesis of fructose 2,6-bisphosphate
The method used was that of Van Schaftingen and Hers 
(1981a), which was a modification of the method of Pontis 
and Fischer (I963) for the synthesis of fructose-2- 
phosphates .
The initial step of this method was to convert the 
sodium salt of F1,6P^ to the free acid by ion exchange 
chromatography on Dowex 50 H"^  ( x 8 - 2 0 0 ) .  This was then 
converted to the pyridinium salt by neutralizing the 
solution with pyridine to give a final concentration of
0.2M-F1,6P^. At the same time, 2.4 g of dicyc lohexyl- 
carbodi-imide (DCC) was dissolved in 10ml aqueous 
pyridine.
The cyclisation reaction was performed by incubating 
6ml of the pyridine salt of F1,6P^ (0.2M) with 0.5ml 
triethylamine (a strong base which prevents further re­
action of the cyclic phosphodiester formed with DCC),
20ml pyridine and the DCC/pyridine solution (10ml). The 
reaction was allowed to proceed for 24h at 20°C. The 
crystalline material formed during the incubation was 
filtered off, after stopping the reaction with 40ml 
water. The product was extracted four times with a 
total volume of 200ml ether. The aqueous phase was 
retained.
The aqueous solution (40ml) was mixed with 0.2 vol. 
of 2.5M-NaOH, in order to hydrolyse the cyclic diester 
formed. The reaction was allowed to proceed for 30min 
at 37^C.
At tlie end of the incubation period, glycine (pk^ 
9 .9 ) was added to a final concentration of 20mM and the 
pH adjusted to 9.4 with 2M-HC1. MnCl^ was also added 
to a final concentration of 0.5mM. Fl,6DPase (0.2 unit 
ml ^) was then added to remove the untreated F1,6P^.
After 3h at 30°C, the reaction was stopped by a 5-fold
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dilution of the solution with water. The solution 
was then passed down a column (30x0 .6cm) of Dowex AG-1 
Cl form. The phosphoric esters were eluted with a 
NaCl gradient (l00-400mM) in 250ml. F2 ,6p2
determined by its capacity to stimulate PFK-1 under 
the conditions defined in II.B.l.d. Fractions 
containing F2 ,6P2 were pooled, diluted 3-fold and 
rechromatographed.
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6 • Statistical analysis
The t - test was used for statistical analysis 
and the calculations of the standard deviation 
and 't* were based on the following formulae:-
(i) SD =
(ii)
where ^  = “sum of"
OCL = observed values
N = number of observations
SD = standard deviation
(SDL )
where 52. = mean o^ arithmetic average
(iii) S.E.M. = SD:
where S.E.M = standard error mean
O L
M
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III. RESULTS AND DISCUSSION
127
The recent discovery of a potent stimulator
of glycolysis and inhibitor of gluconeogenesis in rat liver, 
has resulted in a search for possible regulatory enzymes 
which respond to the metabolite, other than PFK-1 and FI, 6 
BPase. A number of regulatory enzymes which could 
conceivably be regulated by F2,6P^ are considered in this 
thesis. It is well known that high rates of hepatic 
glycolysis are associated with increased lipogenesis and 
thus some of the enzymes which regulate lipogenesis have 
been investigated. In addition, the regulation of the 
supply of NADPH for lipogenesis by the PPP has been 
investigated and a cytosolic NADPH consuming-reaction 
characterized.
A. F2,6P^ a n d LIPOGENESIS
A positive correlation between rates of lipogenesis 
and glycolysis has long been established (Veech and Guynn, 
1974). It seemed appropriate, therefore, to examine the 
rate of lipogenesis under conditions of raised and reduced 
levels of F2 ,6P2 » a known positive effector of glycolysis 
(Van Schaftingen et al., 1980a,b and c; Van Schaftingen 
et al., 198la,b.). These authors have shown that 
incubation of rat hepatocytes with glucose raises the 
intracellular levels of F2 ,6p2 and glucagon has the reverse 
effect.
The rate of lipogenesis Çrorn ^ acetate was
followed in the presence and absence of glucose and 
glucagon as shown in Table 3.1. It was observed that 
incubation of hepatocytes with glucose increased lipogenesis 
and that glucagon had the reverse effect. These results 
support the theory that the regulation of glycolysis and 
lipogenesis may be co-ordinated.
However, in the absence of a demonstrable direct effect
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Table 3.1 : The effect of incubating hepatocytes with glucose and 
glucagon on lipogenesis from [ 1-^^C]acetate
Effector Incorporation of
14 -1 
[ 1- C] acetate nmol min
per 10^ cells
None 0.131 ± 0.098
glucagon (10 M) 0.137 ± 0.062
glucose (25mM) 1.147 ± 0.208
glucose (25mM) +
-9
glucagon (10 M) 0.128 ± 0.041
Hepatocytes isolated from 24h starved female rats were incubated with 
the indicated effectors for 30min after preincubation of the hepatocytes 
for 20min. Each incubation mixture (1ml) contained 10^ cells and 
effectors as indicated in II.B.3b and the amount of radioactive label 
incorporated into fatty acids was determined as in II.B.2e
129
of F2 ,6?2 on the regulatory enzymes of lipogenesis, namely 
acetyl-CoA carboxylase and fatty acid synthase, the 
postulation remains theory. With this in mind, an attempt 
was made to demonstrate a direct effect of F2 ,6?2 FAS. 
Acetyl-CoA carboxylase has been studied by other workers 
(Davies et al., unpublished results).
1. Fatty acid synthase
Plate et al. (1968) in their work with pigeon liver 
fatty acid synthase have shown that this enzyme is 
sensitive to inhibition by malonyl-CoA, one of the sub­
strates of FAS. They showed that the inhibition is of the
mixed type with respect to acetyl-CoA and is competitive
with respect to NADPH. The for NADPH is 19-fold greater 
at an inhibitory concentration (37*5>iM) of malonyl-CoA than
at the V concentration (lOuM) of the substrate, max ^ —
These authors further showed that this inhibition by 
malonyl-CoA could be reversed by fructose 1,6-bisphosphate 
(Fl,6Pg), and that this reversal is reflected in a progress­
ive decrease in the K for NADPH with F1,6P_ concentration.m 6
F1,6P2 was shown not to markedly affect the values for 
either acetyl- or malonyl-CoA. In the work with human 
liver FAS, Roncari (1975) reported that 10mM-Fl,6P2 
activated FAS by decreasing its for NADPH. The range 
of concentration (10-40mM) of F1,6P2 required to reverse 
the inhibition of FAS activity by malonyl-CoA exceeds the 
expected liver content of Fl,6P2i which has been estimated 
to be about 32 - 4 nmol g“  ^ liver wet weight (Van Schaftingen 
et al., 1980a).
In the present study the effect of F1,6P2 has been 
demonstrated, but in agreement with Plate et al. (I968) the
concentration of FI,6P2 required to stimulate FAS is out­
side the physiological range. Since F2,6?2 has been shown 
to be a 1000-fold more effective than Fl,6?2 in the stimu­
lation of PFK-1 (Hers and Van Schaftingen, 1982), it seemed
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appropriate to investigate the effect of on FAS
activity. The effect of Fl^GP^ and malonyl-CoA on the rat 
liver enzyme were also investigated.
a. F2 ,GP^ und FAS activity (spectrophotometrie assay)
The effect of F2,6P2 on FAS activity in a dialysed 
100,000g supernatant of a rat liver homogenate was determined 
(Table 3*2). At subsaturating concentrations of malonyl-CoA 
and saturating concentrations of other substrates, F2,6Pg 
was found to cause an apparent stimulation of the enzyme 
activity, but it did not overcome inhibition of the enzyme 
by high concentrations of malonyl-CoA. The results shown 
in Table 3.2 confirm the reported inhibition of FAS by high 
concentrations of malonyl-CoA. In agreement with the 
results of Plate et al. (I968) F1,6P^ was shown to stimulate 
FAS activity at high and low concentrations of malonyl-CoA.
The apparent stimulation by F2,6Pg was also demonstrated 
with a partially purified FAS preparation and there was an 
apparent synergism between AMP and F2,6P2 (Table 3.3). AMP 
is known to act synergistically with F2,6P2 in the stimu­
lation of PFK-1 activity at the concentration of effectors 
similar to those used in the present study (Hers and Van 
Schaftingen, I982).
However, with these relatively crude preparations a 
high background rate of NADPH oxidation was observed before 
the addition of malonyl-CoA to start the reaction (Table 3*3). 
Since the FAS activity was determined by following the rate 
of oxidation of NADPH at 340nm, the high background rates 
cast some doubt on the validity of the results obtained by 
this method of assay since there was an apparent inhibition 
of the background rate of NADPH oxidation by F2,6P2 and 
AMP (Table 3.3). For this reason, the enzyme activity was 
measured by following the incorporation of ^1- acetyl-
CoA into fatty acids.
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Table 3.2 : The effect of F1,6P2, F2,6P2 and varying concentrations
of malonyl-CoA on FAS activity
Malonyl-CoA
(MJM)
Enzyme activity (nmol NADPH oxidised min ^ mg  ^ protein)
No effectors 10mM-Fl,6P2 40mM-Fl,6P2 3ijlM-F2,6P2
5 0.77 1.33 1.66 1.10
10 1.60 1.33 1.60 1.40
50 0.67 0.67 1.33 0.90
80 0.70 0.63 1.33 0.67
FAS activity was spectrophotometrically assayed (II B.l.c(i)). The enzyme 
source was a high speed supernatant of a rat liver homogenate. The super­
natant was extensively dialysed against O.lM-KPi, pH 7.5 before FAS activity 
was determined at pH 6.8. The results are expressed as the mean of trip­
licate readings. The reaction was initiated with the appropriate concen­
tration of malonyl-CoA.
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Table 3.3 ; The effect of F2,6P? and AMP on FAS activity at 
subsaturating concentrations of malonyl-CoA
Effectors/concn.
Total activity 
(nmol NADPH 
oxidised min“l 
mg-1)
Background 
rate (nmol 
NADPH (o) 
min"l mg"l)
Net FAS 
activity (nmol 
min~l mg-1)
% of
correc. Vq 
rate
None 0.550 0.473 0.077 100
F2,6P2 (l.SuM) 0.625 0.520 0.105 129
AMP (lOOliM) 0.580 0.510 0.070 87
F2,6P2 + a m p 
(l.SpM) (100m m )
0.659 0.360 0.299 375
A partially purified FAS (PEG fractionation followed by DEAE-cellulose 
fractionation (IIB.4.c)) was used in this experiment. The results are 
the mean of triplicate readings. The assay conditions were as in 
Table 3.2. The malonyl - GoA. concentration used vas 5
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b. F2 ,6P2 and FAS activity (radioactive assay)
The malonyl-CoA dependent incorporation of 
acetyl-CoA into fatty acids catalysed by a dialysed high­
speed supernatant fraction from rat liver was followed and 
taken as a measure of the activity of FAS. This alternative 
method of assay overcame the inaccuracy introduced by high 
NADPH-dependent background rates associated with the spectro- 
photometric assay (Table 3.3).
Table 3*4 shows the results obtained with the radio­
chemical method. Two concentrations of F2,6?2 were used: 
10|lM which approximates the in vivo concentration of F2,6?2 
in fed rats (Neely, et al. I98I), and 0. ^ concentration 
which might be expected to reflect the levels of F2,6?2 under 
conditions of starvation.
At the higher concentration of F2,6P2 an apparent 
inhibition of FAS activity by F2,6Pg was observed at all 
concentrations of malonyl-CoA examined (Experiment 1,
Table 3.4 ). AMP (100|I^ ) partially overcame this inhibition 
at lower concentrations of malonyl-CoA. Activation of the 
enzyme by AMP was not observed. At the lower concentration 
of F2,6P21 an apparent stimulation of FAS activity was 
observed.
Since F2,6P2 levels have been reported to increase 2.5- 
fold in rat liver during conditions of induced hyper- 
lipogenesis (Neely, I981), the results obtained in the 
present study suggest that F2,6Pg at physiological 
concentrations is not a positive effector of FAS activity 
as one might expect. The observed inhibition (Table 3.4 ) 
does not correlate with the role for FZi^Pg as a positive 
effector of glycolysis, the latter having been associated 
with high lipogenic rates (Veech and Guynn, 1974). These 
results are inconclusive and require further investigation. 
However, due to reasons of time and finance, this was not 
possible. It is quite possible that a stimulation can
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Table 3.1:
The activity of FAS, in the presence of the indicated effectors, 
was determined. The incubation mixture was composed of lOOmM-KP^ 
pH 6.8, 200)1^NADPH, 30|1M-DTT, 30MM~acetyl-CoA and the indicated 
concentration of malonyl-CoA in a final volume of 1ml. The enzyme 
source was an extensively dialysed crude high speed supernatant of 
a rat liver homogenate (II.B.4.C). The reaction was allowed to 
proceed for lOmin after which the reaction was stopped with 10% 
perchloric acid. The fatty acids were extracted and monitored as 
in II.B.S.b. The results are expressed as the mean ± S.D. (n=3 
for each experiment). The symbols *, **, *** represent the level 
of significance and refer to the difference between the test incu­
bation and its appropriate control.
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only be observed when the assay conditions are suitable 
and since only a limited number of experiments could be 
performed it may be that these conditions were not realised. 
By analogy, the other enzymes which are susceptible to 
F2 ,6P2 i.e. PFK-1 and Fl,6BPase, the conditions under which 
the effector exerts an effect on enzyme activity are very 
critical.
Table 3»4 also shows the inhibition of FAS activity by 
high concentrations of malonyl-CoA and the reversal of this 
inhibition by F1 ,6P2 * This is in agreement with the 
results obtained by Plate et al.(l968) with pigeon liver 
FAS and with the results obtained by the spectrophotometric 
assay in the present study (Table 3»2) for the rat liver 
enzyme. F2 ,6P2 (lOjIM) enhanced the malonyl-CoA-induced 
inhibition of the enzyme (Table 3.4). AMP, on its own, 
did not significantly affect the activity of FAS under the 
conditions of assay.
Otto et al. (1983) have reported very similar malonyl- 
CoA concentrations, 6.4 and 7.6 nmol g  ^ cells for starved 
and carbohydrate refed rats, respectively, whereas Veech 
and Guynn (1974) have reported a value of 25 nmol g ^ liver 
in freeze clamped livers from fed rats. It is not likely, 
therefore, that the malonyl-CoA content of the liver cells 
exerts an important inhibitory effect on FAS in vivo, and 
consequently, the enhanced inhibition by F2 ,6Pg is probably 
of no physiological significance.
Unfortunately, the apparent stimulation of FAS activity 
by F2 ,6P2 and AMP observed with the spectrophotometric 
assay (Table 3.2) could not be shown when the radiochemical 
method was used, indicating that the result found previously 
was an artifact resulting from a change in the background 
rate. The significance of the effect of F2 ,6P2 observed 
at the lower concentration of the effector is uncertain as 
the experiment was only performed once.
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2 . Acetyl-CoA carboxylase
F2 ,6P2 , at physiological concentrations, has been shown 
not to affect either the activity or the degree of poly­
merization, in the presence or absence of citrate, of 
acetyl-CoA carboxylase (Davies et al., unpublished results) 
This enzyme has, therefore, not been assayed in the 
present study.
B. THE PENTOSE PHOSPHATE PATHWAY
1. Fructose 2,6-bisphosphate and the PPP dehydrogenases
Fructose 2,6 bisphosphate has been shown to be a 
positive physiological effector of glycolysis (Hers and 
Van Schaftingen, 1982; Pilkis et al., 1983b). It was of 
interest, therefore, to determine the effect of this 
compound on the PPP dehydrogenases, the rate-limiting 
enzymes of the PPP, another pathway of glucose oxidation. 
The idea that the two pathways may be co-ordinately 
regulated has been supported by the observations of 
Sommercom and Freedland (I982), who have demonstrated 
the stimulatory action of 6-phosphogluconate on PFK-1. 
Furthermore, this stimulation has been shown to be 
additive to that caused by F2 ,6P2 in the presence of 
physiological concentrations of AMP, ADP and ATP.
However, while indirect evidence that implicates 
F2 ,6Pg in the regulation of the flux through the PPP 
exists (Blackmore and Shuman, I982), a direct effect of 
this compound on the PPP dehydrogenases has not been 
demonstrated.
In the course of this work much time was fruitlessly 
spent in altering conditions in the hope of demonstrating 
an effect by F2 ,6P2 on the PPP dehydrogenases. F2 ,6P2 
was shown not to inhibit or stimulate the PPP dehydro­
genases. The compound did not reverse the NADPH-induced
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inhibition of G6PDH or 6PGDH. Addition of AMP, which 
has been reported to enhance the effect of F2 ,6P2 on 
PFK-1 (Van Schaftingen, 198la), did not enable F2 ,6P2 to 
stimulate or inhibit the dehydrogenases. Various sub­
strates and effectors which are related to the PPP, either 
because they are substrates for lipogenesis or known 
effectors of the enzymes of carbohydrate metabolism, were 
combined with F2 ,6P2 in an attempt to ascertain the role
of the bisphosphate in the regulation of the PPP. These
2 +
included ADP, ATP, Mg , lactate, citrate, Sn glycerol-3- 
phosphate, acetyl-, malonyl- and oleoyl-CoA. The results 
obtained were negative. F2 ,6P2 had no effect on the 
oleoyl-CoA-induced inhibition of the dehydrogenases.
The lack of positive results with F2 ,6P2 shifted the 
emphasis of the project from F2 ,6P2 to the general 
regulation of the PPP dehydrogenases, in particular to 
the possible mechanisms that may result in the reversal 
of the inhibition of the dehydrogenases by NADPH.
2. The regulatory role of GSSG in the de-inhibition
of the PPP dehydrogenases
A physiological role for GSSG as a de-inhibitor of 
the PPP dehydrogenases has been postulated by Eggleston 
and Krebs (1974). These authors confirmed the inhibition 
of G6PDH by NADPH and reported that the inhibition was 
greater at low NADP* concentrations and that the activity 
depended on the NADPH / NADP* ratio. This inhibit­
ion was also reported to be competitive with respect to NADP
(K. 7|iM). The K of the enzyme for the NADP* under the 1 — m
same conditions of assay was reported to be 3^M.
Eggleston and Krebs (1974) reported that GSSG 
(l0-100|iM), in the presence of an unidentified small 
molecular weight cofactor, could reverse the NADPH-induced 
inhibition of G6PDH activity. This mechanism of de­
inhibition was reported to be independent of the gluta­
thione reductase catalysed reaction.
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In the present study it was shown, using 100,000g 
supernatants from rat liver, that glutathione exerts a 
small inhibitory effect on 6PGDH (Fig.3.1) and also on 
G6PDH activity (results not shown). The latter effect 
confirming the observation of Krebs and Eggleston (1974). 
However, under the experimental conditions used in this 
study, which were similar to those reported by Eggleston 
and Krebs, a high glutathione reductase activity comparable 
to that of 6PGDH (Fig.3.2 ) was observed. It is likely, 
therefore, that the slight inhibition observed is due to 
glutathione reductase activity.
In order to determine the effect of GSSG and the
cofactor on the NADPH-inhibited dehydrogenases, a 100,000g
2 +supernatant, which was not de-salted was used and Zn and 
GSSG were added. The de-inhibition of G6PDH by GSSG and 
the low cofactor reported by other workers (Eggleston 
and Krebs, 1974; Rodriguez-Segade et al., 1978, 1979) 
could not be repeated in the present study. It was
2 +
observed in the course of this work that addition of Zn 
to the high speed supernatant caused a precipitation of 
the protein during the assay, which in turn resulted in a 
change of absorbance at 340nm which resembled the time 
course for an enzyme reaction. Furthermore, the rate of 
precipitation resulted in an apparent de-inhibition 
(results not shown) of both dehydrogenases.
Since then Levy and Christoff (I983) have also
O ^
reported this Zn mediated phenomenon which results in a 
spurious rate of change in absorbance. They have in­
hibited GSSG reductase by using mercuric acetate instead 
of ZnClg, and under their conditions no de-inhibition of 
the dehydrogenases was found, in agreement with the 
results presented here and those of Gonzalez and 
Lagunas (1977).
Eggleston and Krebs reported that the cofactor for
I'lO
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Fig. 3.1:
Concentration of oxidised 
glutathione (yuM )
The effect of oxidised glutathione on 
6PG1DH in the absence of NADPH
The activity of 6PGDH was assayed in the presence of 
different concns. of glutathione (oxidised). The 
source of the enzyme was a dialysed high speed 
supernatant (lOO,OOOg) from a rat liver homogenate. 
The points are mean - S.D (n=3)« 6PGDH activity 
was determined as in II.B.l.b.
I M
LU
)  40 60 60 100 120
Glutathione concentration(/jM )
Fig. 3.2: The relationship between 6PGJ)H activity
and glutathione reductase activity
GSSG-reductase and 6PGDH activity were assayed as 
in II.B.l.r and II.B.l.b, respectively. The 
enzyme source was as in Fig. 3.1. The points 
represent the mean of three readings. Glutathione 
reductase activity is indicated by open circles (0) 
and 6PGDH activity by closed circles (•).
I'i2
GSSG in the de-inhibition mechanism was present in 
perchloric acid extracts of high speed supernatant liver 
preparations. Addition of such extracts to the incubation 
mixture in the presence of GSSG did not result in a de­
inhibition. On the contrary such extracts inhibited both 
dehydrogenases of the PPP(Fig. 3.3a),
The conclusions drawn from this work were essentially 
that GSSG, with or without the cofactor preparation, does 
not directly affect the activity of the PPP dehydrogenases. 
Furthermore, the inhibitory effect of GSSG in the absence 
of the cofactor preparation could be attributed to the 
activity of glutathione reductase, since even under 
conditions where Eggleston and Krebs (1974) claimed there 
was no GSSG reductase activity (such as when the GSSG 
concentration was less than 200|iM , it was found in the 
present study that glutathione reductase was active. In 
fact maximal rates were obtained with 200 p.M"GSSG.
A further consideration is that some of the 
activation of the enzyme reported by these authors could 
be the result of a shift in the NADPH / NADP* ratio 
due to NADPH oxidation (III.C). Since the NADPH- 
oxidising activity reported in III.C would be expected to 
be present in the Amicon filtrates. The preincubation 
period of 15min at 38°C would result in the oxidation of 
virtually all the NADPH (see their Table 4). The in­
hibitor, NADPH, having been removed, addition of G6P to 
the reaction mixture would give an enhanced rate of G6P 
oxidation.
The pitfalls of the actual methods of determination 
of G6PDH activity in crude extracts have been extensively 
discussed by Levy and Christoff (I983) and will not be 
further discussed here.
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Fig. 3.3a: Concentration dependence of the perchlorate
extract - induced inhibition of GéPDH
The activity of G6PDH was determined in the presence 
and absence of HCIO^ extracts, as detailed in II.B.l.a, 
obtained from fed (#) and 48h starved (O) rats. The 
enzyme source was a dialysed high speed supernatant 
obtained from fed rats.
Ih h
3^ Comparison of the inhibitor in the perchlorate 
extract with oleoyl-CoA
The effect of the inhibitor in the perchlorate extract 
described above on the pH profile of rat liver G6PDH was 
determined and compared to that found with oleoyl-CoA, 
since fatty-acyl CoA derivatives have been reported to be 
effective inhibitors of G6PDH (Eger-Neufeldt et al.. 1965; 
Taketa and Pogell, I966).
Both inhibitors were found to be most effective at 
alkaline pH values (Fig.5.5b), although the profiles did 
not exactly parallel each other; the inhibitor in the 
HCTO^ extract was more effective than oleoyT-CoA at the 
lower pH values.
The concentration of long chain acyl-CoA derivatives
in rat liver has been reported to be about 0 .03pmol g ^
-1
fresh weight, and this increases to O.l^mol g liver in 
starved or fat-fed rats (Fritz et al., 1974). Further­
more it has been stated that the most abundant forms of 
long chain acyl-CoAs in vivo are palmitoyl-CoA and oleoyl- 
CoA (Tippett and Neet, 1982a,b). This implies that the 
final concentration of oleoyl-CoA in the HCl-0^ extract 
would be expected to be less than 0 .25|lM. In the 
present study the for oleoyl-CoA was found to be about 
26[iM (Fig. 3.4a). This suggests that oleoyl-CoA is un­
likely to be the inhibitor in the perchlorate extract. 
However, the possibility remains that palmitoyl-CoA (K. 
value 0 .6|iM as determined by Eger-Neuf eldt et al., I965) 
may be responsible for the inhibition. It is also 
possible that the inhibition was due to fatty acids, 
which are also reported to inhibit G6PDH (Yugari and 
Matsuda, 196?). That some of the inhibition was due to 
fatty acid or to fatty acyl-CoA was supported by the 
observation that addition of bovine serum albumin (fatty 
acid free) to a final concentration of 0.75% reversed 
the inhibition partially.
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Fig. 3»3b : Effect of oleoyl-CoA and the HCIO  ^ extract
on the pH profile for partially purified 
rat liver G6PDH
Enzyme activity was measured at the appropriate pH in 
BTP/HCl buffer with no effectors (0 ), 50|iM oleoyl-CoA (A) 
or HCIO^" extract (#). G6PDH was partially purified 
(DEAE-cellulose eluate) as described in II.B.4 .a(ii) and 
assayed as in II.B.l.a. The concentration of NADP and 
G6P in the assay mixture was lOOpM and 1.5mM, 
respectively.
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Fig. 3.4a: 01eoyl-CoA~induced inhibition of 
G6PDH activity
To determine the degree of inhibition induced by 
oleoyl-CoA, desalted, purified yeast G6PDH (Sigma 
product) was used. It was assayed in the same 
manner as rat liver G6PDH (II.B.l.a) at pH 7«5* 
The reaction cuvette contained 2 ng of enzyme 
protein per ml of reaction mixture.
1'‘7
However, when the degree of inhibition by extracts 
from livers of fed and starved (48h) rats were compared 
it was found that the degree of inhibition obtained with 
equivalent amounts of tissue was greater with extracts 
from fed rats than from starved ones (Fig.3.3a). This 
is contrary to what one would expect if the inhibition 
was due to fatty acyl-CoA or to free fatty acids, since 
these compounds are increased by starvation (Bortz and 
Lynen, 19^3; Garland and Tubbs, I963; Wieland, I964). 
This observation suggests that the inhibitor is not a 
fatty acyl-CoA or a fatty acid, and further work is 
required in order to identify the inhibitor.
b • The effect of oleoyl-CoA on the kinetic parameters
of G6PDH from rat liver
Inhibition of liver G6PDH by acyl-CoA has been 
reported previously, but most studies of the effect of 
the inhibition on the kinetic properties have been on 
the purified yeast enzyme. A physiological concentration 
of acyl-CoA (50flM) was selected in order to examine the 
effect of acyl-CoAs on the kinetic parameters of partially 
purified (DEAE-cellulose eluate) rat liver G6PDH 
preparation. Oleoyl-CoA was used and this concentration 
of the inhibitor appeared to exert a potent inhibition 
(Table 3.6).
A plot of /v against[s] indicated that the
for NADP* was increased from 22|JLM to about 60jJLM and that
the V was lowered to 6% of the original value (Fig.3.4b)max
Similarly, the for G6P was increased from 42p,M to 280p.M
(results not shown), and the V reduced to 299  ^of the 
control value. The inhibition is therefore of the mixed 
type (Dixon and Webb, 1964) with respect to both NADP and 
G6P. In contrast, Eger-Neufeldt (I965) reported that the 
acyl-CoA-induced inhibition only affected the of
G6PDH from yeast when NADP was varied.
1^8
Table 3.6 ; The oleoyl-CoA induced inhibition of rat liver Q6PDH
Concn. of NADP'*’ 
(hM)
Concn. of 
G6P (mM)
Control rate 
(nmol min“l mg~^ 
protein )
Inhibited rate 
(nmol min'l mg“  ^
protein)
%
20 1.50 66 5 7.7
40 1.50 72 6 8.3
60 1.50 ' 172 11 . 6.6
80 1.50 249 10 3.9
100 1.50 222 15 6.7
200 1.50 223 15 6.7
100 0.02 60 7 11.0
100 0.04 90 7 7.3
100 0.08 120 7 5.5
100 0.16 120 25 20.5
100 0.50 126 18 14.3
100 1.00 159 60 37.7
100 1.50 180 55 30.6
The concentration of NADP+ and G6P were varied as shown in the table, and 
the activity of Q5PDH, in the presence and absence of oleoyl-CoA (50pM), 
determined as in II.B.l.a. The enzyme source was the DEAE-cellulose eluate 
(II.B.4.a(ii) ). The assay was performed at pH 7.5 and 25°C with a 2min pre­
incubation period.
l'<9
400-^
300
200
OLEOYL- Co A; - JH H <
100
-20-100 100 140 180
Fig, 3.4b : Determination of the kinetic parameters of G6PDH in
the presence of oleoyl-CoA at subsaturating 
concentrations of NADP
The data used is the same as that recorded in Table 3.6.
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Pre-incubation with NADP* (Table 3.6) appeared to 
protect the enzyme from complete inhibition by oleoyl- 
CoA. It is known that NADP^ protects G6PDH against 
inactivation; for instance NADP has been shown to 
antagonise the fatty acid-induced disaggregation of 
crystalline rat liver G6PDH (Yugari and Matsuda, 196?) 
and to protect against protein-induced inactivation of the 
enzyme (Bonsignore and DeFlora, 1972).
The physiological significance of the acyl-CoA- 
induced inhibition of various enzymes has been questioned 
because of the lack of specificity with respect to the 
enzymes inhibited. It has been postulated that the in­
hibition of numerous unrelated enzymes by the acyl-CoAs 
can be attributed to their detergent properties (Tippett 
and Neetj 1982a,b). However, recent work by these authors 
with glucokinase suggests that the inhibition by acyl-CoAs 
of this enzyme is an allosteric, site-specific process.
On the basis of their results, they have proposed a 
physiological role for palmitoyl- and oleoyl-CoA in vivo. 
Further work is necessary to determine whether the in­
hibition of G6PDH described in the present study is 
physiologically relevant.
4 . ATP and the PPP dehydrogenases
ATP has been reported to be an inhibitor of rat 
liver G6PDH and 6PGDH (Kauffman et al.. 1979). However 
conflicting observations have been reported for G6PDH 
(Bonsignore and DeFlora, 1972) and it has been argued that 
the effect of ATP may depend on the degree of purity of 
the enzyme. Avigad (1966), using a crude rat liver
preparation as the enzyme source, claimed an inhibition 
of G6PDH by ATP. Similarly, Kauffman et al.(1979) using 
partially purified preparations, were able to demonstrate 
an effect of ATP on both G6PDH and 6PGDH. On the other 
hand, Yugari and Matsuda (19^7) using extensively purified 
rat liver G6PDH failed to demonstrate any inhibitory 
effect by ATP on G6PDH, although ATP was shown to
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facilitate the fatty acid-induced inhibition of 
crystalline rat liver G6PDH.
Avigad (1966) also reported that the ATP effect was 
more pronounced at neutral pH values than at pH values 
greater than 8.0, and further postulated that the effect 
may be dependent on the concentration of NADP^. This 
inhibition was found to be substantially reduced in the
2 - f
presence of Mg , an observation which has since been con­
firmed by others.
In the present study the effect of ATP-Mg on both 
6PGDH and G6PDH from rat liver and yeast has been 
determined.
a. G6PDH:
Table 3*7 shows the effect of ATP-Mg on purified
G6PDH from yeast and a partially purified rat liver
enzyme preparation. The yeast enzyme was found to be
more susceptible to inhibition than the liver enzyme.
The physiological concentration of ATP in the liver cell
-1
has been reported to be 3.42^mol g liver wet weight 
(Van Schaftingen et al., 1980a). At a similar 
concentration of ATP-Mg the rat liver enzyme was less 
than 33% inhibited. In contrast the yeast enzyme was 
almost 50% inhibited.
The physiological relevance of this ATP-induced 
inhibition of rat liver G6PDH is difficult to ascertain 
in view of the known potent inhibition of G6PDH at the 
calculated in vivo NADPH / NADP* ratio, which has 
been discussed previously. Fig. 3*6a shows almost 
complete inhibition of G6PDH at NADPH / NADP ratios 
which are much lower than those found in the cell.
With this consideration in mind, the effect of ATP-Mg on 
an NADPH-inhibited rat liver G6PDH preparation was 
determined (Table 3.8). Further inhibition by ATP-Mg
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Table 3.7 : The effect of ATP-Mg on Q6PDH from yeast and rat liver
ATP-Mg (mM) Yeast G6PDH 
 ^Vmax
Rat liver G6PDH 
 ^^max
0 100 100
0.03 100 N.D.
0.15 100 N.D.
0.3 96 N.D.
0.6 97 N.D.
1.2 85 N.D.
1.5 64 82
3.0 52 77
4.5 N.D. 67
6.0 N.D. 65
7.5 N.D 56
N.D. Not determined
The activity of yeast and rat liver G6PDH was assayed at pH 7.4 and 
25°C in the presence of saturating concentrations of NADP""" (140pN) 
and G6P (1.33mM). The specific activity of the rat liver enzyme was 
0.63|imol min'l mg"^ protein, being a Blue Sepharose CL-6B eluate (
The final concentration of crystalline yeast G6PDH protein (Sigma product) 
was 9 ng ml”  ^ per assay.
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Table 3.8 : The effect of ATP-Mg on the NADPH-inhibited Q6PDH 
from rat liver
ATP-Mg 
concn. (mM)
% determined 
at pH^7.1
% Vmax determined 
at pH 8.0
0 100 100
1.5 80 115
2.5 92 115
3.5 92 116
4.5 80 131
5.0 80 108
The assay was performed as in Table 3.7 except that 50|iM- 
NADP+ and 100pM-NADPH were used, and the reaction was started 
with 100|iM-G5P. The rat liver enzyme preparation was as in 
Table 3.7.
15^
was found at pH 7.1, but not pH 8.0.
The data shown above indicates that ATP-Mg may exert 
a small inhibitory effect in vivo, but the NADPH / NADP* 
ratio appears to be much more important. Substantial in­
hibition of the liver enzyme has only been demonstrated with 
free ATP but since ATP exists in the cell as the Mg^* com­
plex, and since ATP-Mg exhibits a reduced inhibitory effect, 
ATP would not be expected to exert a large inhibitory 
effect on G6PDH in vivo. The possibility of the existence 
of isoenzymes of G6PDH with different kinetic properties 
warrants further investigation as it was observed that some 
fractions eluted from Blue Sepharose columns with 
different concentrations of NADP* and KCl did not appear to 
be sensitive to inhibition by ATP-Mg. That the multiple 
molecular forms of G6PDH may respond differently to 
regulatory effectors is supported by the work of Martins 
et al. (1985) who have shown the presence of three different
molecular forms of G6PDH which respond to varying degrees 
when animals are treated with insulin. All three dimer 
species are increased by insulin treatment but it was found 
that electrophoretic forms I, II and III, which correspond 
to the dimeric forms of G6PDH, increased 5i 3 and 2-fold 
respectively. These authors also showed that starvation 
(72h) only decreased the amounts of enzyme corresponding 
to bands II and III. Although these observations are 
related to the long-term regulation of G6PDH it would be 
interesting to know if multiple molecular forms are 
important in the short-term regulation.
b. 6PGDH:
6PGDH from rat liver has been reported to be more 
sensitive to ATP inhibition than G6PDH (Kauffman et al., 
1979), the K^ for the latter enzyme being l6-fold higher 
than that for 6PGDH. Again these figures apply to free 
ATP and not ATP-Mg. In the present study, an inhibition 
of the rat liver enzyme by ATP-Mg could not be demonstrated
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in the presence (Fig.3.5 ) or absence (Table 3.9 ) of 
NADPH. Some inhibition was obtained with crystalline 
yeast (Sigma) 6PGDH (Table 3*9). This inhibition of yeast 
6PGDH by ATP-Mg could only be demonstrated on concentrat­
ions of 6PG that were less than 500|lM^
An overview of the results obtained in this section
suggest that since ATP in vivo exists to a considerable
2 4 -
extent chelated with Mg (Alberty, I968; Rose, I968; 
Veloso et al., 1975), it is unlikely to be of general 
regulatory significance as far as rat liver G6PDH and 
6PGDH are concerned.
5• Phosphorylated hexose matabolites and the
PPP dehydrogenases
The effect of hexose phosphates and inorganic 
phosphate on G6PDH and 6PGDH was investigated. It was 
found that G6PDH activity was not affected by any of these 
compounds which included FlP (up to lOO'MM), F6P (up to 5»^) , 
FTiéPg (up to 5mM), F^fGPg (up to 12|IM) and Gl,6Pg (up to 
100#M), at pH 7.0 .
It was, however, shown that G1,6P^ does inhibit 6PGDH, 
confirming the observations made by Beitner and Nordenberg 
(1979). Table 3.11 shows the results obtained for the 
rat liver enzyme. The liver enzyme preparation in the 
present study was somewhat less sensitive to inhibition 
than that used by Beitner and Nordenberg (1979); these 
authors recorded a 77% inhibition at 100pM G1 ,6P2 » whereas 
the enzyme in the present study was only 43% inhibited.
The only difference between their experimental conditions 
and those used here was that they used Tris-HCl buffer, 
whereas bis—tris propane—HCl was used in the present study. 
Beitner and Nordenberg (1979) reported a cellular con­
centration of G1 ,6P2 of 6.3 - 0 .3PM in rat liver. This
concentration of G1,6P2 would be expected to cause an in­
hibition of less than l8% (Table 3.11). The physiological 
range of G1,ÔP^ concentration was reported to be 9-30pM in
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Fig. 3.5: The effect of ATP-Mg on NADPH-inhibited 6PGDH
ATP-Mg was added to the Incubation mixture of
6PGDH (II.B.l.b) in the presence of NADP* (50^ iM) and the 
indicated concentration of NADPH, where used. The assay 
was performed at pH 7.0 and 2$°C, and the graph shows the 
effect of ATP-Mg (•) on the NADPH-inhibited enzyme (0). 
The enzyme source was the 50-70% (NH^)2S0  ^ fraction 
(II.B.4.b.).
157
Table 3.9 : The effect of ATP-Mg on crystalline yeast and 
partially purified rat liver 6PGDH
ATP-Mg (mM) % V/Vo (yeast) % v/vQ (liver)
0 100 100
0.5 87 105
1.5 80 95
2.5 N.D. 116
5.0 67 N.D.
N.D. Not determined
Yeast (Sigma product) and rat liver 6PGDH (DEAE- 
cellulose eluate) activity was determined as in 
II.B.lb in the presence of the indicated concen­
tration of ATP-Mg; ADP and AMP were absent from 
the incubation medium.
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rat liver by the same authors. Beitner and Nordenberg 
(1979) have proposed that the diminished levels of 01,6?^ 
in the dystrophic muscle may be responsible for the 
diversion of glucose from the PP^  to^glycolysis.
In the present study it was found that an NADPH- 
inhibited 6PGDH was insensitive to further inhibition by 
01,6P^ (lOOp^) (Table 3.11). Since 6PGDH is known to be 
inhibited by NADPH in vivo, the inhibitory effect of G1 ,6P2 
on 6PGDH activity would appear to be of limited relevance, 
in the absence of mechanisms to enhance this inhibitory 
effect.
Since Gl,6Pg was shown to inhibit 6PGDH in vitro, and 
since F1 ,6P2 has been reported to be an inhibitor of sheep 
liver 6PGDH (Dyson and D'orazio, 1971), the effect of 
F1 ,6P2 and F2,6P^ on 6PGDH from rat liver was determined. 
However, it was found under the experimental conditions 
used in this study that Fl+GPg had no effect at 
concentrations up to 5mM. The reported for the sheep 
liver enzyme by Dyson and D'orazio (1971) was 70.S(i.M, a 
physiologically relevant concentration (Van Schaftingen 
et al., 1980a). The reasons for the lack of effect of 
Fl,6Pg on the rat liver enzyme (Table 3-12) are not clear, 
but Procsal and Hoiten(1972) also failed to demonstrate 
an inhibitory effect of this compound on 6PGDH. Similarly, 
F2 ,6P2 failed to inhibit rat liver 6PGDH (Table 3*12).
It was thought that F2,6Pg could have a role in the 
regulation of 6PGDH because of its structural similarity 
to Gl,6Pg, but as the results obtained indicate, F2,6P^ 
does not appear to affect 6PGDH activity in vitro. 
Furthermore, F2,6Pg did not enhance or reverse enzyme 
inhibition by various metabolites as discussed previously.
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Table 3.11 : The effect of glucose 1,6-bisphosphate on 6PGDH activity
G1,6P2 (mM) 6PGDH activity
(nmol min~l mg“  ^ protein)
* v/vo * v/vo*
0 9.5 100 39
12.5 7.7 81 39
25 7.0 74 39
50 6.0 63 39
100 5.4 57 39
* in the presence of NADPH
6PGDH activity was measured at pH 7.6 (BTP/HCl, 0.2M) in the presence 
of 100 mM-NADP'*', 100mM-6PG, In^-Mg Ac and SOp-l of 6PGDH. The enzyme 
was partially purified as in II .B.4 ,b, and was assayed at 25®C. is
the velocity in the control cuvette i.e. in the absence of Gl,6P2- 
V is the velocity at a given concentration of G1 /GPg. The results 
are the mean of three experiments. In experiments with NADPH, 50mM- 
NADP+ and lOOpM-NADPH was used.
i6o
Table 3.12 : FT,6P2, F2,6P2 and 6PGDH activity
F2,6P2 (liM) % v/vo F1,6P2 (liM) % v/vo
0 100 0 100
1 113 25 90
2 106 50 89
3 106 100 89
6 107 200 95
12 116 250 93
- - 500 89
- - 1000 100
- - 5000 110
6PGDH activity (II.B.4b) was determined as in 
II.B.lb in the presence of lOOhM-NADP"*" and 100mM~6PG 
at pH 7.0. F1,6P2 and F2,6P2 were varied as indicated,
l6l
6 . Concluding remarks
Although a wide variety of compounds have been tested 
for the ability to reverse the well-established NADPH- 
induced inhibition of G6PDH and 6PGDH (Fig.3.6 ) in the 
present study, no de-inhibition has been demonstrated.
In physiological terms it is possible that the in­
hibition of the PPP dehydrogenases is essential in the 
resting cell in order to prevent the over-production of 
NADPH. It is conceivable that in the normal resting fed 
cell NADP -dependent malic enzyme and isocitrate dehydro­
genase could supply all the necessary NADPH, assuming that
these two enzymes are able to function in vivo. The
effect of NADPH / NADP* ratios on the activity of
these two enzymes is not well documented although in­
hibition of both enzymes by NADPH has been reported, with 
values of 30 and IQpM for malic enzyme and isocitrate 
dehydrogenase, respectively (Fabregat et al., I985). 
Nevertheless, the activity of cytosolic NADP*-isocitrate 
dehydrogenase is one order of magnitude higher than the 
PPP dehydrogenases so that one would expect this enzyme 
to produce more NADPH even if both enzymes were inhibited 
to the same extent in vivo. Hence the enzyme could 
contribute sufficient NADPH to the liver cytosol in concert 
with malic enzyme and the PPP dehydrogenases to meet the 
demands of the resting cell, even though the flux through 
the latter would be low. On the other hand increased 
demand for NADPH, such as is the case during enhanced 
lipogenesis or mixed function oxidation, would cause an 
alteration in the NADPH / NADP* ratio which would 
favour the activation of the PPP dehydrogenases. This 
view is supported by recent work by Fabregat et al. (1985)
who have shown that inhibition or activation of NADPH- 
consuming pathways correlate with the activity of the PPP, 
and that NADPH / NADP* ratios are inversely 
proportional to the activity of the PPP. Hence, an 
active PPP, in conjunction with the other NADPH-producing 
enzymes would meet the extra requirement for NADPH and
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Fig. 3.6: The NADPH-induced inhibition of 6PGPH and G6PDH
The effect of NADPH on GôPDH (a) and 6PGDH (b) was determined, 
Partially purified GôPDH (specific activity 0.24 Jlmoles min”  ^
mg ^ protein) and 6PGDH (0.4 Jimol min ^ mg  ^protein) were 
assayed in the presence of varying concentrations of NADPH 
as shown. GÔPDH activity was determined at pH 7.4 in the 
presence of yOlxM-NADP"*" and lOO^iM-GôP. ÔPGDH was assayed at 
pH 7*0 in the presence of lOOpM-ôPG and 30pM—NADP . BTP/HCl 
was the buffer and the experiments were performed at 25 C.
The results are the mean of three readings.
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restore the NADPH / NADP+ ratio. The latter 
effect would, in tum; reduce the flux through the PPP 
dehydrogenases and possibly the other NADPH producing 
enzymes.
C. ISOLATION AND CHARACTERIZATION OF A 
CYTOSOLIC NADPH-CONSUMING REACTION
In the course of trying to find a de-inhibitor for 
the PPP dehydrogenases, a major NADPH-utilizing reaction 
has been characterized. The procedure used to obtain 
liver cytosolic extracts containing the reactive components 
of this reaction was essentially that of Dunaway and Segal 
(1976). These authors purified what they called'a peptide 
stabilizing factor of rat liver phosphofruetokinase••
This stabilizing factor, reported to have a molecular 
weight of 3800 (Dunaway and Segal, 1976), shares some 
common properties both with F2 ,6P2 the cofactor reported
(Eggleston and Krebs, 1974) to act in conjunction with GSSG 
in reversing the NADPH-induced inhibition of the PPP dehydro­
genases.
The peptide stabilizing factor of PFK-1 was reported 
to contain glutamate, glycine and a half-cystine ( 1 : O .96 ;
0 .85). However, Dunaway and Segal (I976) dismissed the 
possibility that this peptide was identical to GSSG or GSH. 
Like the cofactor reported by Eggleston and Krebs (1974), 
the peptide stabilizing factor was shown to be acid labile, 
sensitive to storage at -20^C and heat labile. On the 
other hand. Van Schaftingen and Hers (I983) have 
claimed that the so-called peptide is in fact F^t^Pg since 
the peptide stabilizing factor of PFK-1 co-migrates with 
F2,6Pg on gel filtration. In addition, like F2 ,6Pg, the 
peptide (i) stimulates PFK-1 by increasing the affinity of 
the enzyme for F6P, (ii) is an inhibitor of Fl,6BPase and 
(iii) is acid labile. However more recent work by Kruep
I6'i
and Dunaway (1984a,b) provides further support for the 
existence of two peptide stabilizing factors, neither of 
which is F2 ,6P2 «
The common properties shared by F2 ,6P2 , the PFK-1 
stabilizing peptide and the cofactor reported by Eggleston 
and Krebs (1974) justified an investigation into the 
effect of the PFK-1 stabilizing factor on the PPP dehydro­
genases.
However, in the present study, it was demonstrated 
that addition of heat treated liver extracts, which were 
devoid of G6PDH and 6PGDH activity, to the reaction 
mixtures of either of these enzymes results in an apparent 
concentratration-dependent inhibition of their activities 
(Fig.3*7a). Upon further investigation it became evident 
that (a) constituent(s) of the heat extracts remove(s) the 
NADPH produced by the action of the dehydrogenases. The 
basis of this conclusion was the observation that addition 
^ / of exogenous NADPH to the heat extract in the absence of 
added enzyme and substrate resulted in a rate of NADPH 
oxidation faster than the activity of G6PDH (Fig.3*7b). 
Furthermore, it was observed that the inhibition only 
occurred for a limited time period and that this time 
period was dependent upon the volume of the heat extract 
added to the incubation mixture (Fig.3.7c). This latter 
fact suggested that the substance(s) responsible for the 
inhibition was being removed by some other reaction or 
that an opposing reaction was occurring concurrent to the 
G6PDH-catalysed reaction, and that the former reaction 
was running out of substrate, when the apparent inhibition 
ceased. Since NADPH production was being followed at 
340nm, it seemed likely that the apparent inhibition could 
be due to a reaction utilizing the NADPH produced by the 
G6PDH-catalysed reaction, and hence causing a zero net 
change in the absorbance. This theory was shown to be 
the case by the results shown in Figs.3*7b, and 3»8a.
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3•7a« Apparent inhibition of the PPP dehydrogenases 
by the heat extract
Rat liver G6PDH ( O)  and 6PGDH (•) were assayed 
as in II.B.la and b, respectively, in the presence 
the indicated volumes of the heat extract 
(II"B.4.d), at pH 7*5 in the presence of lOOjiM- 
6PG or G6P and IOO^ lM-NADP'*'. Both G6PDH and 6PGDH 
were partially purified by PEG-6OOO precipitation 
(3.5 - 20%) followed by DEAE-cellulose 
chromatography•
Fig. 3.7b : NADPH oxidation by the heat extract
The activity of G6PDH (O) assayed as described 
above and the oxidation of NADPH ( lOOjlM) (O) by 
a constituent of the heat extract (50|Il) were 
followed at 340nm.
Fig. 3.7c: The relationship between the volume of the heat
extract added and the*activity*of rat liver
G6PDH
Rat liver G6PDH activity was determined in the 
absence (A) of or in the presence of either 
50}ll (0) or lOOfXl (•) of the heat extract.
The conditions of assay were the same as in 
Fig. 3.?a.
Fig. 3.7d: Estimation of the molecular weight of the
apparent inhibitor of G6PDH
The heat extract (iml) was applied to a Bio- 
Gel P-2 column (Void volume 30.5ml) which 
was standardised and equilibrated with 20mM- 
BTP/HCl, pH 8.3 containing ImM-EDTA and 
eluted with the same buffer. The volume 
of fractions collected was 3™1«
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Fig. 3.8a: The enzyme-substrate velocity curve
The curve shows the effect of varying the volume of the 
combined enzyme-substrate complex present in the heat 
extract, and assaying for NADPH-oxidising activity (II.B.l.e) 
The heat extract used contained 12mg ml  ^ of protein.
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Table 3.13 : Effect of the substrate moiety on G6PDH activity
Additions G6PDH activity (nmol min"l mg' protein)
Expt. I Expt. II
Control incubation 3.9 ± 0.0 14.2 ± 0.3
Control incubation + 
substrate (lOOiil)
3.2 ± 0.2 12.7 ± 0.6
Control incubation + 
NADPH (lOOpN)
N.D. 9.4 ± 0.2
Control incubation +
NADPH (IOOmU) + sub­
strate (lOOiil)
N.D. 9.9 ± 0.0
N.D. Not determined
The G6PDH sources were DEAE-cellulose preparations (II.B.4a(ii ) ) and 
the substrate was the Dowex 50 eluate (cf. C.2.c.),The assay con­
ditions were as in II.B.la except that lOOnN-NADPH and 100w^NADP+ 
were present. The final concentration of the substrate was estimated 
to be about 116|iM—NADPH equivalents. The results are expressed as the 
mean ± S.D. (n=3). Experiments I and II were done at different times 
with different preparations of enzyme.
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The NADPH-oxidising activity, as determined by the 
apparent inhibition of G6PDH activity by a constituent of 
the heat extracts, was eluted from both Sephadex G-25 and 
Bio-Gel P-2 . On Sephadex G-25 two peaks of "inhibitory 
activity" were obtained. The first peak appeared l6ml 
after the void volume (36ml) and the second at 36ml after 
the void volume. On the Bio-Gel P-2 column (void volume 
50.5ml) the "inhibitory activity", which was measured by 
the degree of inhibition of G6PDH, eluted as a single peak 
8ml after the void volume. This corresponded to a molec­
ular weight of about 680 (Fig.3.7d).
Since the component of the heat extract was initially 
identified by its capacity to negate the G6PDH (or 6PGDH) 
activity, the effect of the components of this constituent 
(C.3) on G6PDH activity was determined. The fraction 
containing the enzyme (cf..C.3b) had no effect, whereas 
the substrate moiety (cf. C.3c) exhibited a slightly in­
hibitory effect (Table 3.15)" Francis and Ballard 
(1980a,b) have reported the existence of a protein in­
hibitor of GÔPDH, as discussed previously. However, it 
is unlikely that this is identical to the substrate found 
in the present study, since the degree of inhibition 
induced by the protein reported by Francis and Ballard 
is much greater.
1 . Preparation of crude liver extracts containing the
NADPH-oxidising activity
Three month old female rats were either anaesthetized 
or killed by cervical dislocation. The livers were re­
moved, weighed and homogenised in 20mM-bis-tris propane 
(BTP/HCl) pH 8 containing ImM-EDTA (pH 7.0) and 0.25M- 
sucrose (l ; 2, w/v). The homogenate was centrifuged
at 100,000g for 90min. The resulting supernatant was 
heated in a water bath to 60 C for Imin and cooled on ice. 
The denatured protein was removed by further centrifugat­
ion at 100,000g for 30min. The supernatant was used as
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the source of the component under study and is referred 
to as the "heat extract". The NADPH-consuming component 
of the extract was determined by following the oxidation 
of NADPH in BTP/HCl buffer, pH 7«5i in the presence of the 
heat extract.
a. The stabilizing effect of EDTA
When EDTA was excluded from the homogenisation buffer 
but added to the reaction mixture, the NADPH-oxidising 
activity was not affected. However, when different 
concentrations of EDTA were added to portions of this 
extract, and stored for 24h at -20° (Table 3.14), it was 
found that concentrations of EDTA up to 3raM conferred 
some stability upon the NADPH-oxidising activity (Table 
3.14). Higher concentrations of EDTA caused an in­
hibition of the activity. Since ImM-EDTA was as 
effective as 3mM-EDTA in stabilizing the activity ImM- 
EDTA was routinely included in the homogenising buffer.
b. Selection of pH of extraction
The NADPH-oxidizing activity was found to be 
abolished by pH values less than 3 and greater than 13 
after 15min incubation at 25°C (results not shown). To 
determine the effect of the pH on the stability and 
abundance of the NADPH-oxidising activity, the extraction 
was performed at pH 8.3 and pH 10.0.
It was found that the pH 10 preparation did not lose 
activity after storage at -20°C for 24h. In the same 
time period and under the same conditions, the pH 8.3 
extract lost 3 0 % of the NADPH-oxidising activity.
However at pH 10 p r q t e i n  dénaturation was less tha* at 
pH 8 .3. The pH 10 heat treated extract contained 
20*9 - 0.1 mg protein ml  ^whereas the pH 8.3 extract 
had 12.6 - 0.06 (n = 6 ) mg protein ml The total
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Table 3.14 : Stabilization of the NADPH-oxidising activity by 
EDTA after 24h storage at -20°C
EDTA (mM) Initial activity 
(nmol min~^ mg~M
Activity after
24h (nmol min~^ mg“ )^
0 27.2 9.8
1 27.2 15.7
3 27.2 15.2
4 27.2 11.5
5 27.2 8.8
The data represent the mean of triplicate readings deter­
mined at each of the five EDTA concentrations indicated.
The heat treated extract was obtained as in II.B.4 .d, with 
the important difference that EDTA was omitted from the 
extraction buffer. NADPH-oxidising activity was determined 
as in II.B.l.e. Portions of the extract (10ml) were treated 
with the various concentrations of EDTA and assayed for 
NADPH-oxidising activity before and after storage at -20 ®C 
for 24h.
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activity as assayed at pH 6 and 7 (Fig.3.8b) was slightly 
higher in the pH 10, than in the pH 8.3 extract and this 
difference was pronounced when the assay was performed at 
pH values greater than 7.5 (Fig.3.8b). Since the latter 
extract contained less protein and since it was easier to 
adjust the pH of the extract to the pH of the assay, pH 
8.3 was chosen for routine extraction purposes.
c. Selection of temperature of extraction
Fig.3.9 shows the effect of temperature on the NADPH- 
oxidising activity in the crude heat extract. The rapid 
decline in activity at temperatures higher than 70°C 
clearly indicated that lower temperatures should be used 
for extraction. The loss of activity is presumably due 
to the dénaturation of the enzyme moiety of this complex 
(cf. Ill C.2 ), since the purified substrate was later 
found to be stable under these conditions. Since the
yield of the NADPH-oxidising activity did not apparently 
change between 60° and 70°, the former temperature was 
selected for routine extraction purposes.
d. Comparison of the effect of the heating process and 
ultrafiltration on the NADPH-oxidising activity.
To determine that the reaction was not an artifact 
resulting from the heating process, the heating step was 
omitted and ultrafiltration of high speed supernatants 
through Amicon filters with a nominal molecular weight cut­
off of 10,000 was performed at 4°C.
The ultrafiltrate was tested for 6PGDH, G6PDH and 
NADPH-oxidising activity. 6PGDH ( 102,000) and G6PDH 
(M^ 110,000) activity were excluded from the ultrafiltrate, 
indicating that there was no leakage through the filters 
of higher molecular-weight substances. However, the NADPH- 
oxidising activity was found to be present.
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Fig. 3.8b: The effect of the pH of extraction on
the pH profile of the NADPH-oxidising 
activity
The heat treated extracts obtained at pH 10 
(•) and pH 8.3 (0 ) were assayed for NADPH-oxidising 
activity at the pH values indicated as in II.B.l.e. 
The extracts were adjusted to pH 7*5 with 6N-HC1, 
and in the case of the pH 10 extract, solid BTP was 
added to a final concentration of 20mM to maintain 
the pH at 7.5. The pH 10 extract was prepared in 
glycine/NaOH buffer (II.B.4.d).
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Fig. 3.9: Effect of temperature on the NADPH-
oxidising activity
The heat treated extract was further incubated 
at the indicated temperature and at pH 8.3 for 
Imin, cooled on ice and assayed for NADPH-oxi­
dising activity as in II.B.l.e. The points
represent the mean - S.D (n=3)*
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This experiment excluded the possibility that the 
reaction was an artifact of the heating process. Ultra­
filtration could not, however, be used routinely as the 
filters were blocked by the protein in the high speed 
supernatant. The volume of extract that could be obtained 
by this method was, therefore, restricted to a maximum of 
about 10ml. Hence the heating process was used for 
routine purposes.
Intracellular localization of the NADPH-oxidising 
activity.
The rat liver homogenate was prepared as described 
above (C.l) and fractionated by differential centrifugation 
to give nuclear, microsomal, mitochondrial and 
soluble fractions. The particulate fractions were re­
suspended in BTP/HCl pH 8.3 and sonicated for 30s (2xl5s) 
at maximum amplitude at 4° and assayed for NADPH-oxidising 
activity after heating each extract to 60° for Imin, cool­
ing on ice, centrifuging and discarding the precipitate 
formed. There was no detectable activity in any of these 
fractions (results not shown) and it was therefore con­
cluded that the reaction was associated exclusively with 
the cytoplasmic compartment.
As a result of the observations made in this section 
of the work the NADPH-oxidising activity was routinely 
obtained from the soluble fraction of the rat liver 
homogenate. The extractions were performed at pH 8.3, 
in the presence of ln^*“EDTA, 0 .25M~sucrose, and the high 
speed supernatants were heated to 60 C for Imin. Dialysis 
of the heat-treated extracts was found to result in a loss 
of the activity, presumably as the result of the dissocia­
tion of the enzyme-substrate complex.
2 . Purification
In the early stages of the work the NADPH-oxidising 
activity was thought to be present on a single molecular
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unit, as it could be isolated and partially purified in 
an intact state by two different purification schemes that 
would be expected to separate an enzyme from its substrate 
(Tables 3.16 and 3.17). However, at a later stage in the 
study a polyethylene glycol (PEG-6OOO) fractionation 
procedure was found to resolve the NADPH-oxidising activity 
into two fractions which were inactive separately but when 
re-combined were active in carrying out the oxidation of 
NADPH. Hence it was concluded that the heat-extract 
contained the enzyme-substrate complex and that the in­
active fractions were the enzyme and the substrate moieties 
of the complex.
a. Purification of the enzyme-substrate complex
The results shown in Tables 3-16 and 3.17 are for the 
schemes for the attempted purification of the enzyme-sub­
strate complex.
In scheme I the heat-treated extract was obtained as 
in C.l and the activity and protein content determined.
An equal volume of chilled ethanol was added to the extract 
and the resulting precipitate, which did not contain NADPH- 
oxidising activity, was discarded. The supernatant was 
then passed through an Amicon ultrafiltration filter with 
a nominal molecular weight cut-off of 10,000. At this 
step of the initial activity was lost, compared to 20%
activity lost between the heat step and the ethanol- 
precipitation stage. The larger loss at the ultra­
filtration step could be attributed to the loss of some 
of the enzyme assuming that the of the enzyme is near 
to 10,000.
The ultrafiltrate was then treated with three volumes 
of chilled ethanol and the precipitated complex was 
collected by centrifugation and resuspended in bis-tris 
propane (20mM), EDTA (ImM), pH 8.3. This sample was
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applied to a DEAE-Sephadex A-30 column (5ml capacity) and 
eluted in a stepwise manner with KC1 (Fig.3.10). The peak 
activity was obtained at a KC 1 concentration of O.I6M. The 
total activity obtained was only 1.2% of the initial activity 
but the protein content was very low after this step, hence 
the high specific activity observed. In retrospect the 
large loss in activity observed after ion-exchange 
chromatography was probably the result of enzyme dénaturation 
or substrate loss. Nevertheless enough enzyme and substrate 
co-purified through the procedure to yield an active 
component.
In scheme II (Table 3*17) a polyethylene glycol precipi­
tation followed the heat step. The heat extract obtained 
in the same manner as in scheme I,was treated with lOg/lOOml 
of solid polyethylene glycol 6OOO. The precipitate was 
removed by centrifugation, and the supernatant, which 
contained the NADPH-oxidising activity was applied to a 
DEAE-Sephadex A-50 column (Fig.3.11). It was found that 
only 10% of the activity was lost, and this loss could be 
attributed to the volume of the supernatant lost between 
transfers from tube to tube in the course of the experiment.
The sample applied to the DEAE-Sephadex A-50 column 
was eluted with a continuous gradient (O-IM) of KCl in a 
total volume of 300ml (Fig.3.11). The enzyme-substrate 
complex was eluted between 0.48 and O.6OM KCl. The eluates 
containing activity were pooled, diluted with an equal 
volume of BTP/HCl, pH 8.3 and re-applied to a smaller 
Sephadex A-50 column and eluted with KCl (Fig. 3*12). In 
scheme II 96% of the NADPH-oxidising activity was lost at 
the first ion-exchange stage relative to the proceeding 
stage, and a further 75% (compared to the first iOn-exchange 
stage) was lost at the second ion-exchange step. These 
large losses are probably due to the loss of the enzyme or 
dissociation of the enzyme-substrate complex on the ion- 
exchangers,as found for scheme I.
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Fi 3» 10; Ion-exchange chromatography of the 
enzyme-substrate complex
The ethanol concentrated extract (5ml) (II.B.^.d.(i)) 
was passed down a small DEAE-Sephadex A-50 column 
(5ml capacity) equilibrated at pH 8*3 with BTP/HCl* 
Fractions (3ml) were collected and assayed for 
activity as in section II.B.I.e. The volume of 
eluate used was 350fJ-l in a final volume of 1ml.
l8o
Fig. 3.11: Ion exchange chromatography on DEAE-
Sephadex of the enzyme-substrate complex 
(continuous gradient) '
The figure shows the elution pattern of the NADPH-
oxidising activity on DEAE-Sephadex A-50. The
sample (90ml), which was the 10% PEG supernatant, was
applied, after a two-fold dilution with BTP at pH 8.3,
to the column. The column (2 .5xl8cm) had been
previously equilibrated with BTP/HCl pH 8 .3. The
excess polyethylene glycol was washed off with BTP
(until the flow through was clear) and a continuous
gradient of potassium chloride (0-lM) applied in a
total volume of 300^1 • The flow rate was about 12ml 
-1
h and 3.3ml fractions were collected and assayed 
for NADPH-oxidising activity (II.B.l.e). The volume 
of eluate used in the assay was 300^1 in a final 
volume of 1ml.
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Fig. 3.11b: Protein content and the activity profile 
of the NADPH-oxidising activity
The conditions of assay are as those described in 
the legend to Table 3.11. The sample material 
is the same as in Pig. 3.11 and the protein content (•) 
was estimated as detailed in II.B.2.d(i).
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Fig. 3.12: Ion exchange chromatography of the
enzyme-substrate complex (Scheme II)
A portion of the pooled DEAE-Sephadex A-50 column 
eluates (5ml), diluted with an equal volume of BTP/ 
HCl pH 8 .5 , was applied to a smaller (5ml capacity) 
column. Fractions (3*3ml) were collected and 
assayed for protein content (A) as in section 
II.B.2.d.(i) and NADPH-oxidising activity (#) as 
in II.B.l.e. The volume of eluate used in the 
assays was 250pl in a final volume of Irai.
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Both purification methods resulted in low yields 
with a purification factor of just over 100. The puri­
fication factor is expressed relative to the heat extract 
(which on average contained 20% of the protein content of 
the high speed supernatant) and is therefore an under­
estimate. Nevertheless, an attempt was made to improve 
the degree of purification and to minimise the apparent 
inactivation and loss of NADPH-oxidising activity. Since 
the minimum loss of activity occurred at the polyethylene 
glycol fractionation stage (Table 3.17), an attempt was 
made to further fractionate the sample at this point in 
the purification procedure. It was during this phase of 
the work that it was shown that polyethylene glycol treat­
ment could resolve the complex into an enzyme and a sub­
strate (Table 3«l8).
The 10-30% (w/v) PEG-6000 precipitate was thought to 
contain the enzyme since the activity was lost when this 
fraction was subjected to temperatures greater than ?0^C 
or to pH values less than 3 or greater than 11 (data not 
shown). These treatments did not affect the activity of 
the 30% PEG-6000 supernatant when added to an untreated 
10-30% PEG fraction. The former was, therefore, thought 
to be the substrate-containing fraction.
Fig. 3.13a shows the substrate saturation curve of the 
enzyme. Since the molar concentration of the substrate 
was unknown, the amount of NADPH that could be oxidised by 
a given volume of the supernatant containing the substrate 
was determined. Hence the concentration of the substrate 
was expressed as "NADPH-equivalents". On this basis it 
was determined that if a 1 : 1 NADPH : substrate stoichiom­
etry was assumed, the heat treated extract contained I.07 
- 0.21 (n=6 ) nmoles of NADPH equivalents per ml of extract.
The K of the enzyme for the substrate was found to be
m •’
about 80[iM NADPH equivalents (Fig. 3* 13b). Tbe
—  1 ”1
these conditions was found to be 133 nmoles min mg 
protein.
186
with PEG-6000
Fraction Rate of NADPH 
oxidation 
(nmol min“l ml~l)
Heat extract 424.2
10% PEG supernatant 420.0
10-30% PEG precipitate 7.2
30% PEG supernatant 0.0
30% PEG supernatant + 
10-30% PEG precipitate 
(equal volumes)
376.4
Polyethylene glycol-6000 (PEG) was added as 
a solid. The activity of each fraction was 
assayed as in II.B.le. The precipitate was 
resuspended in BTP/HCl pH 8.3 containing ImM- 
EDTA to the original volume of the heat extract, 
This fractionation has been used routinely in 
the various purification procedures employed in 
the course of this work.
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Fix 3.13a: The substrate saturation curve of
the NADPH-oxidising enzyme
The heat treated extract was treated with PEG-6000 
as in Table 3.I8. The 10 - 30% precipitate re­
suspended in 20n^-BTP/HC 1 pH 8.3 containing InM- 
EDTA was used as the enzyme source. The 30% 
supernatant was the substrate source and the 
assay conditions were as in Table 3"1&* The 
points are the mean - S.D. (n=3)»
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Having determined that the NADPH-oxidising activity 
was composed of an enzyme and a substrate, which are 
apparently very tightly bound together, an attempt was 
made to partially purify the enzyme and to identify the 
substrate.
b. Partial purification of the enzyme moiety
A partial purification of the NADPH-oxidising enzyme 
was attempted and the procedure adopted is recorded in 
detail in II.B.^.d (ii). The scheme involved four steps as 
shown in Table 3.19.
The heat treated extract was obtained as in III. C.l 
and treated with 30g/l00ml of PEG 6000. The precipitate 
was collected by centrifugation at 10,000g. This treat­
ment separated the enzyme from the substrate. The 
precipitate, which was the enzyme-containing fraction was 
re-suspended in the original volume of 20mM-BTP/HCl, ImM- 
EDTA, pH 8.3. The preparation was then treated with 10% 
(w/v) PEG 6000 and the resultant precipitate was discarded 
The supernatant, was assayed for activity and 
then treated with solid PEG 6OOO such that the solution 
was made 30^ with PEG 6OOO. The 10-30% PEG 60OO 
precipitate was collected and suspended in the original 
volume of buffer. This fraction was assayed for enzyme 
activity. DEAE-cellulose chromatography was attempted
and it was at this point that the greatest loss of 
activity occurred. Fig. 3*14 shows the elution profile 
of the enzyme upon DEAE-cellulose chromatography.
Although a major peak of the enzyme activity was found to 
elute at 0 .15M-NaCl, the possible existence of iso­
enzymes is indicated by minor peaks at 0 .19M and 0 .21M 
NaCl. It would be of interest to determine whether the 
existence of these isoenzymes is related to their 
specificity for the cofactor or the substrate, or to 
their intracellular localization.
The overall purification was poor being only 12-fold
190
Fig. 3.14: DEAE-celluloae chromatography of the enzyme
The 10 - 30% PEG 6000 precipitate (see text) was re­
suspended in 80ml of 20n^—BTP/HCl pH 8.3 and In^-EDTA, 
pH 7.0 . The sample was washed onto a DEAE-cellulose 
column, previously equilibrated with 20n^-BTP HCl 
pH 7 .5, with an equal volume of buffer. The enzyme 
was eluted with a continuous linear gradient of NaCl 
(0-lM) in 20mM-BTP/HCl pH 7-5 and ImM-EDTA. A total 
volume of 300ml was used for the elution. The 
activity of the enzyme was determined as in II.B.l.e. 
The protein content was determined as in II.B.2.d.(ii). 
The graphs represent the activity (•) and the specific 
activity ( A ) profiles.
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and the percentage recovery was low (Table 3.19). It 
is, however, noteworthy that the purification factor, as 
stated previously, is an under-estimate since it is 
compared to the heat treated extract, as it was not 
possible to detect a significant rate of NADPH oxidation 
in high speed supernatant preparations, even in the 
presence of added substrate.
The lack of activity in the high speed supernatants 
could be due to a number of reasons. One is that the 
reaction is inhibited by a macromolecule which is removed 
by the heating process or by ultrafiltration. Another 
possibility is that there are two redox reactions of 
comparable magnitude working in opposition in the high 
speed supernatant so that there is little change in the 
concentration of NADPH.
The massive loss of enzyme activity upon DEAE- 
cellulose chromatography is consistent with the results 
obtained in the purification of the enzyme-substrate 
complex (Tables 3-l6 and 3*17)* Clearly, the enzyme is 
in some way inactivated on the DEAE-containing material. 
Since there was no enzyme activity in the flow through 
or in the buffer used to wash off excess protein and un­
bound material, one can only assume that the inactivation 
is either due to the interaction between the enzyme and 
the column material or, more likely, there is a cofactor 
involved in the reaction which is removed by the 
chromatographic procedure. It is also possible that 
some of the substrate is lost at this stage either as a 
result of disintegration or by remaining attached to the 
column.
A comparison of Fig.3*11 with 3*1^ shows that the 
enzyme-substrate complex requires a higher concentration 
of salt to elute than the enzyme. This implies that the 
substrate moiety is highly charged in comparison to the 
enzyme moiety. This theory is consistent with the higher 
salt concentrations required to elute the substrate off
19h
the ion exchangers used in C.2.c.
In the course of this work it has not been possible 
in the time available to improve the degree of purification 
or indeed to characterize the enzyme in detail, and this 
work will have to await another project. The relatively 
crude enzyme preparation did not permit accurate substrate 
specificity studies.
c . Purification of the substrate
In order to attempt an identification of the reaction, 
it was imperative to purify and characterise the substrate. 
Of the various methods for the purification of the sub­
strate tried, the best results were obtained with the scheme 
depicted in Fig.3.15.
In this scheme, the 30% PEG-60OO supernatant was 
obtained by treating the heat extract with 30g/100ml PEG- 
6000. The protein precipitate was removed by centri­
fugation and discarded. The supernatant was applied to a 
Dowex Cl 1 (x 8-200) column with an equal volume of 20mM- 
BTP/HCl, pH 8.3 containing ImM EDTA, pH 7*0. The PEG- 
6000 was washed off with buffer (300ml). It was important 
to remove all the PEG-60OO since it was found that the 
presence of the polymer interfered with protein and carbo­
hydrate estimations. The substrate was eluted with a 
linear concentration gradient (O-IM) of NaCl, in a total 
volume of 350ml. The substrate was found to elute between 
0.21 and 0.42M - NaCl (Fig.3.16). The fractions were 
assayed for carbohydrate and amino acid content (II.B. 2c 
and II.B. 2d(iii), respectively). The carbohydrate content 
did not correlate with the activity profile, but the 
presence of certain amino acids in the acid hydrolysates 
of the substrate correlated with the activity profile 
(Table 3.24). The distribution of activity in fractions 
off the Dowex Cl” 1 (x8 - 200) column suggested hetero­
geneity of the substrate (Fig.3*l6). ^
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1:2 (w:v) Rat Liver Homogenate
100,000g Supernatant
Heat 60°C Imin
Supernatant + 30g/l00ml 
PEG-6000 
0^% PEG 6000 Supernatant
Dowex Cl (Elution with NaCl)
Dowex H^ (Elution with Ammonia)
Small 
Dowex Cl 
Column
Bio—Gel P—2
Sephadex G-25
Pig. 3.15: Purification of the substrate
The scheme depicts the various methods employed in the 
purification of the substrate. For experimental 
detail see section II.B.4 *d.(iii)•
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Fin, 3.16: Substrate elution off Dowex Cl
—  rrx’8-2oo)-----------------------------------------------------------------
The figure shows the elution profile of the sub­
strate on Dowex Cl l(x8-200). A J 0 % PEG supernatant 
obtained as in Table 3.I8 , was applied to the column 
(2x26cm) and the excess PEG was washed off with 20mM- 
BTP/HCl, pH 8.3 (300ml). A continuous concentration 
gradient (0-lM) of NaCl in 20mM-BTP/HCl, pH 8.3 
(350ml) was applied. Fractions (4 .8ml) were collected 
and assayed for substrate content. The volume of 
the fractions used in the assay, performed as in 
II.B.l.e, was lOO^il. Fractions 21 - 32 were pooled 
for further purification. The enzyme source was the 
10 - 30% PEG-6000 precipitate (Table 3.19).
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The fractions containing the highest substrate content 
were pooled and the minor peak eluting at 0.2SM-NaCl was 
discarded. The substrate-containing fractions were diluted 
with an equal volume of buffer as above and applied to a 
Dowex-50 H'*’ 50 (x8 - 'tOO) column. The column was then 
washed with O.OIM- NH^OH (60ml) and eluted with a linear 
concentration and pH gradient (O.OIM, pH 8.5 to O.IM, pH 
13.0 ) of NH^OH in a total volume of 300ml. The substrate 
eluted between pH 8.8 and pH 9.1; i.e. between O.O6M and 
0.16M-NH^0H. The most active fractions eluted as a 
single peak (Fig.3.17). The substrate obtained at this 
stage of the purification was stable to storage at -20°C.
The fact that the substrate binds to both a cation and an 
anion exchanger suggests that the substrate has an 
amphoteric nature.
The substrate-containing fractions from the Dowex 50 
H^ column were pooled and the pH adjusted to 8.3 by adding 
solid bis-tris propane to a final concentration of 20mM 
and adjusting the pH with 6N-HC1. This product was 
divided into three portions, which were applied separately 
to Sephadex G-25, Bio-Gel P-2 and a small Dowex Cl 1 
(x8 - 200) column.
On Sephadex G-25, the substrate elution peak was 
found to be l6.4ml from the void volume (Fig.3.18). This 
indicated a molecular weight of less than 5,000 but greater 
than 709, since the compound eluted before NADH. In the 
absence of NaCl, which was included in the elution buffer 
for the substrate, the standard cystine appeared to be 
retarded on the Sephadex G-25 column. This was probably 
due to adsorption of the compound on to the gel material, 
since it has been reported by the manufacturers (Pharmacia 
Fine Chemicals) that some small molecules behave anomalously 
on such columns. They have also reported that the use of 
buffers with an ionic strength greater than 0.02 overcomes 
the interaction between charged solutes and the matrix, 
hence the inclusion of NaCl ( lOOtnM) in the eluting buffer
199
Fig. 3.17: Elution of the substrate off a
Dowex 50 H*** column
The pooled Dowex Cl eluates (57ml) were 
applied to a Dowex 50 50 (x8-400) column
(1.5 X 19cm) which had been previously washed 
in 6N-hydrochloric acid and de-ionised water.
The column was then washed with 60ml of O.OIM- 
NH^OH (pH 8.5) and a continuous gradient (total 
vol. 300ml) of NH^OH (O.OIM pH 8.5 to IM pH I3.0 ) 
was applied and 4.1ml fractions collected. The 
pH of the eluate fractions was adjusted to 
pH 7.5 with 6N-HC1 immediately before assay. 
Portions of the eluates (lOO^l) were assayed 
for activity as in Fig. 3.16.
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Fig» 3.18: Sephadex G-25 chromatography
of the substrate
A portion of the Dowex 50 pooled sample 
(3ml) was applied to a Sephadex G-25 column 
(void volume 47ml) equilibrated with BTP/HCl 
(imM-EDTA) pH 8 .3 , containing lOOmM-NaCl.
The substrate was eluted with the same 
buffer and 4 .1ml fractions were collected 
and assayed for substrate content (II.B.l.e), 
A fixed volume of 300|Il of the eluates and 
50|il of the PEG precipitated enzyme were 
used.
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of the substrate.
On Bio-Gel P-2 the substrate elution peak was found 
30.4ml after the void volume, indicating a molecular weight 
of between 440-529 (Fig.3.19). It is clear that there is 
a large discrepancy between the results obtained with the 
Bio-Gel P-2 and the Sephadex G-25 columns. It is possible 
that the substrate is being retarded as a result of some 
interaction with the Bio-Gel P-2 material.
The portion of the substrate-containing pooled 
fractions from the Dowex-50 column did not bind to the 
Dowex Cl 1 (x8 - 200) column, suggesting a change in the 
charge on the substrate molecule at the Dowex-50 
chromatography stage. The results obtained are shown in 
Fig.3.20. The diagram also indicates the separation of 
the phosphate groups from the main substrate, implying a 
decomposition of the substrate molecule. This supposition 
is underlined by the fact that the phosphate-content peak 
is at O.5M NaCl, which is in the region normally associated 
with the substrate-elution peak on Dowex Cl 1 (x8 - 200) 
(Fig.3.16 and Fig.3.23). In this case, however, most of 
the substrate was found in the flow through fraction of 
this column.
Table 3.20 shows the recovery of the substrate at 
various stages of the purification. The recovery of the 
substrate was measured as a function of the activity 
obtained with a fixed amount of enzyme with known specific 
activity. The largest loss in activity was found to be 
between the PEG-6OOO and the Dowex Cl 1 (x8 - 200) 
stages, the loss being about 58%" Some of the loss could 
be attributed to the fact that only fractions 21-32 were 
pooled (Fig.3*l6). Another possibility is that the 30% 
PEG-6000 fraction contains more than one substrate for 
the enzyme and that the ion exchange step is selective, 
resulting in an apparent decrease in the substrate content 
of the ion exchange product. Alternatively, the ion
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Fig. 3.19: Bio-Gel P-2 chromatography of the
substrate
The experiment was performed as in Fig. 3.I8, 
with the difference that only 1ml of the 
sample was applied to the Bio-Gel P-2 column 
(void volume 49ml) and that NaCl was not 
present in the buffer. Fractions (3.8ml) 
were collected and 300^1 portions assayed for 
substrate content as in Fig. 3.I9.
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Fig. 3.20: lon-exchange chromatography
the gutatrats. an
(xÔ-200)
of
The Fig. shows the elution of the substrate (#)j 
and the phosphate estimation )^on Dowex Cl 
1( x 8-200). The sample (5ml) was applied in 
20n^-BTP/HCl pH 8.3 and eluted with an 
ascending stepwise gradient of sodium chloride 
(O.O-l.OM). Fractions (5ml) were collected 
and assayed for NADPH oxidation (II.B.l.e.) 
and phosphate content (lI.B.2.b.(i). The 
enzyme source was the same as in Fig. 3#l6#
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Table 3.20 ; Recovery and purification of the substrate
Purification Total activity % recovery
step (nmol min”l )
30% PEG-6000 
supernatant
19,290 100
Dowex Cl” 
ion exchange
8,144 42
Dowex 50 H"*" 
ion exchange
5,600 29
BIO-Gel P-2 
(1ml)
196 16*
Sephadex 
G-25 (3ml)
588 16*
Dowex Cl”
ion exchange 300 5*
(5ml)
* volume used relative to the previous step 
accounted for.
The Table shows the purification procedures 
and recovery of the peptide substrate. 
Details of the methods used are recorded in 
II.B.4 d(iii).
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exchange step may be a poor method of purification for the 
substance under study. It was also found that 31% of the 
activity was lost between the anionic and cationic ion- 
exchange chromatographic steps.
The recovery after Sephadex G-25 chromatography was 
about the same as that obtained with Bio-Gel P-2 chromato­
graphy, representing a loss of about 13% relative to the 
previous step.
As NaCl and KCl were routinely used in the purificat­
ion procedures it was important to determine the effect of 
these salts on the rate of the reaction (Fig.3.21 and 3*22). 
Both were found to be inhibitors of the reaction. However, 
KCl was a more potent inhibitor of the reaction that NaCl, 
being effective at concentrations as low as 0.05M. On the 
other hand, NaCl was shown to be an activator of the re­
action at low concentrations (less than 0.15M). For this 
reason, in later experiments NaCl rather than KCl was used 
for elution purposes. Since the final concentration of 
NaCl in the reaction mixture never exceeded 0.2M for the 
various purification steps, the salt would not be expected 
to significantly interfere with the reaction.
In conclusion, it is clear from this section on 
purification that the enzyme and substrate form a stable 
complex, which is not the result of covalent bonding as 
the two can be separated with PEG-6000. The latter,being 
non-polar, can be readily separated from the substrate by 
ion exchange chromatography, since the polymer will not 
bind and can, therefore, be washed off the column prior 
to elution of the substrate.
It has been suggested that PEG removes water from the 
hydration envelope of protein molecules and causes a 
corresponding alteration in the dielectric constant of the 
medium, which in turn alters the steric relationship of 
the hydrophilic groups of the protein molecule (Chun et al.,
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Fig. 3,21; The effect of NaCl on the rate 
of the reaction
The substrate and enzyme were obtained by PEG- 
6000 fractionation as in Table 3*18 and 3*19* 
The enzyme source was the 10 - 30% fraction 
and the substrate source was the 305^  PEG- 
6000. NADPH oxidation was followed as in 
II.B.l.e in the presence of increasing 
concentrations of NaCl as shown. The 
results are the mean of three readings.
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Fig. 3.22: The effect of KCl on the rate of
the reaction
This experiment was performed on the enzyme 
substrate-complex in the heat treated extract, 
since this was the stage at which the salt was 
used. The assay conditions were as in II.B.l.e 
and the initial rates were determined in the 
presence of increasing concentrations of KCl.
211
1967). Since the substrate appears to be charged, it can 
be expected to be hydrophilic. If it is associated with 
the enzyme by virtue of its charge, then it is conceivable 
that as the PEG-6OOO concentration increases, the two 
molecules will increasingly dissociate, and that the enzyme 
moiety will precipitate out as a result of the removal of 
the water from its hydration envelope.
Although no attempt has been made to characterize the 
enzyme in any detail, some conclusions about the nature of 
the enzyme moiety can be drawn from this section. One is 
that it appears to be a small molecule, as evidenced by 
the observation that the enzyme-substrate complex passed 
through Amicon ultrafilters (M^ cut off 10,000), which 
excluded 6PGDH and G6PDH, and that a relatively high 
concentration of PEG-6OOO was required to precipitate it 
out. The other observation is that the enzyme appears to 
be stable and survives the heating to 60^ (which destroyed 
G6PDH and 6PGDH activity) and the ethanol fractionation 
treatment. Small molecular weight enzymes have been 
reported and include thioltransferase (M^ 11,000)
(Mannervik and Axelsson, 1975).
3. The components of the reaction
Since a number of reactions utilize NADPH it was 
important to exclude the possibility that the oxidation of 
NADPH was due to a well-known reaction such as the reduct­
ion of glutathione by glutathione reductase. An attempt 
was therefore made to characterize the substrates of the 
reaction.
a • The fate of NADPH
It was readily shown that NADPH was being oxidised 
to NADP* (Table 3.21). The experiment was performed with 
partially purified preparations of both enzyme and sub­
strate. It was determined that 97)^ of the NADPH added
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Table 3.21 : Production of NADP'*' Iby the KADPE - dependent reductase
Reactants NADPH oxidized 
(nmoles ml"l)
NADP"*" reduced 
(nmoles ml"^)
1. Enzyme + substrate 
+ NADPH
580 -
2. G6P + G6PDH + (1 ) - 563
3. G6P + G6PDH +
enzyme + substrate N.D. N.D.
but no NADPH
4. NADPH + G6P + 
G6PDH
N.D. N.D.
N.D. No detectable change in absorbance
The partially purified enzyme (10-30% PEG 6000 fraction) 
was reacted with NADPH and the substrate (the charcoal- 
treated 30% PEG fraction) (1) until no further change in 
O.D. was observed at 340nm. NADPH was added in excess to 
ensure that the substrate was completely reduced. G6P 
(in excess) and crystalline yeast G6PDH were then added 
(2) and the reduction of NADP'*' followed at 340nm. At the 
end of the reaction more G6P was added to ensure that all 
the NADP"^ was reduced. The amount of NADPH oxidized and 
NADP+ reduced was calculated from the change in O.D. Con­
trol experiments (3) and (4) were also performed.
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was converted to NADP+, as determined by the reaction of 
the latter with G6P and crystalline yeast G6PDH. Table 
3.21 also shows that the NADP^ used in the GüPDH-catalysed 
reaction was the product of the NADPH-oxidising activity, 
since there was no oxidation of G6P in the absence of 
added NADPH. Conversely, addition of NADPH to the 
incubation mixture of G6PDH in the absence of the NADPH- 
oxidising activity did not result in G6P oxidation. Hence 
it was concluded that the reaction under discussion 
involves the transfer of reducing equivalents from NADPH 
to a second substrate.
b . Attempted characterization of the second substrate
The reaction was followed at various wavelengths to 
examine the possibility of an identification of the com­
ponents of the reaction by a characteristic change in the 
absorption spectrum, but the only change in absorbance 
observed was at 3^0nm (Table 3*22). There was no change 
in the absorbance when the reaction was followed at 290, 
415, 520, 550, 556 and 450nm. These wavelengths are 
associated with the oxidation and reduction of quinones 
and the cytochromes. The molar absorption coefficients 
of quinones, cytochromes and NADP in their reduced and 
oxidised forms are comparable at their wavelengths of 
maximum absorption (Dixon and Webb, 1964).
Another reaction that could be expected to consume 
NADPH is that catalysed by NADPH oxidase:
NADPH + 20g ------- ► 20“ + NADP+
To exclude the possibility that this reaction was involved, 
the incubation mixture was gassed with oxygen-free nitrogen 
The reaction was allowed to proceed in sealed cuvettes.
It was observed that the rate of the reaction was not 
diminished as a result of this treatment, and it was con­
cluded that NADPH oxidase was not the enzyme involved in
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Table 3.22 : Absorbance changes induced by the reaction at 
different wavelengths
Wavelength
(nm)
Reaction rate 
nmols min"l mg“^
Substance likely to induce 
change in absorbance
290 0 quinones
340 18.5 NAD(H), NADP(H)
415 0 a-oxidised cyt. a^
520 0 g-reduced cyt.c.
550 0 a-reduced cyt.c.
556 0 a-reduced cyt.bg (NADH)
450 0 reduction of cyt.P^gQ
The partially purified substrate (Dowex 50H+eluate) was 
incubated with lOOjiM-NADPH, 1 OOmM-BTP/HCl pH 7.5 at 25°C and 
partially purified enzyme (30% PEG-6000 fraction) in a total 
volume of 1ml. The reaction was followed at the wavelengths 
indicated and the rates recorded.
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the oxidation of NADPH observed in the present study.
The substrate was also assayed for carbohydrate content 
Where carbohydrate was detected, the carbohydrate profile 
did not correlate with the NADPH-oxidation profile 
(Fig.3.23 ), and in the more purified substrate preparations 
no carbohydrate was detectable. It was therefore assumed 
that the substrate did not contain carbohydrate.
Preliminary experiments had indicated that the sub­
strate was a low molecular weight substance and that it was 
amphoteric (C.2 .c). The possibility that the substrate 
was a peptide was therefore explored. The substrate was 
found to react positively with ninhydrin. The presence 
of peptide bonds in the substrate was investigated.
( i ) Detection of peptide bonds in the substrate
Since it was suspected that the substrate was a 
peptide, the effects of a peptidase and a carboxypeptidase 
on the substrate was determined (Table 3-23)•
Peptidase treatment destroyed the substrate completely 
within 3h, as determined by the lack of oxidation of NADPH. 
Since the degradation of the substrate was being determined 
by the loss of activity of the enzyme towards the substrate, 
it was important to ensure that the observed loss of activ­
ity was not due to the degradation of the enzyme by the 
peptidase. To demonstrate this, both the control (sub­
strate incubated in the absence of the peptidase) and the 
test (substrate incubated with the peptidase) substrate 
incubation mixtures were heated to 90 0 for 45min just 
before they were assayed for NADPH-oxidising activity.
It was found that the heat treatment destroyed the pepti­
dase activity without affecting the substrate. This was 
demonstrated by adding a portion of the heated peptidase- 
treated test sample to the reaction mixture containing the 
active enzyme and substrate. There was no reduction in
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Fi%. 3.23: Carbohydrate content of the
Dowex Cl"l txÔ-200) eluates
A barium acetate and ethanol treated ^0% PEG- 
6000 supernatant (II.B.^.d.) was washed onto 
a Dowex Cl” l (x8-200) column (5ml capacity). 
The column was washed with 50ml of 20n^-BTP/ 
HCl, pH 8.3 containing In^-EDTA. The sub­
strate was eluted with a discontinuous 
gradient of NaCl (O-l.^M). The samples 
were assayed for substrate content as in 
Fig. 3.1 6 The carbohydrate content was 
also determined (II.B.2.C. The points
are the mean of 3 readings. The enzyme 
source was the 10 — 30)^  PEG-60OO fraction.
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Table 3.23 : Detection of peptide bonds in the purified substrate
Experiment I Experiment II
Incubation mixture Activity after 3h 
incubation (nmol min“^)
Activity after 18h 
incubation (nmol min'l)
Unhydrolysed con­
trol substrate 
(incubated in the 
absence of peptide 
hydrolysing enzymes )
15.27 ± 0.72 6.39 ± 0.69
Carboxypeptidase 
hydrolysed sub­
strate
8.77 ± 0.84 N.D.
Peptidase hydro­
lysed substrate
N.D. N.D.
N.D. = not detectable
The Table shows the effects of peptide hydrolysing enzymes on the substrate. 
The experiment was performed in triplicate and the results are mean ± S.D. 
Three portions of the substrate were individually incubated with 142.8 units 
ml”  ^ of carboxypeptidase , 1 unit ml  ^ of peptidase or with an a p p r o ­
priate volume of deionised water (II .B. 2d(ii ) ). At the end of the incubation 
period the reaction mixtures were all heated to 90° for 45 min, to destroy 
peptidase activity, cooled and the reaction of the substrate with the enzyme 
preparation followed as in II.B.le. In addition portions of the super 
natants containing the enzyme-hydrolysed substrate were added to an active 
preparation to ensure that there was no peptide hydrolysing activity associa 
ted with these supernatants. It was found that the heat treatment had 
destroyed the carboxypeptidase and the peptidase activity and the enzyme 
under investigation was not being hydrolysed. The reduction in the reaction 
rates could therefore be attributed to the destruction of the substrate 
rather than the enzyme which showed no loss of activity during the course 
of the experiment. Experiments I and II are independent experiments and 
are not directly comparable.
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the rate of NADPH oxidation, implying that there was 
nothing in the peptidase-treated substrate preparation that 
could account for the loss of NADPH-oxidising activity in 
the test incubation other than the destruction of the sub­
strate itself.
If the enzyme was being hydrolysed by the peptidase 
activity in the 'test* supernatants, one would expect to 
observe a reduction in the reaction rate if a portion of 
this preparation (added to the same final concentration as 
in the 'test* incubations) was added to the control 
incubations. This was not found to be the case and the 
results obtained were therefore taken to be a valid 
indication of the presence of peptide bonds in the 
substrate.
To eliminate the possibility that the loss of activity 
with the peptidase-treated samples was due to the cleaving 
of peptide bonds, rather than destruction by heating to 
90°, the control incubations were also heated to 90° and 
treated in a manner identical to that of the test incubat­
ions. The substrate was found to be stable under these 
conditions and no significant loss of activity was 
registered.
The effect of carboxypeptidase on the substrate was 
also investigated. It was found that the destruction of 
the substrate by this enzyme was slower than that caused 
by the peptidase. After 3h incubation the carboxy­
peptidase destroyed only 50% of the substrate, which was 
measured as a function of the activity with a fixed 
concentration of enzyme. Since the activity of the 
carboxypeptidase, as stated by the supplier was higher per 
ml of incubation mixture than the peptidase, it was 
concluded that the carboxypeptidase reaction was hindered 
in some way. Both enzymes were incubated with substrate 
under their optimum conditions (II.B.2 d (ii)).
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A number of factors could account for the slower rate 
of hydrolysis of the substrate by carboxypeptidase. The 
carboxypeptidase used in these experiments (Carboxypepti­
dase A) requires a free carboxyl group and does not 
hydrolyse amides or esters of simple alcohols. The 
specificity of the enzyme is determined primarily by the 
amino acid bearing the free carboxyl group and only to a 
small extent by the amino acid adjacent to this. The 
enzyme acts best on peptides with a C-terminal aromatic 
amino acid, the configuration of which must be L- . As 
Table 3.24 shows, aromatic amino acids were not detected 
in the substrate, and this could account for the reduced 
rate of peptide hydrolysis observed with carboxypeptidase. 
Furthermore, it is possible that the substrate has a 
modified C-terminal. In addition the enzyme has been 
reported to act only slowly on dipeptides unless the amino 
acid group is acylated, although in tripeptides and higher 
peptides the length of the peptide chain has little 
effect. The length of the side chain is not critical 
(Dixon and Webb, 1964).
In contrast, the peptidase does not require the 
presence of aromatic amino acids in the peptide chain and 
acts with maximum efficiency on compounds containing an 
N-terminal amino acid with an aliphatic side chain, the 
efficiency increasing with the size of the side chain.
The peptidase does, however, require a free -amino 
group and blocking of this group prevents the action of the 
enzyme. The enzyme lacks esterase activity and does not 
therefore hydrolyse the corresponding amino acid esters. 
Amides of most amino acids are hydrolysed, although those 
of leucine, norvaline and 2-aminocaproic acid are attacked 
more rapidly than others. The configuration of the amino 
acids on both sides of the bond which is split is important, 
particularly that on the N-terminal side of the bond. The 
presence of leucine on either side of the bond being 
hydrolysed has a particularly favourable effect on the rate
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of hydrolysis (Dixon and Webb, 1964).
Another possibility that could account for the slow 
rate of carboxypeptidase inactivation of the substrate is 
that the enzyme may have to digest a substantial proportion 
of the substrate before a modified substrate is produced 
which has no affinity for the NADPH-dependent reductase.
Another explanation for the slower rate of hydrolysis 
obtained with carboxypeptidase is that the latter enzyme 
preparation is contaminated with a residual activity of 
peptidase which is responsible for the hydrolysis and that 
carboxypeptidase itself is inactive.
(ii) Amino acid content of the substrate
Amino acid analysis, following acid hydrolysis of a 
partially purified substrate preparation (Fig.3.23) 
revealed that the substrate contained at least four differ­
ent amino acids which coincided with the presence of the 
substrate (Table 3*24). These included methionine, 
cystine, valine and possibly leucine. The amino acid 
composition of the substrate was also determined by t.l.c. 
after carboxypeptidase treatment (Table 3*25). In this 
method of analysis, the substrate in the purest form 
obtained (Fig.3.18), was treated with carboxypeptidase 
for various time intervals. After each time interval 
dansyl chloride derivatives of the released amino acids 
were prepared (II.B.2 d (iv) and the sample chromato­
graphed on t.l.c. as described in the legend to Table 3*25* 
The amino acids appeared in the sequence valine, cystine, 
"a" and "b", the latter two not being readily identifiable 
by t.l.c. as they did not coincide with any of the 
standards used which were dansylated derivatives of the 
amino acids detected with the autoanalytical method.
In a separate experiment the N-terminal amino acid, 
determined by dansyl amino acid formation followed by 
acid hydrolysis and t.l.c. analysis, was found to be
valine. Hence it appeared from these observations that
Table 3.24 : Amino acid
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content of the Dowex Cl" 1 (x8 - 200) eluates
NaCl (M) Amino acid content of the fractions
0 methionine* , leucine*, isoleucine
0.2 + methionine* , leucine*, isoleucine
0.4+ methionine, cystine, valine
0.6+ methionine, cystine, valine
0.8+ methionine. cystine, leucine
1.0+ methionine
1.2+ methionine
1.4 methionine
* Identification inconclusive but nearest to the expected 
peak of the indicated amino acid.
The amino acid content of the samples, which are the same 
as those recorded in Fig. 3.23, was determined with a 
Joel JLC-6AH analyser as in II.B.2d(iii ). The unhydro­
lysed samples did not yield free amino acids, hence the 
recorded amino acids were taken to be the products of 
acid hydrolysis. The active samples are indicated in 
Fig. 3.23 and correspond to the NaCl concns. marked (+) 
in the table.
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Table 3.25 : t.l.c. analysis of the products of carboxypeptidase 
treatment of the purified substrate
Time of incubation with 
carboxypeptidase (min)
Amino acids detected
0 None
10 valine
45 valine. cystine
60 valine. cystine
180 valine, cystine
360 valine, cystine, 'a '
1080 valine. cystine, 'a'
The substrate obtained at the Sephadex G-25 stage 
(Fig. 3.15) was hydrolysed with carboxypeptidase 
(II.B.2d(ii) ) for the indicated time. The carboxy­
peptidase was removed by heating to 90° for 45min 
followed by centrifugation. The supernatants were 
reacted with dansyl chloride (II.B.2d(iv)) and the 
dansylated derivatives of the free amino acids formed 
were separated by t.l.c. (II.B.2d(iv)). The dansyl 
derivatives were located under u.v. light. 'b' is a 
faster moving molecule (Rf 0.6) than 'a' (R^ 0.5)
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valine was present in the peptide at both the N- and C- 
terminal ends.
The results in Table 3.23 and 3.25 indicate that 
after 3h, when some of the valine and cystine were shown 
to be removed by carboxypeptidase treatment, only about 
50% of the original amount of the substrate was destroyed. 
The appearance of the amino acids referred to as "a" and 
"b" correlate with the total inactivation of the substrate.
It was noted in these time course experiments that 
the stationary spot at the base line due to the dansylated, 
unhydrolysed peptide diminished with prolonged incubation 
with carboxypeptidase, and eventually disappeared after l8h.
The conclusion drawn from this section of the work 
was that the substrate was a cystine-containing peptide 
and that valine was at both terminals of the peptide.
(iii) Correlation of the reduction of the disulphide
bonds in the substrate molecule with NADPH oxidation
On the basis of the results obtained in the pro­
ceeding section a working hypothesis, which assumed that 
the cystine associated with the substrate was being 
reduced by NADPH during the reaction, was adopted. The
reaction proposed is depicted below;-
R-S-S-R^ + NADPH --------- ^ RSH + R^SH + NADP^
To test this hypothesis, the purified substrate was
subjected to both chemical and enzymatic disulphide reduct 
ion procedures. The resulting thiol groups were assayed 
by the method of Zahler and Cleland (1968), which uses 
5, 5^ - dithiobis (2-nitro-benzoic acid) (DTNB). In the 
present study dithiothreitol (DTT) was used as the reduc­
ing agent as follows:-
CH.S
CH.OH
> CH.OH AsOH
CH.S
22U
DTT + RSSR^  --------- — ► DTT-SSR^ + RSH
D T T - S S R l  ^ DTT + b^SH
(oxidised)
DTT was added in excess. In order to distinguish between 
the monothiols formed and the dithiols of DTT, arsenite, 
which forms a tight complex with the dithiols, but not the 
monothiols, was added after reduction. The formation of 
the dithiothreitol-arsenite complex is shown below:-
CH.SH
I ^
CH.OH 
1
CH.OH + H AsO,
CHgSH
The free monothiols were then reacted with DTNB and the 
formation of the yellow complex followed at &12nm until 
there was no further change in the absorbance.
The free thiol content of the enzyme preparation, as 
determined by its reaction with DTNB was negligible under 
the conditions of assay. Fig.].2^ shows the results 
obtained when the purified substrate eluted from a 
Sephadex G-25 column was chemically reduced with DTT.
There is a clear correlation between the NADPH oxidation 
rate and the thiol content of the substrate, after 
chemical reduction. There was no detectable free thiol 
in the substrate preparation before chemical or enzymatic
reduction•
Free thiol production was also found to occur when the 
enzymatically-catalysed reduction of the substrate occurred 
(Fig.3.25). The rate of free thiol production catalysed 
by the enzyme was proportional to the substrate concentra­
tion and was correlated to the rate of NADPH oxidation.
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Sephadex G-25 fractions
Fig. 3.24: Detection of disulphide bonds in
the substrate
The Sephadex G-25 column chromatography fractions 
(Fig. 3.19) which reacted with the enzyme were 
assayed individually for disulphide content ( A ) 
and NADPH oxidation (#). The disulphides were 
chemically reduced with DTT (Zahler and Cleland, 
1967). The free monothiols were assayed by 
following the absorbance at 4l2nm after addition 
of DTNB (lI.B.2 .f.).
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Fig, 3.25: Enzymatically catalysed thiol
production and NADPH oxidation 
expressed as functions of 
substrate concentration
The total NADPH iéL) oxidised and thiol groups 
produced (•) were determined after enzymatic 
reduction of the substrate II.B.l.e and II.B.2.f.) 
The thiol group content of the partially purified 
enzyme was determined (2.20 nmol SH/ml) and sub­
tracted from the values obtained for the substrate 
A portion (0.8ml from a total reaction volume of 
1ml) of the substrate was assayed for the 
disulphide after NADPH oxidation had ceased 
(33mins.).
227
A time course experiment (results not shown) was 
also performed. It was found that NADPH oxidation was 
essential for the release of the thiol groups. Table 3.26 
shows that thiol production was dependent on the presence 
of the enzyme, the substrate and NADPH. The rate of thiol 
production, measured at 4l2nm was proportional to that of 
NADPH oxidation, measured at 340nm. It was checked that 
the following reactants and combination of reactants did 
not react with DTNB: NADPH; enzyme (the thiol content
where detected was subtracted); substrate (before 
reduction); enzyme and substrate or NADPH; NADPH and 
substrate.
Since amino acid analysis of the substrate had 
indicated the presence of a cystine residue, and since the 
rate of thiol production was proportional to the substrate 
concentration (Fig.3.23) it was concluded that the sub­
strate was a cystine-containing peptide. It is also 
clear from the results recorded in this section that there 
is a direct correlation between NADPH oxidation and thiol 
production.
(iv) Phosphate content of the substrate
Inorganic phosphate, as estimated by the method of 
Fiske and SubbaRow (II.B.2.b.(i)), was associated with the 
substrate at all stages of the purification and was there­
fore assumed to be an integral part of the substrate 
molecule. Figs. 3-20, 3-26, 3.27, 3.27b show that the 
P^ content and the NADPH oxidation profiles coincide and 
indicate that the substrate may be a phosphorylated 
peptide. It was checked that the disulphide bonds of 
cystine in oxidised glutathione did not react in the 
method used for phosphate determination.
These results justified a further investigation of 
the role of phosphate in the substrate molecule, and the 
effect of alkaline phosphatase on the substrate was
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Table 3.26 : The NADPH-dependence of the reaction releasing 
thiols from the purified substrate
Incubation mixture nmols thiol produced
min"l mg"l protein
E + DTNB 0
E + DTNB + NADPH 0
E + DTNB + NADPH + S 64.1
S + DTNB 0
S + DTNB + NADPH 0
S + DTNB + NADPH + E 59.5
The enzyme (E), which was the 10-30% PEG 6000 resuspended 
precipitate was initially incubated with DTNB. The change 
in absorbance was followed at 412nm cind the zero rate 
recorded. NADPH was then added and the absorbance change 
recorded again. Finally the substrate (S) was added and 
the rate recorded. The experimemt was repeated but with 
the substrate replacing the enzyme in the incubation medium. 
The enzyme was used to start the reaction in the latter case 
The assay was performed at pH 7.0 (lOOmM-BTP/HOl and ImM- 
EDTA, pH 7.0) in the presence of iOOjiM NADPH, 200|il of the 
charcoal treated substrate (Table 3.28) and lOOpl of the 
enzyme in a final volume of 1ml.
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Fi&. 3.26: Phosphate content profile of the
enzyme substrate complex
A purified enzyme-substrate complex containing 
sample (heat — ^ PEG — ^DEAE-Sephadex) was applied 
to a small DEAE-Sephadex column and eluted with 
KCl (discontinuous gradient). The eluates were 
assayed for NADPH-oxidising activity (#) (II.B.l.e.) 
and phosphate content (A) (II.B.2.b.(i).). The 
results are the mean of 3 readings. The data is 
the same as in Fig. 3.12.
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Fis. 3.27: Phosphate content of substrate- 
containing fractions obtained from 
a Dowex Cl“l (x8-200) column.
The 3096 PEG-6000 supernatant was treated with 
activated charcoal for 20min. The charcoal 
was removed by centrifugation and the super­
natant (5ml) was applied to a small Dowex Cl 
1 (x 8-200) and eluted with a discontinuous 
gradient of NaCl as indicated. The phosphate (•) 
and substrate content was determined (II.B.2.b.(i) 
and II.B.l.e.). The enzyme source was the 10 - 
30)6 PEG-6000 fraction.
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Fig. 3.27b ; Phosphate-content of the substrate- 
containing fractions
A 30% PEG-6000 supernatant was passed down a Dowex Cl 
1(x8-200) column and eluted as in Fig. 3*16" The 
samples were assayed for the substrate (•) as in 
Fig. 3.16, phosphate (A ) as in II.B.2.b(i) and 
total NADPH oxidation (O), the latter being estimated 
from the total absorbance change at 340nm. The 
volume of the fractions was 4.1ml.
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tested. It was found that the activity of the enzyme 
towards the substrate was substantially reduced, but not 
abolished, by alkaline phosphatase treatment of the sub­
strate (Table 3*27). The optical density changes at 
340nm indicated that the substrate had been destroyed in 
some way and control experiments ruled out the possibility 
that the observed reduction in the rate of reaction was 
due to the inhibition of the enzyme or destruction of 
NADPH by alkaline phosphatase. The experiment with 
alkaline phosphatase was repeated at least 3 times with 
different preparations and in each case it was observed 
that there was always a residual activity left after the 
alkaline phosphatase treatment. This implied that the 
presence of the phosphate in the molecule was not 
essential for the reaction of the substrate with the 
enzyme and NADPH but that the phosphate was required for 
maximum activity.
(v) The nature of the phosphate group in the substrate 
Barium acetate precipitation:
The substrate was precipitated by barium acetate 
(0 .2M) in the presence of 80% ethanol. This suggested 
that if the compound was phosphorylated, it was likely to 
be a monophosphate (Cardini and Leloir, 1957). However, 
the substrate itself was also found to be precipitated by 
80% ethanol in the absence of barium acetate. This 
experiment did not, therefore, provide conclusive evidence 
for the existence of a phosphate group in the substrate 
molecule.
Charcoal treatment of the substrate:
Activated, acid washed, charcoal is known to 
selectively adsorb purines and pyrimidines and their 
derivatives. Inorganic phosphate, sugar phosphates, 
salts and proteins are not adsorbed significantly. In
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Table 3.2?: The effect of alkaline phosphatase 
treatment on the substrate
Treatment Rate of NADPH oxidation 
(fimol min ml )
Total 
NADPH 
oxidised 
(p.moI ml ■}
control
alkaline phosphatase 
treated substrate
0 .N8 - 0.08
0.09 i 0.009
1.50
0.^8
The table shows the effect of incubation of the substrate 
with alkaline phosphatase for 17h at The results are
mean - S.D (n = p). Alkaline phosphatase (6 units ml ^) was 
added to a portion of the substrate; a control incubation 
of the substrate was also performed in the absence of 
alkaline phosphatase. After the incubation period both the 
alkaline phosphatase-treated and untreated substrate were 
heated to 80°C for l^min. The precipitated alkaline 
phosphatase was removed by centrifugation and the resultant 
supernatant (designated the "test supernatant") was tested 
for the presence of the substrate by incubation with the 
enzyme and NADPH (II.B.l.e.). The destruction of the 
alkaline phosphatase by the heating process was confirmed 
by the observation that the addition of the "test super­
natant" to the reaction mixture of G6PDH (the removal of 
G6P and NADP* by alkaline phosphatase is assessed in this 
experiment) had no effect on the activity of G6PDH. If 
alkaline phosphatase was still active addition of the 
phosphatase would have destroyed the G6P. The fact that 
some inhibitory contaminant was not present in the "test 
supernatant" was shown by adding the same amount of test 
supernatant to the control substrate incubation; the 
latter was found to exhibit the same rate of NADPH
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Table 3.27 continued;
oxidation as that observed in the absence of the "test 
supernatant". Thus the reduction in activity following 
alkaline phosphatase treatment of the substrate is due 
to the destruction of the substrate, rather than the 
removal of NADPH or destruction of the enzyme in some 
way by alkaline phosphatase.
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addition, activated charcoal adsorbs most of the nucleo­
tide co-enzymes (Crane and Lipmann, 1953, Cardini and 
Leloir, 1957).
The substrate in the present study was stirred with 
about 50mg ml of activated charcoal for 20min. The 
mixture was then centrifuged at 10,000g for a further 
20min. The results obtained are shown in Table 3.28.
The table shows that 78%  of the substrate (measured as a 
function of its reactivity with the enzyme) was not 
adsorbed on charcoal. When the charcoal was washed 
with ammonia ( 5N ) a further 19.2% of the substrate was 
recovered. It is possible that the substrate preparation 
at this stage is heterogeneous (see Fig.3.16) and that the 
substrate is contaminated with a nucleotide derivative 
such as GSS-CoA which can be expected to contribute to 
the rate of NADPH oxidation, since the enzyme preparation 
was shown to contain an active glutathione reductase 
activity.
As a result of this experiment, which was reproduc­
ible, it can be said that the substrate responsible for 
the main reaction is not a purine - or a pyrimidine- 
based phosphorylated compound. The results are consist­
ent with the peptide nature of the substrate.
Phosphate has been shown to be covalently attached 
to amino acid residues in three forms : as acyl phosphate
attached to the carboxyl function of aspartic or glutamic 
acid; as a phosphoamidate with either the imidazole 
nitrogens of histidine or with the epsilon amino group of 
lysine; and as an 0 -monoester with the hydroxyl group of 
serine, threonine or tyrosine (Buss and Stull, 19&3i 
Taborsky, 1974; Weller, 1979). None of these amino 
acids were found in the hydrolysate of the substrate, and 
it is unlikely from the amino acid peaks observed on the 
amino acid autoanalyser chart that the unidentified amino 
acids in the substrate could be any of these. However,
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on the rate of NADPH oxidation
Treatment of Rate of NADPH oxidation
substrate (nmol min"l mg"l protein)
NO TREATMENT
After charcoal 
treatment
182.8
142.8
The 30% PEG supernatant (Table 3.18) was stirred 
with 50mg ml"! of charcoal for 20rain. The charcoal 
was removed by centrifugation at 10,000g. The 
supernatant was tested for its reactivity with the 
enzyme (II.B.le). The results are the mean of 
three readings. The experiment was repeated 3 times 
with similar results.
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if the reaction with alkaline phosphatase (Table 3.2?) is 
genuine, the substrate is likely to be a monoester of 
phosphoric acid.
(vi) Comparison of the substrate with GSSG and cystine
Amino acid analysis of the peptide substrate under 
study showed that glycine and glutamic acid were absent 
from the peptide. Thus the possibility that the substrate 
was the tripeptide glutathione was unlikely. Further­
more, phosphate groups were always associated with the sub­
strate. The possibility that the peptide may be the 
mixed disulphide of GSH and CoA was rendered unlikely by 
the observation that the peptide did not absorb light at 
260nm, was not significantly adsorbed on activated charcoal 
and was devoid of glutamic acid and glycine after acid 
hydrolysis. Since the ratio of cystine : glutamic : 
glycine in glutathione is 1 : 1 : 1 , it is unlikely that
the lack of detection of these amino acids was due to in­
sufficient amounts of these amino acids being present, as 
the cystine peak was large and distinct and was only 
observed after acid hydrolysis.
Both GSSG and cystine were found mainly in the flow 
through fraction of the column. A small proportion of 
the glutathione applied to the column was retarded and was 
eluted as a peak emerging at 0.4M-Nacl (Fig.3.28). The
peptide substrate on the other hand was totally retarded 
and emerged as a single peak at 0 .6M-NaCl. This is 
further evidence that the substrate under investigation 
is neither glutathione nor cystine. Furthermore? cystine 
was not a substrate for the reductase under study.
The cellular concentration of the substrate was 
estimated to be about 4.84 - 1.50 (n=9) ^mol g liver, 
assuming a stoichiometry of one disulphide bond cleaved 
per NADPH oxidised. In the absence of knowledge regard­
ing the specificity of the enzyme under study, this figure
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Fig. 3.28: Comparison of GSSG, cystine and 
the substrate
The elution profile of glutathione (•) and cystine (A)  
after ion exchange chromatography on a Dowex Cl" column 
was determined. The experiment was performed at 
pH 8.3 20mM-BTP/HCl In^-EDTA pH 7.0) and eluted in a 
stepwise manner with NaCl in 20mM-BTP/HCl pH 8.3.
The elution profile of the substrate under study was 
also determined (O). The assay conditions for 
glutathione and the disulphide reductase were as in 
II.B.l.e and f. The disulphide content of the 
cystine containing fractions was determined as in 
II.B.2.g .
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can only be considered as a rough estimate of the substrate 
(or substrates) being reduced. The cellular concentration 
of GSSG has been reported to be about l8 nmol g"^ liver in 
perfused rat liver (Sies et al., I983). Lower values 
have been reported by Veech et al (1969) and Owen et al.
(1965).
(vii) Comparison of the substrate to thioredoxin and 
glutaredoxin
The reduction of ribonucleotides to the corresponding 
deoxyribonucleotides, needed for DNA synthesis is catalyzed 
by ribonucleotide diphosphate reductase, which has been 
shoAvn to depend on two different hydrogen donor systems 
(Thelander and Reichard, 1979; Luthman and Holmgren, 1982a,b) 
One of these is the NADPH-dependent thioredoxin system 
(Thelander and Reichard, 1979) and the other is a gluta­
thione-dependent system where the protein glutaredoxin 
couples the oxidation of GSH to the reduction of ribo­
nucleotides (Luthman and Holmgren, 1982b). Fig.3.29 shows 
the proposed scheme for the latter system. The thio­
redoxin system has already been discussed in the 
Introduction.
Since both these systems use NADPH and involve the 
reduction of disulphide bonds, it is not unlikely that 
glutaredoxin or thioredoxin or a phosphorylated derivative 
of these, could be the substrate under investigation in 
the present study. However, an analysis of the amino 
acid composition of the substrate in the present study 
shows that this is unlikely. While both thioredoxin 
and glutaredoxin have been shown to contain high levels 
of glutamic acid (Luthman and Holmgren, 1982a,b) relative 
to cystine, glutamic acid could not be detected in the 
present study at any stage of the purification of the 
substrate. Thioredoxin has also been shown to consist 
of high levels of lysine, aspartic acid and alanine 
relative to cystine, this was not found to be the case
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Ribonucleotide
reductase
0—P—0 “P—0 “CH, —0—P—0 —CH,
Glutaredoxin
GSSGGSH
,+NADP NADPH + H
Glutathione
reductase
Fig. 3.29: The glutaredoxin system
In this sytem, the ultimate source of electrons is 
NADPH, but they are passed to glutathione (catalyzed 
by glutathione reductase). Reduced glutathione 
then reduces glutaredoxin, which in turn acts as the 
reducing substrate in the ribonucleotide reduction 
(Luthman and Holmgren, 19Ô2).
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for the substrate in the present study. Whereas the 
ratio of valine ; cystine has been reported to be 2.75 
and 2.22 for thioredoxin and glutaredoxin, respectively, 
it was found in this study that the ratio of valine to 
cystine was in favour of cystine (l: 0 .4 ) in the various 
analytical experiments performed on the substrate.
Thioredoxin and the substrate in the present study 
do, however, share at least one property in common and 
that is that they both appear to have valine as the only 
N-terminal amino acid. The cellular concentration of 
thioredoxin and glutaredoxin (both have an of 12,000) 
has been reported to be 45 mg/kg wet weight and 14.0 
mg/kg, respectively. These concentrations are three 
orders of magnitude lower than the estimated cellular 
concentration of the peptide under study. Furthermore, 
the molecular weight of the substrate under study would 
not appear to be greater than 5000 as determined from 
gel - and ultrafiltration experiments. Furthermore both 
thioredoxin and glutaredoxin are reported (Luthman and 
Holmgren, 1982a,b) to be eluted in the void volume when 
chromatographed on Sephadex G-50 (separation range 1,500-
30,000).  ^ Whereas the peptide under study separated
from the macromolecules on Sephadex G-25 (1,000-5,000). 
Furthermore, DTNB cannot be substituted for the substrate 
under study, whereas Luthman and Holmgren (1982a) have 
reported that DTNB can act as a substrate instead of 
thioredoxin. In the reaction under study, the disulphide 
bonds in DTNB are only broken down after the reduced 
peptide substrate is formed.
There are sufficient differences between the sub­
strate under investigation and both glutaredoxin and 
thioredoxin to eliminate the possibility that one of the 
latter may be identical to the former.
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(viii) General properties of the substrate
The preceeding discussion indicates that the sub­
strate is a peptide, containing disulphide bonds and, 
possibly, phosphate groups. Furthermore, the substrate 
appears to be highly charged as evidenced by the high 
concentrations of NaCl required to elute the substrate off 
the anion-exchanger. For instance the concentration of 
NaCl required to elute from Dowex Cl" 1 (x8 - 200)
was found to be between 0.175M and 0.250M (results not 
shown). The concentration range required for the sub­
strate under study was 0.21 to 0.42M-NaCl. Leucine, 
valine, methionine and cystine were found not to bind to 
the ion exchanger under the same conditions.
Treatment of the 30% PEG supernatant fraction with 
HCl (pH 1) for 20min at 4°C resulted in a 43% reduction 
in the substrate content, as determined by the rate of 
NADPH oxidation. The substrate was heat stable in that 
it was not destroyed by heating to 90° for 45min at pH 8.3.
4. Characteristics of the reaction and comparison with
known NADPH-dependent disulphide reducing reactions
The evidence from the previous sections suggests that 
a NADPH-dependent reductase exists in rat liver cytosol 
with a specificity towards a cystine-containing peptide 
substrate, which can also be shown to occur in the same 
cellular compartment. The properties of the reaction 
between the partially purified enzyme and substrate were 
further investigated.
a. Kinetics of the reaction
A kinetic analysis shows that the enzyme exhibits
simple Michaelis-Menten kinetics with respect to its
natural substrate (Fig.3#13&) and to NADPH (Fig.3»30a).
The estimated value of the K of the enzyme for NADPH is
m
5|iM (Fig. 3.30b) and that for the peptide substrate is
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(Fig. 3.13b), assuming a 1 : 1 relationship 
between moles of peptide reduced and moles of &ADPH 
oxidised. Although &ADH was oxidised by crude heat 
extracts (5% of NADPH) it was not oxidised by
partially purified preparations of enzyme and substrate 
(results not shown).
b . Effect of pH and temperature on the reaction
The enzyme was found to be active over a broad pH 
range. The pH optimum of the reaction was, however, 
shown to be 6 (Fig. 3.31), and the acetate buffer was 
found to be somewhat inhibitory compared to BTP/HCl 
(Fig.3.31). The temperature optimum was found to be 
37°C (Fig,3.32).
c . Apparent irreversibility of the reaction
An interesting feature of the reaction is that it 
appears to be irreversible. Addition of excess NADP 
at concentrations up to ImM, failed to reverse the re­
action catalysed by the 10-30% PEG-6OOO fraction. The 
purified substrate was used. The reaction was allowed 
to proceed to completion in the direction of NADPH 
oxidation (II.B.l.e) after which NADP^ was added in 
excess but, as stated, no reversibility could be 
demonstrated.
The rationale behind the experiment was that if 
the reaction, shown below, was reversible, one would 
expect that once the forward reaction had come to a 
stop, the equilibrium of the reaction could be displaced 
such that the addition of excess NADP^ would favour the 
backward reaction. This was hot found to be the case 
under the condütions used in the present study.
RSSR * + NADPH -------------- R*SH + RSH + NADP
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Fig, 3.31: The effect of pH on the NADPH-
oxidising activity
Two buffers were used to determine the effect of 
pH on the NADPH-oxidising activity. Sodium 
acetate/acetic acid buffer (0.2M) was used in the 
pH range 3-6 and BTP/HCl (0.2M) in the pH range 
6-9. The enzyme and substrate sources were the 
10 - 3 0 % and 30)6 PEG-fractions, respectively.
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Fig. 3.32: The effect of temperature on the
NADPH-dependent disulphide reductase
The effect of temperature on the reaction was 
determined and the rates assayed as in II.B.l.e. 
The incubation mixture was maintained at the 
appropriate temperature for lOmin. The 
temperature of the reaction chamber of the 
spectrophotometer was brought as near as 
practically possible to the required 
temperature. The results are the mean - S.D. 
(n=4). The enzyme source was the 10 - 30%
PEG fraction and the substrate source was the 
30% PEG fraction.
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There are several possible explanations for the 
irreversibility of the reaction. Firstly, the enzyme 
may indeed catalyse an irreversible reaction under normal 
physiological conditions, and that in vivo the reverse 
reaction may be catalysed by a different enzyme possibly 
with different cofactor requirements. In this context, 
an excess of did not reverse the reaction.
A second possibility is that the reaction is rendered
irreversible by further metabolism or instability of the 
peptide product, such that it cannot be utilized in the 
reverse reaction despite the presence of an excess of 
NADP^.
d . The stoichiometry of the reaction
The stoichiometry of the reaction was determined by
following the rate of &ADPH oxidation at 340nm and relat­
ing this to the reduction of disulphide at 4l2nm in the 
presence of DTNB. The initial rate of AADPH oxidation 
was found to be 10.4 - 2.3 (n=6 ) nmol min  ^mg protein. 
Under the same conditions of assay, with the same enzyme 
and substrate (Sephadex G-25 eluate) preparations and 
concentrations, the rate of thiol production was 17.2 - 
2.7 (n = 6 ) nmol min  ^ mg  ^protein. The ratio of NADPH 
oxidation to thiol production was therefore determined 
to be 1 ; 1.7 or, approximately,1 : 2. This indicates
that 1 NADPH is oxidised for every two thiols produced. 
Fig.3.25 shows a linear relationship between the total 
&ADPH consumed, thiol groups produced and the volume of 
substrate reacted with the enzyme. In this case how­
ever the average thiol yield per mole NADPH oxidised was 
3 : 1 , implying that 3 thiol groups were being produced 
per mole of NADPH. The reason for the discrepancy 
between the initial rate data and the redox titration 
data is not clear. It is possible that some NADPH is 
regenerated or that there is an autocatalytic break 
down of the substrate as a result of the initial
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enzymatic cleavage of the disulphide.
e. Comparison of the reductase under study with 
the thioredoxin - and glutathione- 
reductase catalysed reactions
The relatively crude enzyme preparations used in the 
study did reduce glutathione but not cystine (up to ImM).
Mize and Langdon (I962) and Carlberg and Mannervik (1975) 
have shown that glutathione reductase can catalyse the 
reduction of cystine. Other differences between the re­
action described here and that catalysed by glutathione 
reductase are that the pH optimum for the reaction in the 
present study was found to be 6.0, compared to 7-0 for 
the glutathione catalysed reaction (Carlberg and Mannervik, 
1975); 64% of the activity was lost upon incubation of the
enzyme under investigation at 70°C for 30min, whereas 
Tietze (1970b) showed that glutathione reductase was stable 
under these conditions; NADP^ (200p.M) which has been 
reported to inhibit glutathione reductase with a K, of 
lOOjiM (Carlberg and Mannervik, 1975) only caused a 20% 
inhibition of the reaction under study. MgCl^ and CaCl^ 
which have been reported to stimulate GLSSG reductase 
(Mize and Langdon, 1962) had no effect on the rate of the 
reaction under study. These observations suggest that 
glutathione reductase is not the enzyme responsible for 
the reduction of the disulphide in the present study.
The involvement of thioredoxin reductase is thought to be 
unlikely for; the following reasons: The for the sub­
strate in the present study is 33 times that of thio­
redoxin reductase for thioredoxin (Luthman and Holmgren, 
1982a); The enzyme under consideration, unlike thiored­
oxin reductase, was not sensitive to inhibition by 
arsenite (10” '^M); This concentration of arsenite has 
been reported to inhibit thioredoxin reductase by 96%
(Luthman and Holmgren, 1982a); Finally, these authors 
also reported that thioredoxin reductase catalysed the 
NADPH-dependent reduction of DT^ iB and that thioredoxin
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inhibited this reaction. In this study, the enzyme 
under investigation did not reduce DTNB and the presence 
of DTNB did not inhibit the reduction of the substrate 
(Table 3.26).
Although an attempt has not been made to further 
characterize the reductase under study, experiments 
involving ultrafiltration indicated that the enzyme is 
small in size compared to thioredoxin reductase (M^
116,000) and glutathione reductase (M^ 125,00 0 ), since it 
passed through ultrafiltration membranes with a 
cut off of 10,000.
These observations together with the considerations 
detailed in C.3. have led to the conclusion that the re­
action reported here is separate and distinct from the 
glutathione and thioredoxin reductase catalysed reactions. 
The possibility that either of these enzymes is reducing 
a different substrate and thus exhibiting different 
properties has not been eliminated.
In this work the average rate of NADPH oxidation 
catalysed by the peptide reductase in the heat extract 
has been estimated to be I .98 - 0.68 (n=6 ) pmol min  ^
g  ^ liver during the light period and 0.64 - 0.12 (n=3 ) 
(imol m i n g ^ liver during the dark periods. The re­
action was found to be associated with the parenchymal 
cells. When hepatocytes were isolated between 9 and 
11 a.m., the rate of NADPH oxidatipn was found to be 
2.29 - 0.26 |imol min”^ g”^ cells. In these experiments 
with hepatocytes it was essential to transfer the cells 
from the Krebs-Heni^eit buffer to BTP/HCl (pH 8 .3 , ImM - 
EDTA, O.25M - sucrose) before sonication of the cells, 
in order to obtain significant reaction rates.
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5• Physiological significance of the NADPH-
oxidising system
In an effort to determine the physiological signifi­
cance of the NADPH-oxidising/disulphide reducing reaction 
described in the proceeding chapters, a comparative study 
was carried out. In this study the initial rates of the 
reaction were determined in fed and starved rats; male 
and female rats; in anaesthetized and non-anaesthetized 
rats; and finally, the rates were also measured at 
different times of the day.
a . Comparison of initial rates of NADPH oxidation by
liver extracts from males and females
When animals of similar weight and age (3 months old) 
were compared, it was found that there was no significant 
difference between the initial rate of the reaction in 
liver extracts from males (2.24 - 0.^9 i-imol min  ^ g  ^
liver, n=6 ) and females (2.42 - 0,57 ^mol min  ^ g  ^ liver, 
n=6 ). In this experiment the rats were killed at 2.45 p.m
b . The effect of anaesthetics on the rate of the 
reaction in liver extracts
In this set of experiments, a comparison was made 
between the rates of NADPH oxidation found in liver 
extracts of rats killed with a blow to the head, and those 
anaesthetized with Sagatal or with ether. These rats 
were killed at 2.45 p.m. It was found that there was 
no significant difference between the first group and the 
Sagatal-treated rats (P ^O.lOO). However, a significant 
difference (P > 0 . 0 1  <  O.O2 5 ) was found between the ether-
treated animals (4.20 - 1.52 jimol min g liver, n=6 ) 
and the Sagatal-*ahaesthetized rats (2.46 - 0.4 8 ^mol min ^ 
g~^ liver, n«6 ). Since ether appeared to increase the 
rate of NADPH oxidation, and since this effect could be 
the result of an increase in an NADPH-dependent enzyme or 
reaction not related to the reaction under study, the
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comparisons reported below were performed on Sagatal- 
anaesthetized rats.
c . Demonstration of a diurnal variation of the NADPH-
oxidising activity and the effect of starvation
A diurnal variation was observed in the rates of 
NADPH oxidation catalysed by heat-treated extracts of rat 
liver isolated at various times during the day (Table 
3.29a). It is clear from the table that the initial 
rate of the reaction is higher during daylight hours 
than at night. This difference was found to be 
statistically significant (P O.OO5 ).
The rats used in these experiments were subject to 
a 12h light/12h dark regime, with the dark period start­
ing at 6.00 p.m. Rats are known to be nocturnal feeders 
(Edwards et al., 1972) so that the decreased activity 
observed at 9*00 p.m. may be related to the feeding period 
of these animals and the higher rates found during the day 
may be coincident with the period of fasting.
To test this hypothesis, animals were starved for 
48h, killed at 10.45 a.m., the livers extracted and 
assayed for NADPH oxidising activity (Table 3*30). This 
period of starvation resulted in a 1.8 fold increase in 
the activity (P ^  0.01), confirming the view that the 
diurnal changes observed could be related to feeding and 
fasting.
If the results in Tables 3*29a and 3*3^ are consider­
ed together, it is apparent that there is a 5-fold differ­
ence between the activity observed when the animal is 
feeding (9.00 p.m.) and the activity found in the starved 
rats. This large increase in activity during starvation 
may be related to the high NADPH / NADP* ratio found 
in the livers of starved animals (Greenbaum et al., 1971).
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Table 3.29a : Diurnal variation of the NADPH-oxidising activity
Time of day Total activity Numbers of
(limol min”l g"l) animals
10.45 a.m. 2.91 ± 0.52 6
2.45 p.m. 2.70 ± 0.20 6
9.00 p.m. 1.09 ± 0.28 6 ......
Litter mates of 3 month old female rats were used
in the experiment. The heat extract was obtained 
as in II.B.4d. and assayed for NADPH-oxidising 
activity as in II.B.le. The results are expressed 
as mean ± S.D. and represent the total activity 
per gramme liver. The experiment was repeated three 
times.
Table 3.29b : Statistical analysis of the data in Table 3.29a
Comparison Statistical 
significance (P)
10.45 a.m. and 2.45 p.m. > 0.100 N.S.
10.45 a.m. and 9.00 p.m. < 0.005 S.
2.45 p.m. and 9.00 p.m. < 0.005 S.
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Table 3.30 : The effect of starvation (48h) on the NADPH
oxidising activity
Treatment of the 
animals
Total specific activity 
(limol min"l g“  ^)
48h starved 5.21 ± 0.43
fed 2.89 ± 0.19
Female rats were used in this experiment.
The liver weights were within 1.05g of each 
other. There were 3 animals in each group 
and the experiment was performed twice. The 
results were found to be statistically 
significant (P < 0.005) and the results are 
expressed as mean ± S.D. (n=3).
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The activity measured in the heat extracts reflects 
both the activity of the enzyme and the level of sub­
strate. In order to determine - whether -the <ihang«« -----
observed were the result of differences in enzyme activ­
ity or in substrate content of the liver, the total 
amount of NADPH oxidised in the fed animals was -determined 
in each case (Table 3.3I). This was taken to reflect the 
substrate content of the liver. Although a slight 
decrease in the substrate content was observed at 9*00 p.m. 
(Table 3*31) this was not found to be statistically 
significant. It would therefore appear that the observed 
decrease in the reaction at 9.00 p.m. was the result of 
either an inhibition or a decrease i« the 'quantity of the 
enzyme rather than a change in the substrate content of 
the liver.
In interpreting these results it has been assumed
that the reductase under investigation is saturated with
the substrate both in vivo and in vitro. This assumption
has been based on the comparison of the K of the enzymem
for the substrate and the substrate content of the heat 
extract. Furthermore, addition of excess purified sub­
strate to the heat extract reaction mixture did not 
increase the rate of reaction significantly (results 
not shown).
d . Interpretation of the resu3 ts obtained in
physiological terms
Fig.3.3^ summarizes the conclusions drawn from the 
'Observations made in this study. Firstly, the continual 
oxidation of NADPH with consequent production of NADP 
could conceivably stimulate the PPP dehydrogenases accord­
ing to the *PULL* hypothesis. This would result in -an 
increased production of NADPH , w h i c h  can be utilized by 
pathways such as 1ipogenesis and cholesterogenesis•
However, it is important to realise that the reaction 
under study could also compete with cholesterogenesis
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Table 3.31 : Diurnal variation of the substrate content
of rat liver
Time of day Total NADPH oxidised 
pjnol g”l liver
10.45 a.m. 4.16 ± 1.20
2.45 p.m. 4.08 ± 0.79
9.00 p.m. 3.48 ± 0.64
Litter mates of female rats were used in the 
experiments. The total amount of NADPH 
oxidised was determined for each liver by 
following the change in O.D. at 340nm 
(II.B.le). The results are expressed as the 
mean ± S.D. (n=6). The differences between 
the different times were not statistically 
significant (P > 0.100).
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Lipogenesis
(stimulation NADP— 
of PPP )
PPP > N A D P H
NADPH-oxidising
activity
increased
during
lipogenesis
decreased 
during 
lipogenesis, 
increased in 
the absence 
of lipogenesis
Pig. 3.14: Possible relationship between lipogenesis
and the NADPH-dependent reductase
Fig. 3.34 is a summary of the proposed recycling of NADP*, 
vhich is a stimulator of the pentose phosphate pathway 
dehydrogenases (PPPA ) and the removal of NADPH, which 
is an inhibitor of the P P P A  (Sapag-Hagar et a l . 1970, 
Bonsignore and DeFlora 1972, Eggleston and Krebs 1974, 
Levy, 1979).
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and lipogenesis for NADPH in the normal fed cell and this 
may account for the lower NADPH-oxidising activity observ­
ed during feeding periods when lipogenesis is maximal 
(Kimura et a l ., 1970; Edwards et a l ., 1972; Hems 
et a l.. 1975)* Under these conditions the NADPH-oxidising 
activity was found to be reduced by 50-60)6 of the activity 
found during periods when animals would be expected to be 
fasting. This would suggest that there may be competition 
for NADPH between the reaction under study and lipogenesis 
and cholesterogenesis.
It is clear that the reaction in the present study has 
a diurnal variation pattern which is the reverse of the 
exhibited by lipogenesis and cholesterogenesis.
The enzyme responsible for the oxidation of NADPH in 
fatty acid synthesis is FAS. However, although rates of 
fatty acid synthesis have been shown to vary diurnally, 
being highest during feeding hours, a comparable rhythm 
in assayable FAS activity has not been demonstrated 
(Bruckdorfer et al., 1974). This contrasts with the 
reductase under study, where the enzyme activity appears 
to be inhibited or reduced in some way. In contrast to 
FAS, however, hydroxymethylglutaryl-CoA (HMG-CoA) reduc­
tase, another NADPH-dependent enzyme, responsible for the 
regulation of cholesterogenesis, exhibits a circadian 
(diurnal) rhythm, as does cholesterol biosynthesis itself 
(Edwards et a l ., 1972; Zubay, I983). The peak of 
activity of this enzyme has been shown to be around 
midnight.
The inverse relationship between the times of maximal 
flux through cholesterogenesis and lipogenesis, which are 
probably related to food intake, and pathways of NADPH 
utilization, such as the reaction under study, would 
limit the competition for the NADPH pool of the liver and 
overcome the problems which would be expected to arise as 
a result of excessive oxidation of NADPH and consequent
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disturbance of the NADPH / NADP* ratio. The 
possibility that NADPH content of the liver cell may, 
under conditions of enhanced NADPH oxidation, become a 
limiting factor in lipogenesis has been indicated by 
the work of Thurman and Scholz (1973), who found that 
enhanced mixed-function oxidation inhibits lipogenesis.
The total concentration of NADPH in the rat liver
extramitochondrial compartment has been reported to be
65 nmol g ^ liver wet weight (Sies, 1982). The for
NADPH of FAS is about 50p.M (Volpe and Keshimoto, 1972).
In contrast the K values for NADPH of all the disulphidem
reductases considered in this study are less than 10p,M:
thioredoxin reductase, 2 . glutathione reductase,
7.9liM; the reductase under study, 5^M. This data
suggests that if FAS competed with these enzymes for
NADPH, it would be the least effective. Furthermore
it has been reported that the maximum rate of fatty
-1
acid synthesis in liver is 0.12 p.mol palmitate min
g~^ liver, equivalent to 1.68 ^mol NADPH min ^ g ^
liver, (Holten et al., 1976). By comparison, the
reductase in the present study is capable of oxidising
-1 -1NADPH at a maximal rate of about 2 ^mol min g 
liver. These considerations would explain why it 
would be favourable to inhibit the disulphide 
reductase during periods of active lipogenesis.
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IV. GENERAL DISCUSSION AND CONCLUSION
\
\
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The original aim of the thesis was to establish a 
link between the regulation of glycolysis and of lipo­
genesis by examining the effect of F 2 ,6P^ on some lipo- 
genic enzymes. From a consideration of the literature 
one would expect conditions in which there are high rates 
of lipogenesis to be associated with high F2,6P^ levels.
It is known, for example, that glucose, at high concentrât 
ions, increases F2,6P^ (Van Schaftingen et a l ., 1980a,b,c 
and 1981a ,b ,c ) and can also stimulate fatty acid synthesis 
independently of its role as a carbon source (Salmon et 
al., 1974). On the other hand, glucagon lowers F2,6P^ 
and is a potent inhibitor of lipogenesis (Bartrons et a l ., 
1983; Wakil et al., I983).
Hence the possibility exists that F2,6P^ may have a 
role in the co-ordinated regulation of lipogenesis and 
glycolysis. However, in the course of this work no 
physiologically relevant activation or inhibition of some 
of the key lipogenic enzymes by this metabolite was 
demonstrated. In fact, there are no reports in the 
literature which claim any regulatory role for F2,6P^ 
other than in the control of the F6P/F1,6P2 substrate 
cycle. The enzymes investigated in this study were FAS, 
6PGDH and G6PDH.
In the course of the investigation of the possible 
effects of F 2 ,6P^ on the PPP dehydrogenases, it was 
found that there was an NADPH-consuming reaction, which 
was catalysed by a cytoplasmic liver enzyme and involved 
a cystine-containing peptide substrate, which was also 
found associated with the same cellular compartment.
A comparison of the substrate with other peptides 
which are known to be reduced by NADPH-dependent re­
ductases revealed properties which distinguished it 
from oxidised glutathione, cystine, thioredoxin and 
glutaredoxin. These properties include a high cystine
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content relative to other amino acids in the substrate 
molecule, the acidic nature of the peptide as determined 
by its behaviour on ion-exchange chromatography, its 
phosphate content, and, finally, the apparently high 
cellular content of the oxidised form.
It is not readily apparent why the peptide under 
study exists in the oxidised form in the cell since it is 
readily converted to the reduced form in vitro by the 
enzyme isolated in the present study. Various possibili 
ties could account for this phenomenon. It is possible, 
for instance, that the substrate, the reductase and the 
NADPH are compartmentalized in such a way as to prevent 
the reduction of the substrate. A second possibility is 
that NADPH-dependent reduction of the substrate is exten­
sively inhibited in vivo by a high molecular weight 
component which is removed either by heating or by ultra­
filtration. Alternatively, it is possible that the pep­
tide exists in the reduced form in vivo but becomes oxi­
dised during the extraction procedure. It would be 
instructive to explore the latter possibility.
The physiological role of the peptide substrate and 
the reductase described in this thesis remains a problem. 
It is known that there is a high level of disulphide 
residues associated with rat liver cytosol. preparations 
of which oxidised glutathione content represents only a 
small fraction (Isaacs and Binkley, 1977)» The remain­
der is assumed to be mixed disulphides of glutathione 
with proteins and disulphide residues within proteins. 
This thesis does show, however, that a significant 
proportion of the disulphide residues may in fact be 
associated with an acidic peptide. At this point it is 
worth noting that the existence of protein-GSH mixed 
disulphides in the cell, to the extent reported in the 
literature has been questioned (Meister and Anderson, 
1983). It has been suggested that they may be artifacts 
of the isolation procedures.
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The diurnal variation and the effects of feeding and 
fasting reported in this thesis, of the NADPH-oxidising 
activity in crude extracts indicates a possible physio­
logical role for the NADPH-dependent disulphide reductase 
Although the specificity of the enzyme under study with 
respect to disulphides is unknown and the possibility of 
other substrates being present in the crude extracts 
remains, it is tempting to speculate that this diurnal 
variation may be related to the regulation of other 
hepatic phenomenon known to exhibit such variations- It 
is well known that lipogenesis, cholesterogenesis and 
G6PDH activity undergo diurnal changes. Furthermore, 
these changes are inversely related to the change found 
for the reductase activity in the present study. The 
latter activity is also inversely related to changes in 
the total -SS- / SH ratio in rat liver extracts 
(Isaacs and Binkley, 1977).
It is possible that regulation of these cellular 
processes could be related to changes in the NADPH / 
NADP* and the -SS- / -SH ratios in the hepatic 
cytoplasm. For example it has been reported that G6PDH 
is inactivated by a disulphide-dependent microsomal 
factor which may have a role in the degradation of the 
enzyme (Francis and Ballard, 1980a,b). It would be of 
interest to investigate the possible effects of the pep­
tide under study on various key regulatory enzymes, the 
activities of which may be regulated by covalent modifica­
tion with such a peptide.
It is generally recognised that G6PDH is a key rate- 
limiting enzyme in the PPP; yet a consideration of its 
kinetic properties suggests that the enzyme should be 
extensively inhibited in the presence of the NADPH / 
NADP* ratios reported to occur in the cytoplasm. One
aim of this thesis was to attempt to demonstrate the 
possible de-inhibition of the enzyme under certain 
physiological conditions. Eggleston and Krebs (1974) 
reported that GSSG and a low molecular weight cofactor
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relieved the NADPH inhibition of G6PDH in crude liver
extracts. In agreement with Levy and Christoff (I983)
it was found in this study that the effect was the result
2 +of an artefact caused by the addition of Zn to the assay 
mixture to inhibit GSSG reductase. It has also become 
apparent that the apparent inhibition by GSSG of G6PDH 
reported by Eggleston and Krebs (1974) can be attributed 
to GSSG reductase activity. These observations high­
light the problems of using relatively crude extracts to 
examine the effect of physiologically important regulators 
on enzyme activities. On the other hand, the use of 
purified preparations can also give misleading results.
It is, nevertheless, important to show that effects 
observed with crude preparations can also be shown with 
a re-combined system with purified components.
In addition to the de-inhibition of G6PDH by 
metabolites an alternative method of de-inhibition - the 
so called 'PULL* hypothesis should be considered. This 
hypothesis states that the removal of NADPH (and the 
consequent regeneration of NADP*, the most effective 
known positive effector of G6PDH) is a pre-requisite for 
the activation of the PPP dehydrogenases. It is clear 
that the NADPH-dependent reduction of the disulphide 
substrate described in this thesis could have such a role. 
The diurnal variation in the reductase activity which is 
inversely correlated to that of lipogenesis and cholestero­
genesis may be significant in this respect. It is 
possible that there is competition between FAS and the 
disulphide reductase for the cytoplasmic NADPH. A 
situation such as this would explain the apparent 
inhibition of the disulphide reductase activity during 
periods associated with high lipogenic rates.
Evidence for the 'PULL' hypothesis has accumulated 
in recent years. Yeh et al. (1984) have presented 
evidence correlating the regulation of erythrocyte G6PDH 
activity and NADPH-dependent pyrroline-5-carboxylate
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reductase. Treatment of the normal erythrocyte with 
pyrroline 5 -carboxylate causes a six-fold increase in 
the flux through the PPP. Under the same conditions 
5 -phosphoribosyl 1-pyrophosphate formation increased 2.5- 
fold, and the incorporation of hypoxanthine into inosine 
monophosphate increased 2.6-fold. In contrast, pyrroline 
5 -carboxylate had no effect on G6PDH-deficient erythrocytes. 
Hence, Yeh et a l . (1984) have proposed that pyrroline 5- 
carboxylate is converted to proline by the reductase with 
concomitant production of NADP* which, in turn, augments 
G6PDH activity with an increased production of ribose 5 - 
phosphate.
Similarly, May (1981) has suggested that under 
conditions where GSH is oxidised, increased glutathione 
reductase activity, in adipose tissue, parallels increased 
flux through the PPP dehydrogenases. Elsayed et al. (I982) 
have also shown that oxidant stress (such as exposure to 
o%one) increases glutathione reductase, G6PDH and 6PGDH 
activities in the presence of selenium in mouse lung.
Further evidence for the regulation of the PPP dehydro­
genases by alterations in the NADPH / NADP* ratio, in 
rat liver, has come from the work of Fabregat et al . (I985) 
who have shown that inhibition of fatty acid synthesis with 
kynurenate results in an inhibition of the PPP and an 
increase in the NADPH / NADP* ratio. This implies
that the activity of the PPP is dependent on an active 
fatty acid synthesizing (NADPH utilizing) system.
Conversely, the authors have shown that incubation of 
hepatocytes with ter - butyl - hydroperoxide or paraquat 
compounds, which are metabolized via NADPH-consuming path­
ways, activate the PPP and decrease the NADPH / NADP 
ratio.
These observations strongly support the view that the 
PPP dehydrogenases are regulated by factors which alter 
the NADPH / NADP* ratio, and provides further evidence
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for the 'PULL* hypothesis. This does not, however, 
exclude other mechanisms of regulation such as that pro­
posed by Eggleston and Krebs (197^'). Furthermore it is 
possible that G6PDH and 6PGDH are not as sensitive to 
NADPH inhibition in vivo as they are in vitro. Enzyme 
concentrations are generally much higher in vivo than under 
in vitro assay conditions, a fact that could significantly 
affect the regulatory behaviour of an enzyme. Thus in 
vitro assay conditions may not reveal the true regulatory 
properties of the enzyme in vivo.
In the light of the recent evidence presented by 
Martins et al. (1985), which suggests that individual
multiple molecular forms of G6PDH may respond differently 
to hormonal factors, it would be instructive to determine 
the response of the different multiple molecular forms of 
G6PDH to NADPH / NADP* ratios.
In conclusion, the available evidence suggests that 
the activity of the PPP dehydrogenases is primarily 
determined by changes in the NADPH / NADP ratio. 
These changes can be effected by a variety of conditions 
and in particular by NADPH utilizing reactions.
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